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Abstract 
Taste perception plays a key role influencing human dietary behaviour and 
further health consequences. It has been shown that genetic and neurological 
factors contribute to variation in taste, but their underlying mechanisms remain 
largely underexplored. For example, it is unclear how much of the variance in sweet 
taste is due to genetics, whether the association between sweet and bitter tastes is 
due to genetic covariance, and whether variation in brain structure is associated with 
taste. The goal of this work is to extend current knowledge in individual differences in 
human taste perception of sweetness and bitterness by showing their relationships 
with genes, dietary behaviour, and brain morphology. We perform quantitative and 
statistical genetic analyses using an extensively phenotyped and genotyped twin 
sample of Australian adolescents (n = 1999), with replication and extension making 
use of two publically available datasets from the Human Connectome Project (HCP; 
n = 1101) and the UK Biobank (N = 438,870). 
In Chapter 1, we employed structural equation modelling (variance 
components analysis) to provide the first evidence that approximately 30% of 
variation in the perceived intensity of sweet compounds, including sugars (i.e. 
glucose and fructose) and high-potency sweeteners (i.e. aspartame and 
neohesperidin dihydrochalcone) is due to genetics. Furthermore, we identified a 
common genetic factor accounting for more than 75% of the genetic variance in the 
perception for each of these sweet compounds, suggesting that the perception of 
both sugars and high-potency sweeteners was regulated by a common set of genes.  
In Chapter 2, we demonstrated that a quarter of the genetic variance in 
perceived sweetness (i.e. a weighted mean score of the four sweet tastes from 
Chapter 1) is shared with at least half of the genetic variance in the perceived 
bitterness of quinine, sucrose octaacetate (SOA), and caffeine. The genetic 
association between sweetness and the bitterness of propylthiouracil (PROP) 
becomes evident after adjusting for the TAS2R38 genotype. These results reveal 
shared genetic pathways for the human perception of sweetness and bitterness. 
To pinpoint the source of genetic variation in bitter taste, in Chapter 3, we 
performed a genome-wide association analysis (GWAS). As previous work was 
underpowered to detect variants with small effects, we used a bivariate approach to 
boost power. We identified two putative novel variants with small effects (< 2%) on 
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chromosomes 7 and 12 for the perceived intensity of denatonium benzoate (DB) and 
SOA, respectively. We provided the first independent replication for the caffeine 
bitterness on chromosome 12 and confirmed the previously identified variants on 
chromosomes 7 and 12 for PROP and quinine, respectively. Building on the common 
source of genetic variances identified in Chapter 2, we showed evidence for 
pleiotropy that each of the three variants (for quinine, caffeine, and SOA) on 
chromosome 12 is associated with more than one of the bitter tastes (quinine, SOA, 
caffeine, and DB). These findings offer a useful starting point for determining the 
biological pathways linking perception of bitter substances. 
We investigated the effect of taste perception on diet-related outcomes. 
Although previous findings of the association between bitter taste perception and 
bitter beverage intake were inconsistent, we used two-sample Mendelian 
randomization (Chapter 4) to demonstrate a causal relationship between the 
perceived bitterness of PROP, quinine, and caffeine and the consumption of coffee, 
tea, and alcohol among UK Biobank participants. In Chapter 5, our longitudinal 
analyses showed that the perceived sweetness in adolescence is a predictor for 
body mass index (BMI) in early adulthood. We also showed that this association is 
partly due to genetics using structural equation modelling and polygenic risk 
prediction approaches. 
In Chapter 6, we conducted an exploratory analysis to examine the 
associations between the volumes of 84 brain regions of interest (ROI) and the 
perceived sweetness and bitterness (PROP, quinine, caffeine). The volumes of 5 
ROIs (right cuneus gyrus, right inferior temporal gyrus, left transverse temporal gyrus, 
and left and right caudates) were nominally associated with both sweet and bitter 
tastes. Additionally, we replicated an association between quinine bitterness and the 
volume of left entorhinal gyrus using data from HCP. This study provides the first 
evidence for an association between brain morphology and taste intensity ratings. 
 In conclusion, we used structural equation modelling to show that sweet taste 
is heritable and the association between sweet and bitter tastes is largely due to 
genetic covariance. Additionally, bivariate GWAS identified variants with small 
effects on bitter tastes and revealed their pleiotropy. Furthermore, results from 
Mendelian randomization and longitudinal analyses evidence the potential causal 
impact of taste on dietary behaviour and BMI. These findings enhance our 
understanding in the genetic architecture of taste and shed light on the personalized 
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nutrition and medicine. Lastly, we showed that the volume of specific brain regions is 
associated with taste perception, which provides new insights into the gustatory 
network and suggests a potential role of brain structure in taste. 
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Introduction 
Taste perception has a significant impact on our daily lives. It contributes to 
our enjoyment by stimulating a desire to eat [1], and hence plays an essential role in 
nutrition and food selection [2]. Taste is also a natural defence that prevents food 
poisoning by warning against spoiled foods and potential toxic compounds [3]. 
However, not everyone has the same ability to taste [4] and such differences have 
various impacts on dietary behaviour and health consequences. For example, 
people with lower taste sensitivity are more susceptible to certain diseases, including 
obesity [5], diabetes [6], and hypertension [7], presumably because they need to 
consume more salt, sugar, or fat to achieve the same level of taste sensation and 
satisfaction. In contrast, people with a stronger taste sensitivity can find certain 
vegetables, such as cabbage and Brussels sprouts, more bitter and less preferable 
[8-10], and this in turn decreases their vegetable intake [11, 12]. 
There have been many studies on individual differences in taste from various 
perspectives, including age, gender, and cultural background. Taste perception 
changes overtime as we age. In general, taste sensitivity peaks at late childhood [13], 
and then it declines gradually and the slope becomes flatter when reaching late 
adulthood [14]. Taste perception also differs by sex. For example, girls are more 
sensitive to sweetness, bitterness, sourness and saltiness than boys [13, 15] 
because females enter puberty at earlier ages and a more developed hormonal 
system better shapes their sensory network [16]. Women are more sensitive to 
certain bitter compounds than men [17] because women have denser taste buds and 
papillae on the tongue [18], which directly reflect on the ability to taste [19]. In 
addition, taste perception and preference shift dramatically during pregnancy due to 
changes in the production of sex hormone [20]. Whereas how we taste can influence 
what we eat, a reverse relationship has also been observed. Low-sugar diet for 2-3 
months increases the perceived sweetness of the same food [21], and low-salt diet 
also increases the perceived intensity of salt [22]. Different ethnicities and cultural 
backgrounds also contribute to differences in taste perception and preference, such 
that Taiwanese people have stronger preferences for the taste of sucrose and 
monosodium glutamate (MSG) than Japanese and Australian people [23], and non-
Hispanic whites generally have a stronger perceived intensity than Hispanics and 
African-Americans [24].  
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Ability to taste can be largely changed by disease status and medical 
treatments. For example, middle ear infection (otitis media) and radiotherapy on 
head and neck damage the taste nerves (the chorda tympani nerve [CN VII] and the 
glossopharyngeal nerve [CN IX]) that convey taste signals from the tongue and oral 
cavity to the brain and hence modify the taste sensations [25]. Alterations in taste 
perception also result from brain damages [26, 27] and neurological disorders, such 
as Alzheimer's disease [28], Parkinson’s disease [29], or multiple sclerosis [30]. 
Rise of taste genetics 
Studies on the taste genetics arose from a lab accident in early 1930 when 
Arthur L. Fox accidentally spilled the powder of a chemical phenylthiocarbamide 
(PTC) into the air. Some lab members complained about its bitterness, but Fox 
himself could not taste it [31]. Follow-up studies showed that the ability to perceive 
PTC was a Mendelian recessive trait, with approximately one-third of individuals 
finding it tasteless [32, 33]. This finding spurred hundreds of studies around the 
world to investigate the genetics of PTC perception and how it related to dietary 
behaviour [34] and diseases [17]. In early 2000, association [35] and linkage [36] 
analyses mapped the ability to perceive PTC to a locus on chromosome 7 and 
showed that the haplotype of three single nucleotide polymorphisms (SNP) within a 
specific bitter taste receptor gene TAS2R38 accounts for 55% to 85% of the variance, 
subsequently replicated by others [37, 38]. However, even with a successful story of 
this discovery [39], the genetic pathways and molecular mechanisms underlying 
human taste perception remain largely underexplored. 
Twin and family studies 
Genetic effects on taste have been investigated using twin and family study 
design, taking the advantage of the genetic relationship between family members. 
Sensitivity to PTC and its structurally related chemical propylthiouracil (PROP) is 
largely genetically predisposed (heritability [h2] = 0.64 – 0.72) [40, 41] and the 
perception of other bitter compounds, such quinine, caffeine and sucrose 
octaacetate (SOA), are estimated to be less heritable (h2 = 0.28 – 0.34) using the 
same sample [40]. As for other basic taste qualities, sourness is moderately heritable 
(h2 = 0.53) [42] and saltiness is largely due to shared environmental effects (e.g. 
parenting effects on siblings) [42, 43]. No attempt on estimating the heritability of the 
umami taste (e.g. savoury or meaty taste) has been made, but preferences for meat 
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and fish are moderately heritable (h2 = 0.39 – 0.44) [44, 45]. Regarding sweetness, 
genetic influences on preferences for the sucrose solution and sweet foods range 
from low [41, 44] to moderate [43] (h2 = 0.23 – 0.40); however, the degree of genetic 
influences on the perceived intensity of sweet taste remains unclear [41, 43], which 
is likely due to lack of statistical power in these studies (n < 700) and sweet intensity 
ratings being a less stable phenotype compared with sweet preference [41].  
In Chapter 1, using the largest-to-date twin sample with multiple taste 
phenotypes (n ~ 2000), we perform structural equation modelling (variance 
components analysis) to estimate the heritability of the perceived intensity of two 
sugars (i.e. glucose and fructose) and two high-potency sweeteners (i.e. aspartame 
[200 times sweeter than sucrose] and neoherperidine dyhydrochalcone [NHDC; 
1500-1800 times sweeter than sucrose]), which are commonly used in sugar-
free/low-calorie food and beverages nowadays. As the perception of both sweetness 
and bitterness replies on G protein-coupled receptors (GPCR), in Chapter 2, we 
further investigate whether the association between the perceived sweetness and 
bitterness is due to genetic covariances, which would provide a hint of whether 
genetic effects on sweet and bitter taste is at the receptor (peripheral) level. 
Genome-wide association study 
Genome-wide association studies (GWAS) have been a common approach 
for the identification of genetic variants associated with a trait [46], which helps in 
understanding molecular mechanisms and constructing biological pathways. 
However, since the discovery of the locus within TAS2R38 for PROP perception, 
only two successful GWAS on taste (i.e. the identification of variants within the 
cluster of bitter taste receptor genes on chromosome 12 for quinine bitterness [37] 
and caffeine bitterness [38]) have been published. 
As taste perception, except for PROP bitterness, can be highly polygenic (i.e. 
the total genetic variance is attributed to multiple independent variants with small 
effects rather than one variant with a large effect), it requires a large sample with 
great power to detect associated variants. In Chapter 3, we perform a GWAS on the 
perception of 5 bitter substances (PROP, quinine, SOA, caffeine, and denatonium 
benzoate [DB]) using the same cohort for the discovery of quinine locus [37] with a 
40% increase in sample size. With the exclusion of PROP, these bitter taste 
phenotypes are highly correlated at both the phenotypic and genetic level (Chapter 
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2). This enables us to use a series of bivariate analyses to further boost power [47] 
and reveal previously unidentified variants with small effects (< 5%).  
Influence of taste perception on diet and health 
Taste perception is believed have an impact on health because of its 
influence on food preference [2], which affects what we eat and further reflects on 
health [48, 49]. However, the relationship among taste perception, preference, 
dietary behaviour, and health is complex and inconclusive. For example, findings of 
the association between perceived bitterness and the intake of bitter beverages, 
such as coffee, tea, and alcohol [50-57], are limited and inconsistent. Similarly, 
whether perceived sweetness is associated with BMI has not reach an agreement 
across studies [5, 13, 58-60]. Possible reasons include that the effect of taste is 
accumulative so it takes time to reflect on dietary behaviour and health, and hence a 
relationship cannot be seen in cross-sectional studies. Moreover, these 
investigations were likely limited by small sample sizes. To overcome these 
obstacles, in Chapter 4, we use Mendelian randomization to assess the causal 
association between the perceived bitterness of PROP, quinine, and caffeine and the 
consumption of coffee, tea, and alcohol in the large UK Biobank cohort (N = 
438,870). In Chapter 5, we conduct a longitudinal analysis to investigate the 
relationship between perceived sweetness and BMI measured at the same time and 
BMI measure 9 years later. We further examine their genetic associations using 
variance components analysis and polygenic risk prediction, which could reveal 
underlying molecular mechanisms. 
Gustatory areas in the brain 
Studies on peripheral receptors have been a focus of taste research, but the 
brain also plays a significant role. When we eat, food chemicals are detected by 
taste receptors in the oral cavity and signals are sent via gustatory nerves to the 
brain where taste sensation is generated so we know what we eat and whether we 
like it or not [61]. Positron emission tomography (PET) and functional magnetic 
resonance imaging (fMRI) studies have identified areas in the human brain that both 
respond to taste and are homologous to those found in other primates [62]. However, 
activation patterns of these taste-responsive regions have been inconsistent across 
studies [63, 64], and such variation may be due to different taste stimuli used or 
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tasks performed, as the brain response can be valence-specific [65] or intensity-
specific [66], or, more importantly, small sample sizes (n < 100).  
Structural variations of specific brain regions are related to human senses, 
such as olfaction [67] and vision [68], and recent evidence suggests that volumetric 
differences also associate with taste perception [69, 70]. People with eating 
disorders, e.g. anorexia nervosa, had larger left gyrus rectus grey matter, and there 
was an association between its size and the sucrose pleasantness among both 
patients and healthy individuals [69, 70]. Furthermore, structural alterations (e.g. 
removing parts of the brain) can modify perceived intensity of taste [71]. In Chapter 
6, we conduct an exploratory analysis to examine the association between the 
volume of brain regions and the perceived intensities of sweet and bitter tastes. The 
findings would provide a clue to whether structural variation of specific brain regions 
modifies taste and help delineate the human gustatory circuit. 
Datasets and statistical analyses 
This work employed a dataset of approximately 2000 Australian adolescent 
twins and siblings with taste phenotypes and genotypes. Participants were recruited 
as a part of the Brisbane Adolescent Twin Study (BATS) [72], also known as the 
Brisbane Longitudinal Twin Study (BLTS). Taste tests were conducted between 
2003 and 2014, in which participants tasted 4 sweet (glucose, fructose, aspartame, 
and NHDC) and 5 (PROP, quinine, caffeine, SOA, and DB) bitter substances and 
rated their perceived intensities on a general Labelled Magnitude Scale (gLMS) [73]. 
Approximately a third of the sample later participated in the Queensland Twin 
IMaging (QTIM) study and were MRI scanned. 
The twin characteristics (monozygotic [MZ] twins shared 100% of their genetic 
profiles and dizygotic [DZ] twins on average shared 50%) allow the use of structural 
equation modelling (variance components modelling [74]). This method partitions the 
total phenotypic variance of a trait or the phenotypic covariance between traits into 
genetic (i.e. heritability of a trait or genetic covariance between traits) and 
environmental components (Chapters 1, 2, and 5).  
Genotype data allow the use of GWAS to identify genetic variants associated 
with individual differences in taste perception (Chapter 3). We use the software tool 
GEMMA [75, 76] for GWAS because it controls genetic relationship between 
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individuals and runs, in addition to the conventional univariate analysis, multivariate 
analyses to boost statistical power.  
Genetic variants identified in GWAS are used as instrumental variables (i.e. 
genetic proxies of associated phenotypes) in Mendelian randomization [77] to 
assess causal relationships between taste perception and beverage intake (Chapter 
4). The beverage intake data on coffee, tea, and alcohol were obtained from a large 
genetically informative cohort comprising approximately 500,000 volunteers from the 
United Kingdom (UK Biobank) [78]. 
We take the publically available GWAS summary of BMI [79] to calculate 
polygenic risk score of BMI in our twin sample to examine its genetic relationship 
with taste (Chapter 5). This approach borrows the power from the large cohort of the 
GWAS on BMI (N = 322,154) and the outcomes can compensate the results from 
variance component modelling.  
We conduct mixed-effect linear analyses to examine the association between 
taste and brain phenotypes (Chapter 6). This method controls individual relatedness 
between family members and is used as an alternative of twin modelling (structural 
equation modelling). For replication, we use data from the Human Connectome 
Project (HCP), which includes 1101 participants with taste data on quinine 
perception and brain MRI images [80]. 
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Abstract  
The perception of sweetness varies among individuals but the sources of this 
variation are not fully understood. Here, in a sample of 1901 adolescent and young 
adults (53.8% female; 243 MZ and 452 DZ twin pairs, 511 unpaired individuals; 
mean age 16.2 ± 2.8, range 12 – 26 years), we studied the variation in the 
perception of sweetness intensity of two monosaccharides and two high-potency 
sweeteners: glucose, fructose, neohesperidine dihydrochalcone, and aspartame. 
Perceived intensity for all sweeteners decreased with age (2% – 5% per year) and 
increased with the history of otitis media (6% – 9%). Males rated aspartame slightly 
stronger than females (7%). We found similar heritabilities for sugars (glucose: h2 = 
0.31, fructose: h2 = 0.34) and high-potency sweeteners (neoherperidine 
dyhydrochalcone: h2 = 0.31, aspartame: h2 = 0.30); all were in the modest range. 
Multivariate modelling showed that a common genetic factor accounted for > 75% of 
the genetic variance in the four sweeteners, suggesting that individual differences in 
perceived sweet intensity, which are partly due to genetic factors, may be attributed 
to a single set of genes. This study provided evidence of the shared genetic 
pathways between the perception of sugars and high-potency sweeteners. 
Introduction  
The perception of sweet taste varies among individuals [4]. Discovery of 
genetic variants in the sweet taste genes TAS1R3 and GNAT3 and their relationship 
with sucrose perception establish a role of inborn variation on sweet taste [82-86]. 
Yet, a firm understanding of the molecular-genetic basis of human sweet perception 
remains undetermined.  
New data from model organisms (i.e. mice) indicate there may be a second 
system to sense sweetness [87], in addition to T1R3 and gustducin (protein products 
of TAS1R3 and GNAT3). This second system is sensitive to caloric sugars but not 
high-potency sweeteners [87]. In humans, genetic studies of sucrose perception, 
including perceived intensity, pleasantness, and preferred concentration, have 
suggested a heritability ranging from 0.14 to 0.55 [41, 82, 88-90].  However, there 
are no heritability estimates for high-potency sweeteners in humans and the degree 
to which sugars and high-potency sweeteners share molecular mechanisms of sweet 
taste transduction is not fully understood. 
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Here, in a large adolescent and young adult twin sample (695 complete twin 
pairs), we estimated the heritability of perceived intensity for four sweeteners. These 
included two commonly occurring natural saccharides, glucose and fructose (found 
in fruits and vegetables), and two high-potency sweeteners, aspartame and 
neohesperidine dihydrochalcone (NHDC). Using multivariate genetic modelling we 
examined the extent that any association between the four sweeteners was due to 
common environmental or genetic factors. Further, this modelling allowed us to 
investigate whether any of the genetic variance in the high-potency sweeteners 
could be attributed to a distinct set of genetic factors, separate to that for natural 
sugars. 
Materials and Methods 
Participants 
Participants were adolescent and young adult twins and their singleton 
siblings from the Brisbane Adolescent twin study [72] who have participated in 
previous studies of the genetics of melanoma risk factors [91, 92], and cognition [93, 
94]. Taste data reported here were collected between August 2002 and July 2014. 
The sample comprised 1175 females and 1013 males (mean age 16.2 ± 2.8 years, 
range 12 to 26 years) from 1052 families, including 316 MZ and 586 DZ complete 
twin pairs, and 384 singletons (non-twin siblings and unpaired twins) (Table 1-1). 
This includes all participants from a previous study of bitter perception [40], with a 
150% increase in sample size. Zygosity for 92% of the same-sex twins was 
determined from genotyping (Illumina 610K SNP array) and the remainder by self-
report confirmed by study nurses. Participants (or their parents if under 18 years of 
age) gave written consent to participate in the study which was approved by the 
Queensland Institute of Medical Research Human Research Ethics Committee.  
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Table 1-1. Number of families before and after data screening. 
Family Type Initial After screening a 
MZ twin pairs 234 189 
MZ twin pairs + sibling(s) b 82 54 
DZ twin pairs 491 380 
DZ twin pairs + sibling(s) b 95 72 
Non-twin singletons/unpaired twins 150    320 c 
a Participants were excluded if they scored water as moderate or higher taste (> 20mm on LMS), had large 
differences between presentation one and two and had overly high or low total average scores [40].   
b Families with a twin pair and one or two siblings.   
c The number of non-twin singletons/unpaired twins increases after cleaning as some twin pair families lose one 
twin during the screening procedure. 
 
Taste Test 
As described previously, the taste test included both bitter and sweet stimuli 
[40]. Briefly, it included duplicate presentations of 10 different solutions, of which five 
were bitter (propylthiouracil (PROP), sucrose octaacetate (SOA), quinine HCl, 
caffeine, and denatonium benzoate), four were sweet (described below) and one 
was neutral (i.e. water). The four sweet solutions included the two natural sugars, 
0.60 M glucose, 0.30 M fructose, and two high-potency sweeteners, 8.0 x 10-5 M 
neohesperidine dihydrochalcone (NHDC) and 1.4 x 10-3 M aspartame. Each solution 
and the water control were presented twice (i.e. a total of 20 solutions) in colour 
coded 2mL polypropylene microcentrifuge tubes with flip tops. The first ten tubes 
contained one presentation of each compound plus the water control and the next 
ten contained the same solutions in a different order, but the order of all twenty tubes 
was the same for all participants (SOA, water, caffeine, glucose, quinine HCl, 
fructose, NHDC, PROP, aspartame, denatonium benzoate/ fructose, glucose, PROP, 
aspartame, quinine HCl, NHDC, caffeine, water, SOA, and denatonium benzoate). 
Participants were instructed to: 1) open the tube, swish the solution around in the 
mouth for five seconds and spit out, 2) rate the perceived intensity of the solution, 3) 
rate the quality of the taste, 4) rinse the mouth out four times with tap water and, 5) 
repeat steps 1 to 4 for each tube. Perceived intensity was rated on a general labelled 
magnitude scale (LMS) [73] with labels of no sensation (0mm), barely detectable 
(2mm), weak (7mm), moderate (20mm), strong (40mm), very strong (61mm) and 
strongest imaginable (114mm). This scale minimises ceiling effects and provides a 
continuous measure that is desirable for quantitative analysis.  
In addition, participants and/or a parent answered questions relating to a 
previous head injury and otitis media (middle ear infection), which are two common 
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factors relating to the change in taste perception as they damage the signal 
transduction from the mouth to the brain [60, 95, 96]. History of head injury was 
coded as: 1) Never suffered from a head injury; 2) Yes, but not serious; 3) Yes, had 
either a concussion or loss of consciousness; 4) Yes, both concussion and loss of 
consciousness. History of otitis media was coded as: 0) Never suffered from middle 
ear infection; 1) Yes, had suffered from middle ear infection. 27% and 46% of 
participants had suffered from head injury and otitis media respectively. The taste 
test took 30 – 45 minutes, while total testing time for all components of the study was 
approximately two and a half hours. 
Before March 2004, the taste test was self-administered as part of a mail and 
phone study. Test tubes were embedded in an inch-wide polyethylene sheet, rolled 
up into a padded post bag, and mailed to participants via regular post. The mail pack 
included both detailed written instructions and a summary sheet of the key points 
that participants could refer to while completing the test.  Participants were instructed 
not to complete the taste test if suffering from a cold or flu until they had completely 
recovered, and not to eat or smoke, and drink only water for at least one hour before 
the test. Approximately 40% of the data were collected via mail and the rest were 
collected during participants’ visits at QIMR Berghofer Medical Research Institute.  
Data Screening 
Prior to analysis, the data were screened for outliers [40]. Briefly, participants 
were removed if they 1) rated water stronger than moderate (mean score of first and 
second presentation > 20mm), 2) had a low (< 200mm) or high (> 1800mm) total 
score across all 18 taste stimuli or 3) if there was a large discrepancy (> 80mm) 
between ratings for the first and second presentations. This excluded 13% of the 
sample, with the final sample comprising 243 MZ and 452 DZ twin pairs and their 
siblings, and 320 families of unpaired individuals (mean age of 16.2 ± 2.8 years; 
1023 females, 878 males) (Table 1-1).  
Statistical Analyses 
Since intensity scores for all sweeteners were positively skewed, a square 
root transformation was performed to approximate normal distributions. To establish 
regularity in sampling and measurement, and to check assumptions of the twin 
design, homogeneity of means and variances for birth order and zygosity were 
tested using the statistical package Mx which utilises maximum likelihood (ML) 
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estimation procedures [74]. Outlying families were detected by using the %p option 
in Mx that uses the Mahalanobis distance to identify families having excessive 
similarities or differences relative to other families in the sample and model 
expectation. As removal of outlying families (1 to 3 families for fructose, NHDC, and 
aspartame) did not change any of the estimates, these families were included in all 
analyses. Covariates (sex, age, history of otitis media and head injury) were tested 
for significance in fixed effects mean models (regressions and deviations from the 
mean). Models were assessed by comparing double the negative log-likelihood 
between nested models, as this difference is distributed asymptotically as a 2, which 
is used to decide whether a model is a significant worse fit than its predecessor.    
Variance components modelling partitions the variation of a trait into genetic 
and environmental sources by taking advantage of the differences in genetic 
relatedness between MZ (share all genes) and DZ (share half of genes) pairs.  
These known differences allow the estimation of additive genetic (A), non-additive 
genetic (D), common environment (C) and unique environment (E, includes 
experimental error) parameters in a variance components model.  Because twins in 
this sample were reared together, the C and D parameters are negatively 
confounded and as such, cannot be simultaneously estimated [97].  However, if the 
MZ twin correlation is more than double the DZ twin correlation it is indicative that 
non-additive genetic influences (including dominance and epistasis) are most 
important, whereas if the MZ twin correlation is less than double the DZ twin 
correlation, common environment is likely to be more important.  
As there were two measurements for each compound, their differences were 
tested in univariate models and the phenotypic variation was further partitioned into a 
test unreliability (U) component using a repeated measures model in which two 
presentations were treated as observations of one underlying score by constraining 
the two presentations to be equal. All variance components (A, C, and E) were then 
constrained to affect each presentation variable equally as both are imperfect 
measures of the true underlying phenotype. Test unreliability (U) was then estimated 
from the variance not contributed by A, C, and E.  
As perceived taste intensities of the sweeteners were moderately correlated, 
we specified a multivariate model including all four compounds, utilising the 
additional information gained from the cross-trait correlations to estimate common 
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sources of variation between these traits. Three out of four MZ twin correlations were 
lower than double the DZ twin correlations so a Cholesky decomposition of A, C, and 
E factors was used as a starting point, with covariates modelled as regressions or 
deviation effects on the mean. Alternative models of independent pathways and 
common pathways were also assessed to examine whether there were specific 
genetic components for all four variables. The best model fit was determined by 
Akaike’s Information Criterion (AIC) that penalizes models for increasing complexity 
and can be used with non-nested models [98].    
Results 
The mean perceived intensities of all four sweeteners were between moderate and 
strong (Table 1-2). There is 5% to 15% difference between first and second 
presentations for each sweetener. Head injury had no significant effect on any 
phenotype while age, sex, and otitis media significantly (p < 0.05) influenced some 
measures (Table 1-2). Between the ages of 12 and 26, perceived intensities of all 
four sweeteners decreased with age (2% to 5% per year). For example, a 14-year-
old participant would rate the glucose solution 6.4 higher than a 24-year-old 
participant. Males rated aspartame 7% more intense than females (27.6 versus 25.7, 
p = 0.015). History of otitis media had a small but consistent positive effect on all 
sweeteners, with participants who had suffered from middle ear infections rating 
sweeteners as 6% to 9% more intense than those who had never had a middle ear 
infection. Phenotypic correlations among the four sweeteners (0.4 – 0.64) were 
similar to those between duplicate presentations of the same compound (0.48 – 0.58) 
(Table 1-3).  
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Table 1-2. Sweet intensity characteristics of the twin sample 
 
Glucose Fructose NHDC d Aspartame 
Descriptive statistics     
  Pre1 (N=1876-1888) a 33.6 ± 18.2 32.6 ± 20 33.2 ± 20.4 27.3 ± 18.6 
  Pre2 (N=1868-1873) a 29.2 ± 18.5 30.9 ± 19.2 35.8 ± 21.7 25.8 ± 18 
  Mean (N=1882-1890) a 31.4 ± 16 31.8 ± 17.7 34.5 ± 18.9 26.6 ± 16.4 
Covariate effects     
  Sex (95%CI) 0.01 (-0.12, 0.13) 0.08 (-0.06, 0.22) 0.05 (-0.09, 0.20) 0.18 (0.05, 0.32) 
  Age (95%CI)  -0.06 (-0.08, -0.03) -0.11 (-0.13, -0.08) -0.11 (-0.14, -0.08) -0.08 (-0.11, -0.06) 
  Otitis media (95%CI) 0.19 (0.07, 0.31) 0.19 (0.06, 0.33) 0.22 (0.09, 0.36) 0.15 (0.02, 0.29) 
Twin correlations     
  rMZ (95%CI) (238-240 pairs) ab 0.31 (0.19, 0.42) 0.33 (0.21, 0.44) 0.32 (0.2, 0.43) 0.27 (0.15, 0.39) 
  rDZ (95%CI) (446-449 pairs) ab 0.22 (0.12, 0.3) 0.19 (0.09, 0.28) 0.12 (0.03, 0.21) 0.17 (0.08, 0.26) 
Univariate AEU modelling     
 A (95%CIs) c 25% (18, 32) 26% (19, 33) 25% (17, 32) 23% (15, 30) 
 E (95%CIs) c 25% (18, 33) 34% (26, 41) 32% (25, 40) 35% (27, 43) 
 U (95%CIs) c 50% (46, 53) 40% (37, 43) 43% (40, 46) 42% (39, 46) 
Means, standard deviations, and sample sizes for the perceived intensity (millimetre on a labelled magnitude 
scale) of sweeteners from presentation 1 and 2 and their means. Estimates of phenotypic variation accounted by 
unreliability (U). Age, sex, and otitis media covariate effect estimates, and twin correlations. The regression and 
deviations for covariate effects were applied to the means of the square root transformed variables. Significant 
covariate effects are shown in bold. 
a The number of participants (N) changes between presentations, as not all participants completed the entire test. 
b Twin correlations calculated using means. 
c Estimates of A (additive genetic component), E (non-shared environmental component), and U (unreliability 
component) add up to 100% variance for each sweetener. 
d Neohesperidine dihydrochalcone.  
 
 
Table 1-3. Phenotypic correlation coefficients among the perceived intensity of 
four sweeteners 
  Glucose  Fructose  NHDC a  Aspartame 
  
1 2  1 2  1 2  1 2 
             
Glucose 1 - 
 
 
  
    
  
 
2 0.48 -  
  
    
  
Fructose 1 0.62 0.49  - 
 
    
  
 
2 0.51 0.63  0.58 -     
  
NHDC a 1 0.51 0.50  0.64 0.54  -   
  
 
2 0.43 0.54  0.48 0.53  0.56 -  
 
 
Aspartame 1 0.48 0.52  0.55 0.54  0.54 0.47  -  
 
2 0.40 0.53  0.47 0.49  0.43 0.48  0.56 - 
Two presentations for each sweetener. Coefficients between duplicate presentations of the same compounds 
shown in bold. 
a Neohesperidine dihydrochalcone. 
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Variance Components Modelling 
For all four sweeteners, the MZ twin correlations (0.27 – 0.33) were higher 
than the DZ correlations (0.12 – 0.22), though both correlations were low-modest 
(Table 1-2). Univariate ACE models showed no significant worsening of fit after 
removal of the shared environmental factor for each of the four sweeteners (-2LL 
ranged from 0 to 1.55). NHDC was further tested in an ADE model as the MZ 
correlation was more than double the DZ correlation. Removal of the dominant 
genetic factor from the ADE model did not result in a worse fit for NHDC (-2LL = 0). 
As we found test unreliability (U) accounted for 40% to 50% of the variance for each 
sweetener (AEU model; Table 1-2), in all further modelling we used mean intensity, 
which is a more stable measure. 
Model fit of the multivariate models, which included mean intensity ratings for 
each of the four sweeteners, are shown in Table 1-4. Dropping the shared 
environmental factors from the full ACE Cholesky did not worsen the model fit (-2LL 
= 3.50, df = 10, AIC = 1566.288) and revealed one common genetic factor and a 
specific genetic factor for fructose, NHDC, and aspartame. While the CE model 
(dropping genetic factors) also provided a better fit than the full (ACE) Cholesky, the 
AE model was a better fit according to the AIC. A common pathway model (AIC = 
1559.356), shown in Figure 1-1, provided the best fit among the models tested 
(Table 1-4). From the independent pathway model, heritabilities were estimated to 
be 0.31, 0.34, 0.31, and 0.30 for glucose, fructose, NHDC, and aspartame, 
respectively. A common genetic factor explained the majority of the genetic variance 
for glucose (88%), fructose (87%), NHDC (79%), and aspartame (76%) ratings, with 
specific factors accounting for only a small amount of the genetic variance (12% to 
24%). Genetic correlations ranged between 0.78 and 0.89 with the lowest between 
fructose and aspartame, and the highest between glucose and fructose. 
Environmental factors accounted for 66% to 70% of the variance. 
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Figure 1-1. Common pathway model for perceived intensity of four sweeteners 
(standardized path coefficients and percentage of variance with 95% CIs). Ac 
and Ec are common additive genetic and environmental effects on the 
intensity measurement of four sweeteners. As and Es are specific genetic and 
environmental effects for each sweetener. Heritability estimates (h2) for each 
sweetener are sums of loadings from the Ac and As. For example, h2 for 
glucose is 0.39*0.71 + 0.04. Adding loadings from Ac, Ec, As and Es gives a 
total variance of 100% for each sweetener. 
 
 
Table 1-4. Model Fit of the Multivariate Models for Perceived Intensity of 
Sweeteners 
Model   df -2LL Δdf Δ-2LL AIC 
Cholesky ACE 7495 16572.79 - - 1582.792 
 
AE a 7505 16576.29 10 3.50 1566.288 
 
CE a 7505 16583.39 10 10.60 1573.389 
 
E a 7515 16661.22 20 88.43 1631.222 
Common pathway AE  7512 16583.36 
  
1559.356 
Independent pathway AE  7509 16582.10 
  
1564.096 
Abbreviations: degrees of freedom (df); -2 times the log-likelihood (-2LL); Akaike’s information criterion (AIC). 
Best model shown in bold.  
a Model fitting versus Cholesky full ACE model. 
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Discussion 
This is the first study to estimate the heritability and genetic covariance for 
perceived intensity of four structurally diverse sweet compounds: glucose, fructose, 
NHDC, and aspartame. Moderate heritabilities were estimated at 0.31, 0.34, 0.31, 
and 0.30 for glucose, fructose, NHDC, and aspartame, respectively. These estimates 
are similar to that previously reported for the sucrose intensity [90]. Our finding that a 
common genetic factor accounts for most of the genetic variance suggests that a 
single set of genes influences the perceived intensity of all the sweeteners. This 
factor explained 23% to 30% of the phenotypic (total) variance, whereas specific 
additive genetic components accounted for 4% to 7% of the variance. Although there 
is no evidence for a specific genetic factor influencing the perception of caloric 
sugars, the common genetic factor could include parallel pathways that may account 
for a different amount of the genetic variance in the perception of sugars compared 
with high-potency sweeteners. 
  We found little evidence for a shared environmental factor for sweet 
perception, which is also consistent with prior work examining sucrose intensity [90]. 
Although there is a belief that diets high in sugar can change sweet preference, and 
sweet foods are often withheld from children early in life to modify this, our findings 
and those of Keskitalo et al. [90] suggest that common environmental influences on 
sweet intensity ratings are very small. Similar data from animal models show that 
mice and rats, either exposed or not exposed to sugar early in life, do not differ as 
adults in sweet-related behaviour [99, 100].   
Univariate AEU modelling showed that test unreliability accounted for nearly 
50% of the trait variation. This places an upper ceiling on the heritability estimate by 
removing variance that can be in part explained by genotype and thus results in an 
underestimation of the heritability. Unreliability of sweet intensity is commonly found 
among researchers because sweet responses are subject to influences of circulating 
insulin, glucagon, leptin, and cannabinoids, which vary from meal to meal, time of 
day, and from day to day [101, 102]. However, as all sweeteners were tested within 
a short time frame in this study, the unreliability was more likely to be measurement 
specific. Therefore, a more stable measure of mean intensity was used and the 
heritability estimates were similar to those previously reported [90]. 
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We found that the effect of age on sweet perception was similar to that for 
bitter perception [40], suggesting that as adolescents move from childhood to 
adulthood, the perceived intensity of both sweet and bitter tastes decreases. Despite 
the cross-sectional design of this study, the age effect suggests that the taste 
systems are changing from child-like to adult-like; the results of this study suggest 
that during this period, the perception of intensity from sweet compounds decreases 
[85]. Likewise, longitudinal studies of sweet preference in both humans and mice 
revealed a negative age effect [103, 104]. 
Similarly, history of otitis media positively affected the perceived intensity of all 
sweet measures. It has been proposed previously that the damage of otitis media 
infection to the chorda tympani, a taste nerve from the tongue to the brain that 
passes behind the tympanum, results in an increase in the number of taste buds per 
fungiform papilla [95].  More taste buds correspond to more taste receptor cells, and 
consequently may influence sweetness perception. As a positive effect of otitis 
media was also observed for bitter compounds [40], it may be that otitis media 
infection causes a global increase in the intensity of both sweet and bitter tastes. 
In contrast to the global effect of age and otitis media, we found a sex effect 
only for aspartame, with males rating aspartame slightly more intense than females. 
Previous studies of smaller sample size reported no sex influences on the perceived 
intensity of aspartame, but only on other perception measures such as sweetness 
and pleasantness [105, 106]; this suggests the complexity in human perception of 
sweetness.  
 In conclusion, this study has examined the perceived intensity of four 
structurally diverse sweet compounds: two naturally-occurring saccharides (glucose 
and fructose) and two high-potency sweeteners commonly used as additives to 
human foods (NHDC and aspartame).  We have established that a moderate amount 
of the variation in the perceived intensity of sweeteners is due to genetic factors, and 
that there appears to be a single set of genes responsible for most of the variation in 
perception of these four compounds. This suggests that genetic factor scores for 
sweet intensity may be optimal for genome-wide association analyses. 
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Abstract 
Perceived intensities of sweetness and bitterness are correlated with one 
another and each is influenced by genetics. The extent to which these correlations 
share common genetic variation, however, remains unclear. In a mainly adolescent 
sample (n = 1901, mean age 16.2 years), including 243 MZ and 452 DZ twin pairs, 
we estimated the covariance among the perceived intensities of four bitter 
compounds (6-n-propylthiouracil [PROP], sucrose octaacetate, quinine, caffeine) and 
four sweeteners (the weighted mean ratings of glucose, fructose, neohesperidine 
dihydrochalcone, aspartame) with multivariate genetic modelling. The sweetness 
factor was moderately correlated with sucrose octaacetate, quinine, and caffeine (rp 
= 0.35 – 0.40). This was mainly due to a shared genetic factor (rg = 0.46 – 0.51) that 
accounted for 17% – 37% of the variance in the three bitter compounds’ ratings and 
8% of the variance in general sweetness ratings. In contrast, an association between 
sweetness and PROP only became evident after adjusting for the TAS2R38 
diplotype (rp increased from 0.18 to 0.32) with the PROP genetic factor accounting 
for 6% of variance in sweetness. These genetic associations were not inflated by 
scale use bias, as the cross-trait correlations for both MZ and DZ twins were weak.  
There was also little evidence for mediation by cognition or behavioural factors. This 
suggests an overlap of genetic variance between perceptions of sweetness and 
bitterness from a variety of stimuli, which includes PROP when considering the 
TAS2R38 diplotype. The most likely sources of shared variation are within genes 
encoding post-receptor transduction mechanisms common to the various taste G 
protein-coupled receptors. 
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Introduction 
Taste perception varies greatly among individuals. For over a decade, 
intensity ratings of the bitter compound 6-n-propylthiouracil (PROP) have been used 
to distinguish an individual’s “bitter taster status” [108], with those rating it as 
extremely bitter sometimes described as ”supertasters” [18]. Many studies 
suggested these individuals are also more sensitive to other taste stimuli [51, 109-
113], whereas many others have failed to find such associations [114-118]. 
Therefore, whether individual differences in ratings of a single compound can 
generalize to other taste stimuli has been questioned and, furthermore, whether 
there are pan-quality overarching individual differences remains unclear [108, 113, 
118]. 
Most of the perceptual variability in PROP is due to genetic variation within 
the bitter taste receptor TAS2R38 [36, 37, 119]. Genetic variation in TAS2R38 does 
not appear to be associated with perceived intensity of other taste stimuli (e.g. 
quinine and sucrose) [120], but some evidence shows that the TAS2R38 diplotype 
may modify the association between PROP and other tastes [113]. In addition, the 
PROP response has been shown to be less predictive of overall perceived taste 
intensity than are collective ratings of sucrose, sodium chloride, citric acid, and 
quinine [118], suggesting that PROP ratings are not a sole predictor for overall taste 
perception. Rather, a more complex association across multiple taste classes, such 
as general differences in the “gain” of the taste system, appears to be at play.  
A parallel body of work reveals that genetics plays a significant role in the 
perception of different taste qualities, accounting for over 30% of the variance in 
sweetness, sourness and bitterness [40-42, 81]. Our previous studies identified a 
shared genetic pathway for taste perception across different bitter compounds, 
excluding PROP [40], and more recently a common genetic factor for the perception 
of both sugars and non-caloric sweeteners [81]. Although the perception of 
sweetness has been weakly-to-moderately correlated with bitterness [41, 113, 118], 
whether this association is due to shared genes has not been determined in humans. 
In addition, there is evidence that non-receptor based factors may contribute to the 
correlation between sweet and bitter taste perceptions. For example, prosocial (e.g. 
agreeableness) and antisocial (e.g. psychopathy) personalities are associated with 
elevated sweet and bitter taste preferences, respectively [121, 122]. Further, other 
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concerns, such as psychometric properties of scale use (e.g. a tendency to rate at 
one side of the scale [123]) and even intelligence (e.g. higher IQ is associated with 
less extreme rating styles [124]) need to be raised when studying weak sensory 
associations. 
The present study investigated the sources of association between multiple 
taste qualities using a large adolescent and young adult twin sample. Genetic 
covariances between perceived intensity of four sweet (glucose, fructose, 
neohesperidine dihydrochalcone [NHDC], and aspartame) and four bitter solutions 
(PROP, SOA, quinine HCl [quinine], and caffeine) were estimated using multivariate 
genetic modelling. In addition, this study examined the impact of the TAS2R38 
diplotype on the genetic covariances, and potential confounding effects of scale use 
bias, general cognitive ability, and behavioural factors. 
Materials and Methods 
Participants 
Participants were adolescent and young adult Caucasian twins and their 
singleton siblings from the Brisbane Adolescent Twin Study [72], also referred to as 
the Brisbane Longitudinal Twin Study (BLTS). They were originally recruited for a 
study on melanoma [125], a common form of cancer among light-skinned people. 
The taste data reported here were collected between August 2002 and July 2014. 
The sample comprised 243 MZ and 452 DZ twin pairs, including 126 pairs with one 
to two singleton siblings, and 320 unpaired individuals (mean age of 16.2 ± 2.8 years; 
1023 females, 878 males) (Supplementary Table 2-1). This is the same sample as 
used previously [81]. Zygosity was determined from genotyping (92% of same sex 
twin pairs) or from self-report. The Queensland Institute of Medical Research Human 
Research Ethics Committee approved the study. Written consent was obtained from 
both the participants and their parents (the latter not required for those 18 years and 
over). 
Taste Test 
The taste test battery has been described in Chapter 1.  Briefly, participants 
rated the intensity of five bitter (6.0 x 10-4 M PROP, 2.0 x 10-4 M SOA, 1.81 x 10-4 M 
quinine, 0.05 M caffeine, and 4.99 x 10-6 M denatonium benzoate) and four sweet 
(0.60 M glucose, 0.30 M fructose, 8.0 x 10-5 M NHDC, and 1.4 x 10-3 M aspartame) 
solutions using a general Labelled Magnitude Scale (gLMS) [73]. Mean intensity 
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ratings from duplicate presentations for each of PROP, SOA, quinine and caffeine 
were used in all analyses. For the four sweet compounds, a weighted mean general 
sweet (gSweet) factor was used, as perceived intensity of the sweeteners is highly 
correlated at the genetic level (rg = 0.78 – 0.89) and most of the variance (71% for 
glucose, 77% for fructose, 64% for NHDC, and 59% for aspartame) is accounted for 
by a common genetic factor (Chapter 1). Denatonium benzoate was not included 
due to the violation of the normality assumption, a criterion for twin modelling [126] 
(see Statistical Analyses). Statistical transformation failed to overcome this problem 
because of its distinct bimodal distribution (Supplementary Figure 2-1). In addition, 
the mean intensity rating for denatonium benzoate was double that of other stimuli, 
with the most common rating being the strongest imaginable on the scale, 
suggesting that the concentration may have been too high to detect variation (also 
known as a “ceiling effect”). The intensity rating characteristics for denatonium 
benzoate are summarized in Supplementary Table 2-2.  
TAS2R38 diplotype 
The genotypes for the three TAS2R38 SNPs (rs713598, rs1726866, and 
rs10246939), resulting in three amino acid substitutions (A49P, A262V, and V296I), 
were available for 92% of the sample. Genotyping was done using the Illumina 610-
Quad BeadChip (n = 1254) [37] or HumanCoreExome-12 v1.0 BeadChip. The 
frequencies of the three diplotypes (PAV/PAV = 17%, PAV/AVI = 52% [including 34 
participants with rare diplotypes of AAV/AVI or PAV/AAV, which were shown to have 
similar effects on PROP perception as the PAV/AVI diplotype [119]], and AVI/AVI = 
31%) were similar to the frequencies reported previously for PROP sensitivity (i.e. a 
distribution of 20% high: 50% medium: 30% low-sensitivity tasters) [18, 127]. 
Statistical Analyses  
The heritability and phenotypic correlations among the intensity scores of 
gSweet and the four bitter substances were estimated using univariate and bivariate 
variance components modelling. This twin method partitions the phenotypic variance 
or covariance into additive genetic (A), common environment (C) and unique 
environment (E, includes experimental error) sources by taking advantage of the 
differences in the genetic relatedness between MZ twins who share 100% of their 
genes and DZ pairs who share, on average, 50% of their genes. This method can 
detect genetic effects by comparing the correlations of MZ and DZ twins and without 
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requiring the investigation of specific genes. Variance components modelling was 
performed using the structural equation modelling software package Mx, which 
utilises maximum likelihood estimation procedures [74]. Prior to modelling, a square 
root transformation was applied to each of the five intensity scores to obtain a more 
normal distribution (Supplementary Figure 2-1 and Supplementary Table 2-3). 
Covariates of age, sex, and otitis media were modelled as regressions or deviation 
effects on the mean for all models. Damage to the chorda tympani nerve resulting 
from an otitis media infection can result in an increase in the number of taste buds 
[95], and consequently may influence taste perception. Our previous studies showed 
that the history of otitis media was associated with increased perceived intensity (4% 
– 9%) of the same four sweet and bitter solutions [40, 81]. No outlying families were 
identified using the %p option in Mx, which uses the Mahalanobis distance to 
compute a z-score for each family, with values outside the -3.5 to +3.5 range 
indicating excessive similarities or differences relative to other families in the sample 
and model expectation.  
To estimate the covariance structure between the five traits, a multivariate 
Cholesky decomposition model [126] was used as a starting point. A series of 
models, including dropping A and C components, were tested to determine which 
pattern of covariance best fitted the data. For nested models, we assessed the 
comparative fit by calculating the difference in double the negative log-likelihood, 
which is distributed asymptotically as a 2. For non-nested models, the Akaike’s 
Information Criterion (AIC), which penalizes models for increasing complexity [98], 
was used. The effect of the TAS2R38 diplotype on the covariance structure was 
tested in a partial dominant model with one covariate for the heterozygous effect (i.e. 
PAV/AVI = 1 and PAV/PAV = AVI/AVI = 0) and a second covariate for the PAV 
homozygous effect (i.e. PAV/PAV = 1 and AVI/AVI = PAV/AVI = 0). Consequently, 
the genetic variance in PROP dropped from 0.72 to 0.20 (compared with an additive 
or dominant model where PROP genetic variance reduced to 0.25 and 0.24 
respectively). This model was used to examine the covariance structure when the 
TAS2R38 genetic effect on intensity ratings was removed. A second model in which 
the low-sensitivity tasters for PROP (30% of the genotyped sample) were excluded 
from the analyses was also tested. 
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In addition, this study investigated whether intensity ratings were associated 
with general cognitive ability (Verbal IQ), assessed with the Multidimensional 
Aptitude Battery [128], and personality (neuroticism, extraversion, openness to 
experience, agreeableness, and conscientiousness) assessed with the NEO Five-
Factor Inventory (FFI) [129]. Both cognition and personality were assessed at age 16, 
which for the majority of twins were two years after assessment for sweet and bitter 
taste. Verbal IQ and personality were available for 1282 and 1277 participants 
respectively [130]. Further, to assure that the associations were estimated from taste 
perception and were not inflated by scale use bias, an emphasis score: 0 = neutral, 1 
= somewhat, 2 = strongly was calculated by folding the 5-point Likert scale of the 
sixty responses from the NEO-FFI: strongly agree = 5, agree = 4, neutral = 3, 
disagree = 2, strongly disagree = 1. We tested these scale bias scores for relation 
with the taste ratings. Where an association was indicated, the measure was 
included as a covariate in the multivariate model to examine whether the genetic 
architecture was changed. Lastly, cross-correlations were calculated between the 
intensity ratings of PROP for the first born twin with those of their co-twin’s ratings for 
the other four traits, for both MZ and DZ pairs, to examine any genetic effect on 
scale use rather than taste perception. 
Results 
Mean ratings, standard deviations, twin correlations, and heritability estimates 
for the perceived intensity of PROP, SOA, quinine, caffeine and gSweet are shown 
in Table 2-1. The mean rating was lower for PROP, and the variance was slightly 
larger, compared with the other bitter compounds. This was due to the distinct 
differences in PROP response between the three TAS2R38 diplotype groups and 
31% of the participants being low-intensity tasters who could barely detect the 
bitterness in PROP (Figure 2-1). In contrast, there was no effect of the TAS2R38 
diplotype on SOA, quinine, caffeine or gSweet. Heritability for PROP (h2 = 0.73) was 
significantly higher than that for SOA, quinine and caffeine (h2 = 0.35 – 0.4), in line 
with prior work [40]. The mean and heritability (h2 = 0.36) estimates for the gSweet 
factor are the same as those reported previously [81]. 
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Figure 2-1. Perceived intensity ratings (mean + standard error) for four bitter 
solutions and the general sweetness factor (a weighted mean rating of glucose, 
fructose, NHDC and aspartame). Participants grouped by TAS2R38 diplotypes 
(n = 527 for AVI/AVI, n = 916 for PAV/AVI, n = 313 for PAV/PAV). * indicates 
significant differences (Student’s t-test, p < 0.001). 
 
 
Table 2-1. Taste intensity characteristics 
  PROP SOA Quinine Caffeine gSweet 
Mean ± SD a 36.7 ± 29.6  51.6 ± 22.6  45.6 ± 22.9  52.2 ± 23.3  31.2 ± 15.2  
      Twin Correlations b 
    
  rMZ (95% CI)  0.72 (0.65, 0.78) 0.34 (0.23, 0.45) 0.40 (0.29, 0.50) 0.29 (0.17, 0.41) 0.36 (0.24, 0.46) 
  rDZ (95% CI)  0.34 (0.26, 0.42) 0.25 (0.10, 0.34) 0.18 (0.09, 0.27) 0.21 (0.12, 0.30) 0.20 (0.17, 0.34) 
      Heritability (95% CI)  0.73 (0.67, 0.77) 0.40 (0.31, 0.49) 0.40 (0.31, 0.49) 0.34 (0.24, 0.43) 0.36 (0.27, 0.45) 
      
Phenotypic Correlations (95% CI)     
  Full Sample 
     
    SOA 0.29 (0.25, 0.34) - - - - 
    Quinine 0.25 (0.20, 0.29) 0.59 (0.56, 0.62) - - - 
    Caffeine 0.31 (0.26, 0.35) 0.64 (0.62, 0.67) 0.63 (0.60, 0.65) - - 
    gSweet 0.22 (0.18, 0.27) 0.35 (0.30, 0.39) 0.40 (0.37, 0.44) 0.40 (0.36, 0.43) - 
 
     
 TAS2R38 adjusted c 
     
    SOA 0.37 (0.33, 0.41) - - - - 
    Quinine 0.44 (0.40, 0.47) 0.60 (0.57, 0.63) - - - 
    Caffeine 0.42 (0.38, 0.46) 0.64 (0.61, 0.67) 0.63 (0.61, 0.66) - - 
    gSweet 0.32 (0.27, 0.36) 0.35 (0.30, 0.39) 0.41 (0.36, 0.45) 0.39 (0.35, 0.43) - 
 
     
AVI/AVI excluded d      
    SOA 0.44 (0.39, 0.48) - - - - 
    Quinine 0.48 (0.43, 0.52) 0.60 (0.56, 0.63) - - - 
    Caffeine 0.46 (0.41, 0.51) 0.63 (0.60, 0.66) 0.62 (0.59, 0.66) - - 
    gSweet 0.31 (0.26, 0.36) 0.33 (0.28, 0.38) 0.37 (0.32, 0.42) 0.37 (0.32, 0.42) - 
Means and standard deviations, MZ and DZ twin correlations, heritability estimates and phenotypic correlations for perceived 
intensity ratings (millimeters on a labeled magnitude scale) of PROP, SOA, quinine, caffeine and a general sweetness factor 
(gSweet).  
a n = 1881 - 1892. The sample size (N) varies as not all participants completed the entire test. 
b 238-240 MZ and 446-449 DZ twin pairs; all estimates are from univariate AE models. 
c TAS2R38 diplotype, available for n = 1756, was tested in a partial dominant model. 
d N reduced to 1229 when TAS2R38 AVI/AVI diplotype excluded 
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Perceived intensity for gSweet was moderately correlated with those for SOA, 
quinine, and caffeine (rp = 0.35 – 0.40) and more weakly associated with PROP (rp = 
0.22) (Table 2-1). Multivariate model-fitting showed that the common environmental 
components (C) could be dropped without loss of fit (Supplementary Table 2-4). 
Multivariate AE modelling identified a genetic factor (A2 factor in Figure 2-2) 
accounting for 8% of the variance in gSweet and 17% – 37% of the variance in SOA, 
quinine, and caffeine. Only 1% of the variance in gSweet was genetically shared with 
PROP (A1 factor in Figure 2-2). There was also little shared genetic variance 
between PROP and the other three bitter compounds (i.e. 1% – 3%, A1 in Figure 2-
2). Further, the association between gSweet and PROP was largely due to an 
environmental “PROP” factor (E1), accounting for 27% of the variance in PROP and 
6% in gSweet. This environmental factor also accounted for a small amount of the 
variance (9% – 12%) in SOA, quinine, and caffeine. 
 
 
 
Figure 2-2. The Cholesky AE model showing estimates of standardized path 
coefficients (can be squared to get the variance) and percentage of variance 
with 95% CIs and covariation between perceived intensity of PROP, SOA, 
quinine, caffeine, and gSweet. The boxes and the circles represent observed 
variables (phenotypes) and latent variables, respectively. A and E are the 
addictive genetic and non-shared environmental factors. Dash lines are 
insignificant estimates. See Supplementary Table 2-5 for absolute variances. 
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Figure 2-3. The conditioned Cholesky AE models showing estimates of 
standardized path coefficients (can be squared to get the variance) and 
percentage of variance with 95% CIs and covariation between perceived 
intensity of PROP, SOA, quinine, caffeine, and gSweet. The boxes and the 
circles represent observed variables (phenotypes) and latent variables, 
respectively. Only additive genetic factors (A) are shown here because 
estimates of environmental factors (E) are not different from those estimated 
from the full sample (n = 1901). Dashed lines are insignificant estimates. (a) 
Adjusting for TAS2R38 diplotype (n = 1756). * Modelling results with gSweet 
replaced by glucose and fructose are shown in Supplementary Table 2-7. (b) 
Participants with TAS2R38 AVI/AVI diplotype removed (n = 1229). (See 
Supplementary Table 2-5 for absolute variance.) 
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When the model was adjusted for the TAS2R38 diplotype (i.e. the TAS2R38 
genetic effect was removed), the correlation between gSweet and PROP increased 
(rp = 0.32), as did the correlation between PROP and the other bitter compounds (rp 
increased from 0.25 - 0.31 to 0.37 - 0.44) (Table 2-1). The stronger association was 
due to an increase in shared genetic variance with 6% of variance in gSweet now 
overlapping with the genetic variance for PROP (A1 in Figure 2-3a; h2 of PROP 
decreased to 0.40 after adjustment). Similarly, after adjusting for TAS2R38, there 
was an increase in shared genetic variance for SOA, quinine and caffeine with 
PROP. Notably, no increase in the environmental variance (E1) shared with PROP 
was found for gSweet, SOA, Caffeine or Quinine. Adjusting for TAS2R38 reduces 
the absolute genetic variance in PROP, with environmental variance for PROP and 
the genetic and environmental variances of other tastes remaining the same 
(Supplementary Table 2-5). In addition, removing PROP low-sensitivity tasters, 
rather than adjusting for TAS2R38, produced a similar covariance structure, even 
though the sample size was reduced (Figure 2-3b; Supplementary Table 2-5c). This 
increase in the genetic correlations after adjustment for TAS2R38 or removal of 
PROP low-sensitivity tasters (Table 2-2) contrasts with the environmental 
correlations that remained the same.  In terms of genetic variance as a proportion of 
the heritability (Supplementary Table 2-6), 23% of the genetic variance in gSweet 
(8% of the variance divided by the heritability of 0.36) overlapped with 46% of 
genetic variance in quinine, 49% in caffeine, and 94% in SOA, whereas only 3% of 
the genetic variance in gSweet overlapped with PROP, which increased to 15% after 
adjusting for the TAS2R38 diplotype. 
Since a commonly based definition of sweet taste is the oral perception of 
natural sugars, we used the intensity rating for glucose and fructose instead of 
gSweet to remove any possible bias of a weighted mean intensity rating of both the 
sugars and high-potency sweeteners; the results were similar (Supplementary Table 
2-7). 
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Table 2-2. Genetic (lower-triangle) and environmental (upper-triangle) 
correlations (95% confidence intervals) between perceived intensities of four 
bitter compounds and the general sweet intensity estimated from bivariate AE 
models. 
a. Full sample 
 
  
Environmental correlations 
 
 PROP SOA Quinine Caffeine gSweet 
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s
 PROP - 0.38 (0.28, 0.48) 0.45 (0.35, 0.54) 0.36 (0.26, 0.45) 0.32 (0.21, 0.41) 
SOA 0.26 (0.15, 0.37) - 0.52 (0.44, 0.59) 0.58 (0.51, 0.64) 0.24 (0.14, 0.33) 
Quinine 0.12 (0, 0.23) 0.70 (0.58, 0.80) - 0.60 (0.53, 0.66) 0.35 (0.25, 0.44) 
Caffeine 0.31 (0.19, 0.42) 0.76 (0.65, 0.86) 0.68 (0.55, 0.79) - 0.36 (0.27, 0.45) 
gSweet 0.18 (0.05, 0.29) 0.51 (0.35, 0.67) 0.50 (0.33, 0.65) 0.46 (0.27, 0.62) - 
 
b. TAS2R38 adjusted 
  
Environmental correlations 
 
 PROP SOA Quinine Caffeine gSweet 
G
e
n
e
ti
c
 
c
o
rr
e
la
ti
o
n
s
 PROP - 0.37 (0.27, 0.47) 0.44 (0.34, 0.52) 0.38 (0.28, 0.46) 0.27 (0.16, 0.37) 
SOA 0.36 (0.19, 0.52) - 0.51 (0.42, 0.58) 0.58 (0.50, 0.64) 0.24 (0.14, 0.33) 
Quinine 0.43 (0.26, 0.58) 0.74 (0.62, 0.85) - 0.60 (0.52, 0.66) 0.37 (0.27, 0.46) 
Caffeine 0.50 (0.32, 0.65) 0.76 (0.64, 0.85) 0.70 (0.57, 0.81) - 0.36 (0.27, 0.45) 
gSweet 0.40 (0.22, 0.56) 0.52 (0.36, 0.67) 0.47 (0.29, 0.62) 0.45 (0.26, 0.61) - 
n = 1756. TAS2R38 diplotype was tested in a partial dominant model. 
 
c. TAS2R38 AVI/AVI excluded  
  
Environmental correlations 
 
 PROP SOA Quinine Caffeine gSweet 
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 PROP - 0.46 (0.34, 0.56) 0.53 (0.42, 0.62) 0.43 (0.32, 0.54) 0.29 (0.16, 0.41) 
SOA 0.44 (0.27, 0.57) - 0.50 (0.40, 0.59) 0.60 (0.52, 0.68) 0.19 (0.07, 0.31) 
Quinine 0.44 (0.27, 0.57) 0.75 (0.60, 0.88) - 0.60 (0.51, 0.68) 0.36 (0.24, 0.47) 
Caffeine 0.52 (0.36, 0.66) 0.68 (0.51, 0.80) 0.66 (0.48, 0.79) - 0.34 (0.22, 0.45) 
gSweet 0.34 (0.17, 0.50) 0.55 (0.36, 0.74) 0.39 (0.17, 0.58) 0.42 (0.19, 0.62) - 
     n = 1229. 
 
 
Further, there was little evidence of the effect of scale use bias, IQ, or 
personality on intensity ratings. While some small associations were observed 
(Supplementary Table 2-8), there was no change in the covariance structure when 
the emphasis score, IQ, and personality were included as covariates in the 
multivariate model (Supplementary Table 2-9). In addition, scale use had no effect 
on the genetic estimates; the cross-trait (e.g. PROP for twin 1 with gSweet for twin 2) 
correlations for both MZ and DZ twins were low and of similar magnitude (rMZ = 0 – 
0.10, rDZ = 0.03 – 0.11; Supplementary Table 2-10). 
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Discussion 
This study examined whether there is heritable genetic overlap between the 
perception of sweetness and bitterness of eight different compounds. Using 
multivariate genetic modelling, we showed that up to a quarter of the genetic 
variance in sweet perception is shared with at least half, or more, of the genetic 
variance in SOA, quinine and caffeine. Further, after adjustment of the TAS2R38 
diplotype, 15% of genetic variance in sweetness is also in common with PROP 
perception. These results suggest that human perceptions of sweetness and 
bitterness are linked through shared genes and the extent of overlap depends on the 
specific taste stimuli.  
Confirming prior work, intensity ratings for sweetness were weakly-to-
moderately associated with bitterness ratings [41, 113, 118]. Although Lim et al. [118] 
only found an association between sucrose and quinine and not between sucrose 
and PROP, their sample size was small (n = 83) compared to Fischer’s and ours (n = 
1670 and 1901 respectively). This suggests that a bigger sample size is required to 
detect weak associations with PROP. Our finding that the associations between 
gSweet and SOA, quinine and caffeine were mainly due to a shared genetic factor 
supports the current understanding that, in humans, the perception of both 
sweetness and bitterness is mediated via G protein-coupled receptors (GPCR) and 
other shared transduction proteins in the oral cavity [4, 131]. Genetic variation in 
these taste genes has been shown to link to individual differences in the perception 
of both sweetness [82, 83] and bitterness [37, 38]. Evidence from animal models 
also shows that knocking out common genes in their downstream signalling 
pathways, including genes that encode the G-protein alpha-gustducin, Ggamma13, 
the lipid enzyme phospholipase C beta2, and transient receptor potential ion channel 
TRPM5, leads to a reduced response to both sweet and bitter tastes [132-134].  
Our prior work showed that the perception of PROP was weakly associated 
with the perception of other bitter compounds at the genetic level [40]. Here, using a 
greatly expanded sample, this study confirmed this lack of strong association, but 
also identified, after adjusting for the TAS2R38 diplotype, a shared genetic factor 
accounting for some of the genetic variance in the perception of PROP as along with 
other bitter and sweet tastes. This finding supports the two-locus model [135] of the 
perception of TAS2R38 associated bitter compounds (i.e. PROP and its structurally 
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related chemical propylthiocarboamide [119]), with one locus controlling compound-
specific tasting and the other locus controlling general taste responsiveness. This 
shared genetic factor (A1 factor in Figure 2-3) may correspond to a shared pathway 
at the peripheral level because the perception of PROP is believed to go through the 
same GPCR-based signalling elements as other bitter and sweet tastes [136, 137]. 
Alternatively, shared genetic variation could also involve a shared pathway at the 
central neural level, supporting the hypothesis [138] that a central nervous system 
(CNS) mechanism influences general responsiveness to tastes. In that study, the 
ability to perceive thermally induced taste predicted higher taste responses to sweet 
and bitter stimuli, including PROP, as well as salty, sour and umami taste stimuli. 
They eliminated the potential confounders of papillae density and gustatory afferents 
used in signal transduction and concluded that the overall control of gain in the 
orosensory system is likely centrally determined.  
In addition to the perception of sweetness and bitterness, the shared genetic 
factors identified here could also link to the perception of umami taste, especially at 
the peripheral level, because a glutamate taste receptor is also a member of the 
Class 1 Taste GPCR family [131, 139]. Animal studies have shown that these taste 
qualities (sweetness, bitterness and umami) are encoded by common downstream 
transduction components that are not believed to be used by ionic taste stimuli 
(sourness and saltiness) [132, 134]. Future taste genetic studies involving glutamate, 
salts, and acids could test this hypothesis in humans and would help tease apart 
which common genes are involved. 
To assure that the genetic overlap between sweetness and bitterness was not 
due to confounding factors, we tested a series of alternative hypotheses. First, we 
found only subtle associations between personality traits and taste ratings, in 
contrast to other studies [121, 122]. This difference between our weak personality 
influence and those previously observed may be due to differences in measures of 
taste preference rather than taste intensity in the present study. Second, individuals 
with higher IQ rated taste solutions as less intense. There is some evidence that 
people with higher IQ are less likely to give extreme ratings [124] and we also 
observed a negative correlation between IQ and emphasis scores (rp = -0.24) in this 
study. Therefore, these people could be more conservative in rating the intensity of 
taste solutions. Alternatively, the association may be due to pleiotropic effects with 
shared genes influencing both taste perception and the development of intelligence. 
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Nevertheless, neither personality traits nor IQ modifies the genetic architecture 
between sweetness and bitterness. Third, the emphasis scores were not associated 
with any taste ratings, so an individual’s response style is not likely a concern. Lastly, 
scale use style is not influenced by genetics and did not inflate or deflate the 
estimates of heritability or genetic covariances. The last test supports that the gLMS 
can be a valid instrument to study taste genetics. These four tests of alternative 
hypotheses allow us to conclude more strongly that the genetic correlation between 
sweetness and bitterness results from true correlates of taste perception and that 
these estimates of genetic covariances are valid rather than an artefact of scale use.  
There are some limitations of this study. First, partitioning trait variance using 
Cholesky decomposition is restricted by the trait order in the model, with only the last 
trait in the model including a trait specific factor. For all other traits, the trait-specific 
variance is pushed to a group factor(s), which can, therefore, elevate covariances 
between traits. We tested these models in different orders, however, and obtained 
similar results. Second, although adjusting for the TAS2R38 diplotype increased the 
shared genetic variance between PROP and other taste stimuli, the increase was 
small and the confidence intervals overlapped (e.g. gSweet increased from 3% 
[confidence intervals: 0 and 9%] to 15% [confidence intervals: 5 and 30%]). Future 
studies with larger samples could provide more distinct results. Lastly, whether there 
is a common genetic pathway for the overall taste perception cannot be answered 
from this study. Although we showed a genetic factor for the perception of both 
sweet and bitter tastes, even including PROP, it might simply be a specific taste 
transduction factor that does not also account for the perception of umami, sourness 
and saltiness.  
In conclusion, this study examined the associations among perceived 
intensities of four bitter compounds – PROP, SOA, quinine, and caffeine – and a 
weighted sweet factor from four sweeteners, and modelling results identified two 
latent genetic factors suggesting two shared genetic pathways. We speculate that 
there are genes responsible for the recognition of a GPCR-taste signal or a general 
taste signal. Genetic covariation of downstream signalling elements could involve 
peripheral and/or central mechanisms, including genes encoding molecules that 
transduce information from the taste receptors to the nerves and neural elements in 
the gustatory brain circuits. Future genome-wide association analysis in humans 
could identify common genes across different taste modalities, which have 
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implications for understanding the molecular mechanism of GPCR-transduced taste 
perception as well as the taste-based metabolic signals from the gastrointestinal 
tract, pancreas, liver, thyroid, and elsewhere. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
3  
Joint Analysis Strengthens 
the Role of Bitter Receptor 
Clusters on Chromosomes 7 
and 12 in Human Bitter Taste  
 
 
Chapter modified from a manuscript submitted to BMC Genomics (April 2018) 
 
 
 
 
 
 
 
60 
Chapter 3. Joint analysis strengthens the role of bitter 
receptor clusters on chromosomes 7 and 12 in human 
bitter taste 
 
Liang-Dar Hwang1,2, Puya Gharahkhani1, Paul A. S. Breslin3,4, Scott D. Gordon1, Gu 
Zhu1, Nicholas G. Martin1, Danielle R. Reed3, and Margaret J Wright5,6 
 
1 QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia 
2 Faculty of Medicine, University of Queensland, Brisbane, Queensland 4006, 
Australia 
3 Monell Chemical Senses Center, Philadelphia, Pennsylvania 19104, USA 
4 Dept. of Nutritional Sciences, School of Environmental and Biological Sciences, 
Rutgers University, New Brunswick NJ, 08901 USA 
5 Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, 
Australia 
6 Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland 
4072, Australia  
Acknowledgements 
We thank Kirsten J Mascioli, Christopher Tharp, Fujiko Duke, Deborah Lee 
and Corrine Mansfield from the Monell Chemical Senses Center for manufacturing 
the taste tests; and from the QIMR Berghofer, Marlene Grace, Ann Eldridge, Natalie 
Garden, and Kerrie McAloney for project co-ordination, data collection, and data 
entry, and David Smyth for computer support. We thank Asta Försti from the German 
Cancer Research Center for looking up SNPs in their thyroid cancer GWAS [140]. 
We thank Robino Antonietta from Italian Ministry of Health for looking up SNPs in 
their unpublished GWAS of PROP. In particular, thanks go to twins and their families 
for their participation. This work was supported by the National Institute of Health 
grants DC02995 to PASB and DC004698 to DRR, the Australian National Health 
and Medical Research Council grants 241944 and 1031119 to NGM, and the 
Australian Research Council grants DP1093900 and DP0664638 to NGM and MJW. 
LDH was supported by a QIMR Berghofer International PhD Scholarship and a 
tuition fee waiver from the University of Queensland. 
 
 
61 
Abstract 
Human perception of bitter substances is partially genetically determined. A previous 
genome-wide association study (GWAS) discovered a single nucleotide 
polymorphism (SNP) within the bitter taste receptor gene TAS2R19 on chromosome 
12 that accounts for 5.8% of the variance in the perceived intensity rating of quinine, 
and strengthened the classic association between TAS2R38 genotype and the 
bitterness of propylthiouracil (PROP). Here we performed a GWAS using the same 
sample with a 40% increase in sample size (n = 1999) together with a bivariate 
approach to detect previously unidentified common variants with small effects on 
bitter perception. We identified two signals, both with small effects (< 2%), within the 
bitter taste receptor clusters on chromosomes 7 and 12, which influence the 
perceived bitterness of denatonium benzoate and sucrose octaacetate respectively. 
We also provided the first independent replication for an association of caffeine 
bitterness on chromosome 12. Furthermore, we provided evidence for pleiotropic 
effects on quinine, caffeine, sucrose octaacetate and denatonium benzoate for the 
three SNPs on chromosome 12 and the functional importance of the SNPs for 
denatonium benzoate bitterness. These findings provide new insights into the 
genetic architecture of bitter taste and offer a useful starting point for determining the 
biological pathways linking perception of bitter substances. 
Introduction 
Bitterness is a taste sensation that arises when particular chemicals come into 
contact with receptors in specialized cells on the human tongue [141-143]. But not 
everyone perceives the same bitterness for a given stimulus; this individual variation 
is partially genetically determined and can affect food perception, preferences and 
intake [3, 4, 144]. Genetic effects for bitter taste perception, which are estimated by 
twin studies, range from 36 to 73% [40, 41, 107], with most of the known variation 
arising from inborn variation in the bitter receptor gene family (TAS2R) [37, 38, 145]. 
These bitter receptors are in tissues beyond the tongue and oral cavity, including the 
airways, gut, thyroid, and brain [146] where they may function as toxin detectors or 
early-stage sentinel systems. Bitter taste responses may reflect how well the 
receptors detect ligands in other tissues [147]. Historically, the ability to taste one 
well-studied bitter compound, phenylthiocarbamide (PTC), has been related to many 
diseases [17]; more recently and more specifically, variation in the PTC taste 
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receptor is shown to be involved in the immune system [148] and to predict surgical 
outcome for severe rhinosinusitis [149]. Thus, together with the better-known effects 
on food intake and nutrition, bitter taste perception is of increasing importance to the 
medical field. 
Given the rising importance of taste genetics, studies have focused on 
determining the underlying genetic variation that leads to individual differences in 
bitter perception. An earlier genome-wide association study (GWAS) [37], which 
included 1457 adolescents from 626 twin families, revealed a single nucleotide 
polymorphism (SNP) within the bitter taste receptor gene TAS2R19, accounting for 
5.8% of the variance in the perception of quinine, and replicated the classic 
association between the bitter taste receptor gene TAS2R38 and the perception of 
propylthiouracil (PROP; a chemical relative of PTC). The study, however, could 
neither detect loci for the other compounds tested, such as caffeine and sucrose 
octaacetate (SOA), that are likely to be affected by a large number of small-effect 
alleles nor the previously proposed but yet to be identified second locus for thiourea-
containing compounds like PTC and PROP [135].  
Drawing on studies of complex traits such as body mass index (BMI) [79] and 
schizophrenia [150], here we increased the overall sample size by 40% and used 
multivariate association analysis [76] to identify common genetic variants (minor 
allele frequency [MAF]  5%) with small effects. Multivariate GWAS has been used 
to detect SNP associations that did not reach genome-wide significance in univariate 
analyses, such as autism spectrum disorders [151] and bone mineral density [152]. 
This method can detect not only pleiotropic genetic variants but also variants 
associated with only one of the correlated phenotypes [47]. As shown by Stephens 
[47], bivariate analysis increases power when there is greater separation of genotype 
groups (0, 1 or 2 copies of the minor allele) in two- versus one-dimensional space. In 
Figures 3-1a and b, we provide two illustrations of when a joint analysis of two 
correlated traits can provide greater separation of genotypes associated with the 
primary trait (trait 1). The first example (a) shows the case where only one trait (trait 
1 on the y-axis) is associated with the variant (non-pleiotropic), with bivariate 
analysis providing better separation of the genotype groups in 2-dimensional space 
compared with the y-axis alone. A similar boost in signal would be found in a 
conditional analysis, where the non-associated trait is included as a covariate, as this 
 
 
63 
removes the non-associated part of the variance in the associated trait (i.e. 
covariance between two traits) and, therefore, enhances the association. The 
second example (b) shows that maximum separation can be achieved when both 
traits (trait 1 on the y-axis, trait 2 on the x-axis) are associated with the variant and 
the effect of the minor allele on the two is in opposite direction. In the case where a 
variant has the same effect on both correlated traits (Figure 3-1c), bivariate analysis 
provides minimum/no increase in power. The bivariate approach is especially well-
justified for bitter taste traits because, with the exception of PROP, perception of 
these bitter substances are highly correlated (rp = ~0.6) [153] and their genetic 
variances largely overlap (rg = ~0.7) [40, 107].  
 
 
Figure 3-1. Illustration of three scenarios in a bivariate analysis. Each dot 
represents an individual, coloured according to their genotype (0, 1 or 2 copies 
of the minor allele). In (a) trait 1 and 2 are correlated but the variant is only 
associated with trait 1. When considering traits 1 and 2 jointly in testing for 
association, there is greater separation of the genotype groups for trait 1 in the 
two-dimensional space compared with the y-axis alone. For example, the blue 
and green dots would largely overlap in the one-dimensional space along the 
y-axis. In (b) the minor allele has opposite effects on traits 1 and 2 - increasing 
trait 1 and decreasing trait 2. The three genotype groups are better separated 
in the two-dimensional space than for either trait individually. In (c) the minor 
allele has a similar effect on traits 1 and 2 - increasing both traits. Separation 
of the three genotype groups in two-dimensional space is no greater than 
along the y-axis alone. The figures and text are adapted from Figure 1 in 
Stephens (2013) [47]. 
 
Here we aimed to identify common genetic variants with small effects (i.e. 1% 
– 5%) on the perception of bitterness, building on our previous GWAS [37], which 
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was too underpowered to detect common genetic variants with small effects. We 
performed univariate GWAS for the perceived intensity of 5 bitter substances (PROP, 
quinine, caffeine, SOA, and denatonium benzoate [DB]) using our expanded sample, 
including 1999 individuals from 929 twin families. As these phenotypes were 
collected from the same individuals, to boost power we ran a series bivariate GWAS 
(6 in total) for the correlated phenotypes of quinine, caffeine, SOA and DB [107]. We 
looked for evidence of pleiotropy for each identified variant. When there was little 
evidence for pleiotropy, we tested the SNP association with the primary trait 
conditional on the second. For variants in linkage disequilibrium, we used 
bidirectional conditional analysis (i.e. including the genotype of one SNP as a 
covariate at a time to test the association with the other SNP) and plotted the SNP 
associations for one trait against the other. Finally, to help interpret the genotype-
phenotype associations, we examined the potential function of the identified SNPs 
with bioinformatics tools. 
Materials and Methods 
Sample 
Participants were 1999 adolescent and young adult Caucasian twins and their 
siblings from 929 families from the Brisbane Adolescent Twin Study [72], also 
referred to as the Brisbane Longitudinal Twin Study (BLTS), with data collected 
between August 2002 and July 2014. This sample consisted of 275 MZ and 544 DZ 
twin pairs, including 155 pairs with one to two singleton siblings, and 184 unpaired 
individuals (mean age of 16.0 ± 2.8 years [medium 14.5 years, range 11-25 years]; 
1075 females, 924 males). It included all participants from a previous GWAS [37], 
plus a 40% increase in sample size.  
Taste Test 
The taste test battery has been described in previous chapters. Briefly, it 
included duplicated presentations of five bitter (6.0 x 10-4 M PROP, 2.0 x 10-4 M SOA, 
1.81 x 10-4 M quinine, 0.05 M caffeine, and 4.99 x 10-6 M DB) solutions as well as a 
paper strip rinsed in a saturated PROP solution (0.059M). Participants were 
instructed to rate their perceived intensity for each solution and the PROP paper 
using a general Labelled Magnitude Scale (gLMS) [73] with labels of no sensation (0 
mm), barely detectable (2 mm), weak (7 mm), moderate (20 mm), strong (40 mm), 
very strong (61 mm), and strongest imaginable (114 mm). Mean intensity ratings 
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from duplicate presentations for each stimulus were used in all analyses. A total of 
1757 participants completed the full test battery (solutions and PROP paper) with a 
further 242 providing an intensity rating for the PROP paper only. 
Genotyping, Genetic Imputation and Quality Control 
Genotyping was performed with the Illumina 610-Quad BeadChip (n = 1457 
individuals) and the HumanCoreExome-12 v1.0 BeadChip (n = 542 individuals), with 
approximately 700k SNPs passing standard quality control filters, as outlined 
previously [37]. These SNPs were then phased using ShapeIT [154] and imputed 
using Minimac3 [155] and the Haplotype Reference Consortium of Caucasian 
European ancestry (Release 1) [156]. Individuals who were > 6 SDs from the 
PC1/PC2 centroid were excluded, so our sample was of exclusively European 
ancestry. To ensure SNPs were imputed with high data quality, SNPs with a call rate 
< 90%, MAF < 0.05, imputation score < 0.3, and Hardy–Weinberg equilibrium score 
of P < 10-6 were excluded. Approximately 4.4 million SNPs met these criteria and 
were used in the analyses.  
Genome-wide Association Analysis 
Univariate and bivariate GWAS were conducted using GEMMA [76], which fits 
a linear mixed model for each SNP and uses the genetic relatedness matrix to 
account for the family structure. Covariates included age, sex, a history of ear 
infection, all of which were shown to be associated with taste intensity ratings [107], 
and the first five PCs calculated from the genotypes. Bivariate analysis essentially 
provides a complement to univariate analysis. It can enhance the strength of a SNP 
association, but the estimated effect on each of the two traits remains. For non-
pleiotropic SNPs identified in bivariate analysis, we tested for their associations 
using conditional analysis of the associated trait conditional on the non-associated 
trait. When two identified SNPs were correlated, to test whether they were 
independent signals for the corresponding traits, we performed conditional analyses, 
by fitting each of the SNPs as an extra covariate. Prior to analyses, intensity ratings 
for each stimulus were square root transformed to obtain a more normal distribution 
[107] and then converted to Z-scores. A genome-wide significance threshold was 
defined as P < 5.0e-8. As four of the phenotypes were correlated (rp between quinine, 
caffeine, SOA and DB = 0.58 – 0.64; Chapter 2) the number of independent tests 
was estimated using a matrix spectral decomposition algorithm [157] at 4.96 and 
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accordingly a Bonferroni-corrected threshold was defined as P < 1.0e-8. The 
genomic inflation factor (λ) ranged between 0.99 and 1.02 (Supplementary Figures 
3-4 and 3-5), which indicates that potential technical or population stratification 
artefacts had a negligible impact on the results. As all association analyses were 
performed under an additive model and all phenotypes were converted to Z-scores, 
variance explained by a SNP was calculated as 2 × 𝑀𝐴𝐹 × (1 − 𝑀𝐴𝐹) × 𝛽2 . 
Manhattan and Q-Q plots were created using the “fastman” package [158] in R. 
Regional association plots were created using Locuszoom [159]. 
Functional annotation of the identified SNPs 
To examine the potential role of the identified SNPs, we used Haploreg v4.1 
[160] for functional annotation. Briefly, it annotates all index SNPs and their 
correlated SNPs (r2 was set to be ≥ 0.8 for this study) by their associated chromatin 
states (e.g., conserved regions and DNAse hypersensitivity sites) from the Roadmap 
epigenomics project [161] and Encode project [162] and their effects on regulatory 
motifs. It also reports the effect of SNPs on gene expression in multiple tissues from 
eQTL (expression quantitative trait loci) studies, including results from the GTEx [163] 
project portal. Use of functional annotation provides more information about the 
putative role of a specific gene as well as developing mechanistic hypotheses of the 
impact of the SNP on phenotypes (e.g. variation in taste perception). More details 
are provided in Supplementary Table 3-3. 
Ethical Statement 
The Queensland Institute of Medical Research Human Research Ethics 
Committee approved the study. Written informed consent was obtained from both 
the participants and their parents (the latter not required for those 18 years and over) 
before participation. All methods were performed in accordance with the relevant 
guidelines and regulations. 
Results 
 We confirmed two previously identified associations with large effects on 
PROP and quinine, provided the first independent replication of an association for 
caffeine, and revealed two new associations with small effects (< 2%) on SOA and 
DB (Table 3-1). In addition, we found evidence for pleiotropic effects on quinine, 
caffeine, SOA and DB. 
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Table 3-2. Conditional analyses of correlated SNPs on chromosome 12 
associated with the perception of quinine, caffeine and sucrose octaacetate 
(SOA). 
Trait SNP 
Association 
(P-value) 
Association conditional on correlated SNP (P-value) 
rs10772420 rs2597979 rs67487380 
Quinine 
rs10772420 7.8e-23 - 3.0e-19 1.5e-10 
rs2597979 4.3e-3 4.4e-2 - - 
rs67487380 1.5e-13 0.12 - - 
Caffeine 
rs10772420 2.5e-3 - 0.38 - 
rs2597979 4.2e-8 4.4e-6 - 9.7e-8 
rs67487380 0.11 - 0.47 - 
SOA 
rs10772420 1.0e-4 - - 0.47 
rs2597979 0.38 - - 0.63 
rs67487380 3.8e-7 7.6e-4 5.3e-7 - 
r2 = 0.24 between rs10772420 and rs2597979; r2 = 0.43 between rs10772420 and rs67487380; r2 = 0.08 between rs2597979 
and rs67487380. SNP in bold in the second column are index SNPs for the corresponding traits from Table 3-1. 
 
 
Confirmation of the locus on chromosome 12 influencing quinine and 
pleiotropic effects 
 The peak association for quinine was a missense variant within the bitter taste 
receptor gene TAS2R19 on chromosome 12 (rs10772420, Figure 3-2a). As expected, 
with the increase in sample size the association was stronger (P = 7.8e-23) than that 
found in the initial GWAS (P = 1.8-e15) [37], and the peak SNP explained almost the 
same amount of variance (5.67%). In the bivariate analysis, which included caffeine, 
there was a further boost in signal (P = 4.8e-65, Table 3-1). This was due to the 
nominal association of caffeine with rs10772420 (P = 2.5e-3; Figure 3-2b) and the 
effect of the minor allele being in the opposite direction to quinine (i.e. decrease in 
caffeine versus increase in quinine perception), which provided greater separation of 
the rs10772420 genotypes in two-dimensional space (as illustrated in Figure 3-1b). A 
much smaller increase in the quinine signal was found in the bivariate analysis with 
SOA (P = 1.8e-24) and DB (P = 6.4e-26). Both compounds (SOA: P = 1.0e-4; DB: P 
= 2.8e-3) were nominally associated with rs10772420 (Figure 3-2c and d), but the 
effect of the minor allele was in the same direction as that for quinine, resulting in 
little/no further separation of the genotypes in two-dimensional space (as illustrated 
in Figure 3-1c). Notably the size and direction of the effect of rs10772420 on the four 
bitter substances varied (Supplementary Figure 3-1; Supplementary Table 3-9): the 
strongest effect was on quinine (= -0.337; 5.67% of the variance or 12.32% of the 
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genetic variance), with a smaller fraction of the variance being explained for caffeine 
( = 0.107; 0.57/1.24% of the total/genetic variance), SOA ( = -0.137; 0.94/2.04% of 
the total/genetic variance) and DB ( = -0.106; 0.56/1.22% of the total/genetic 
variance). In Figure 3-3 we show that variants with the largest effect on quinine - a 
cluster of 263 SNPs - were also associated with SOA, caffeine and DB, and that this 
cluster was separate to the top SNPs for SOA (a cluster of 167 SNPs) and caffeine 
(a cluster of 116 SNPs). 
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Figure 3-2. Common variants associated with the perception of bitter taste: (a) 
quinine, (b) caffeine, (c) sucrose octaacetate, and (d) denatonium benzoate (n 
= 1757). The left half of the figure shows the Manhattan plots, displaying the 
association P-value for each SNP in the genome (displayed as –log10 of the P-
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value). The red line indicates the genome-wide significance threshold of P = 
5.0e-8. rs10772420 (labelled in red), rs2597979 (labelled in green), and 
rs67487380 (labelled in blue) are the most significant SNP within a putative or 
associated locus for quinine, caffeine, and sucrose octaacetate, respectively. 
rs10261515 is labelled in (d) because it reaches genome-wide significance in 
the bivariate analysis (Table 3-1 and Figure 3-4). The right half of the figure 
shows regional plots ± 400kb for the top SNPs on chromosomes 12 (a, b, and c) 
and 7 (d) with gene model below. Plots are zoomed to highlight the genomic 
region that likely harbors the causal variant. The top SNP for PROP 
(rs10246939) is also labelled in the regional plot in (d). 
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Figure 3-3. Top SNP associations on chromosome 12 for perceived intensity of 
quinine, sucrose octaacetate (SOA), caffeine and denatonium benzoate (DB). 
The red, blue and green clusters represent the top SNP associations with 
quinine, SOA and caffeine respectively. The top SNPs for these three bitter 
compounds are clustered separately from one another, even though the lead 
SNPs (rs10772420 for quinine; rs2597979 for caffeine; rs67487380 for SOA) of 
each cluster are correlated (r2rs10772420-rs2597979 = 0.24; r2rs10772420-rs67487380 = 0.43; 
r2rs2597979-rs67487380 = 0.08). The top SNPs for DB in this genomic region overlap 
with the tops SNPs for SOA, but the strengths of the associations with DB are 
weaker. In addition, there is evidence of pleiotropy. The red cluster is strongly 
associated with quinine, and more weakly associated with caffeine, SOA and 
DB; the blue cluster is associated with quinine, SOA and DB; the green cluster 
is associated with quinine and caffeine. A total of 1035 SNPs on chromosome 
12 between 10950000 and 113550000 base pairs are plotted here. 
 
 
 
73 
Independent replication of a SNP association on chromosome 12 for 
caffeine 
For caffeine perception, we identified a peak association on chromosome 12 
(rs2597979, P = 4.2e-8; Figure 3-2b), which accounted for a maximum trait variance 
of 1.91%. This SNP was in high linkage disequilibrium with that identified in a 
previous GWAS for caffeine detection threshold [38] (r2 = 0.84 with rs2708377), and 
therefore we provided the first independent replication for this association. Further 
support was provided by our bivariate caffeine-quinine analysis (P = 8.4e-24). The 
enhancement in signal due to quinine also being associated with rs2597979 (P = 
4.3e-3), with the effect in the opposite direction to caffeine (Supplementary Figure 3-
1). Since the lead SNPs for caffeine (rs2597979) and quinine (rs10772420) were 
weakly correlated (r2 = 0.24), we tested whether the associations could be driven by 
the same SNP using conditional analysis, where each of the genotypes are included 
as a covariate. The caffeine-rs2597979 association remained (P = 4.4e-6; Table 3-2) 
after conditioning on the lead SNP for quinine, whereas the caffeine-rs10772420 
association disappeared (P = 0.38) after conditioning on rs2597979, indicating that 
the caffeine-rs2597979 association was not driven by rs10772420. For quinine, the 
results of the conditional analysis were less clear. While the quinine-rs10772420 
association remained highly significant after conditioning on the lead SNP for 
caffeine (P = 3.0e-19), a weak quinine-rs2597979 association remained after 
conditioning on rs10772420 (P = 0.044). Figure 3-3 shows that the top caffeine 
SNPs are weakly associated with quinine and largely independent from the top 
quinine SNPs. 
In contrast to quinine, we found little evidence for an association of either 
SOA or DB with rs2597979 (SOA: P = 0.38; DB: P = 0.62). The small boost in the 
caffeine-rs2597979 association found in the bivariate analysis (caffeine and SOA: P 
= 2.8e-10; caffeine and DB: P = 4.5e-11) was likely due to the correlation between 
the traits, which was supported by the boost in the caffeine-rs2597979 association 
when the intensity ratings for SOA (P = 5.9e-11) or DB (P = 7.9e-12) were included 
as a covariate. Figure 3-3 shows that the caffeine-associated SNPs are largely 
independent from SOA/DB-associated SNPs in this genomic region of chromosome 
12. 
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Putative novel associations identified in bivariate analyses influencing 
SOA and DB  
The strongest association for SOA was found on chromosome 12 
(rs67487380, P = 3.8e-7; Figure 3-2c). This SNP was also associated with quinine (P 
= 1.5e-13; Table 3-2, Figure 3-2a) and DB (P = 8.5e-4), with the size and direction of 
the effect being similar to that for SOA (Supplementary Figure 3-1), so that the boost 
in signal found in the bivariate SOA-quinine analysis (P = 5.4e-13; Table 3-1) was 
likely due to quinine. Even so, we found that the SOA-rs67487380 association 
remained when we conditioned on the lead SNP for quinine (P = 7.6e-4, Table 3-2), 
which is moderately correlated with rs67487380 (r2 = 0.43), whereas the SOA-
rs10772420 association was lost (P = 0.47) when rs67487380 was included as a 
covariate. Similarly, for quinine, the rs10772420 association remained after 
conditioning on the lead SOA SNP (P = 1.5e-10), but the quinine-rs67487380 
association disappeared (P = 0.12, Table 3-2), after conditioning on the lead quinine 
SNP. These conditional analysis results indicated that each of lead SNPs for SOA 
and quinine represents the main signal for its corresponding taste. Figure 3-3 clearly 
shows that the top SNPs for SOA and quinine are clustered separately from each 
other, whereas the top SNPs for DB in the genomic region on chromosome 12 
largely overlap with the top SNPs for SOA. 
In contrast to quinine and DB, caffeine was not associated with the lead SOA 
SNP (P = 0.11; Table 3-2). A small boost in signal in the bivariate SOA-caffeine 
analysis (P = 4.5e-8) was largely due to the correlation between SOA and caffeine. 
Further, the SOA-rs67487380 association remained after conditioning on the 
intensity rating for caffeine (P = 1.0e-8), indicating that the covariance between SOA 
and caffeine was not due to this SNP. Figure 3-3 shows that the top SNPs for SOA 
and caffeine are largely separated and this is because their lead SNPs are only 
subtly correlated (r2 = 0.08 between rs67487380 and rs2597979).  
For DB, while all SNP associations had a P-value > 1.0e-6 (Figure 3-2d), one 
association on chromosome 7 (P = 2.5e-4) was boosted in the bivariate DB-quinine 
analysis (rs10261515, P = 3.1e-8, Table 3-1, Figure 3-4). The bivariate signal was 
mainly driven by the SNP association with DB, as there was no evidence for an 
association between quinine and rs10261515 (P = 0.15), and the DB signal was 
boosted after conditioning on the intensity score for quinine (P-value changed from 
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2.5e-4 to 1.9e-8). There was no evidence that this DB-associated SNP was 
associated with caffeine (P = 0.81) or SOA (P = 0.15), and little evidence of a signal 
boost in either the DB-caffeine (P = 4.0e-6) or DB-SOA (P = 5.6e-4) bivariate 
analyses (Table 3-1). 
The SNP rs10261515 is located within KIAA1147 on chromosome 7, nearby 
three bitter taste receptor genes TAS2R3, TAS2R4 and TAS2R5 (Figure 3-2d), and 
is 274 kb upstream of the PROP-associated SNP rs10246939, with which it is 
weakly correlated (r2 = 0.23; Figure 3-2d). When we conditioned on the lead SNP for 
PROP, the DB-rs10261515 association remained (P = 9.0e-4), including after the 
additional adjustment for the quinine score (P = 1.7e-5). 
 
 
Figure 3-4. Manhattan plot showing a common variant (rs10261515) on 
chromosome 7 associated with the perception of denatonium benzoate (DB) 
based on the Bivariate GWAS of DB and quinine (n = 1757). The signal on 
chromosome 7 is driven by DB (P = 2.5e-4 in the univariate analysis) not 
quinine (P = 0.15). The signal on chromosome 12 is mainly due to the 
association of rs10772420 with quinine rather than DB as shown in Figures 3-
2a and d. The red line indicates the genome-wide significance threshold of P = 
5.0e-8.  
 
Confirmation of previously identified locus on chromosome 7 
influencing PROP 
The peak association for PROP was the well-known missense variant 
rs10246939 within the bitter taste receptor gene TAS2R38 on chromosome 7 (Table 
3-1, Supplementary Figure 3-2), confirming our previous findings [37]. For PROP 
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paper, we identified a secondary locus within the DIRC3 gene on chromosome 2 
(rs6761655 and its completely correlated SNP rs6736242 [r2 = 1.0], P = 2.7e-8, 
Supplementary Figure 3-2b). This SNP accounted for a maximum trait variance of 
1.83% in PROP paper and showed a weaker but nominally significant association 
with the perception of PROP solution (P = 7.4e-4). We note that this signal was 
present in the previous GWAS [37] (Supplementary Figure 3-3), but was less 
obvious (i.e. not a solid peak as there were fewer [2.3 million] SNPs used in the 
earlier GWAS) and therefore was not reported. However, we found no evidence for 
this association with PROP perception in one previously reported GWAS of 225 
Brazilians [145], as well as two unpublished GWAS, one of ~500 individuals from the 
Silk Road population and one of ~2500 Italians (Supplementary Table 3-10). We 
further searched for this association in an earlier linkage study [164], which prepared 
PROP paper in the exact same way as the present study, but the closest marker was 
~500kb away from rs6761655 and it was not associated. 
Functional annotation of the identified SNPs 
We performed functional analysis (i.e. the SNP effect on gene expression and 
DNA methylation) for five of the six SNPs in Table 3-1 using the bioinformatics tool 
Haploreg [160]. We did not include rs6761655 here due to lack of replication in the 
independent datasets. We also searched for bitter taste receptors that have been 
shown to respond to these bitter substances in human cell-based functional studies 
[165, 166]. The key results are presented in Table 3-3 and a summary of the 
functional analysis can be found in Supplementary Table 3-11. 
The SNPs for quinine (rs10772420) and PROP (rs10246939) are missense 
variants within TAS2R19 and TAS2R38 respectively. In addition, the caffeine-
associated SNP (rs2597979) is highly correlated with a missense variant 
rs10743938 (r2 = 0.92) within TAS2R31. This SNP has two possible allele changes 
of T>A and T>G, leading to residue changes of Leu162Met and Leu162Val 
respectively. In the present study, only rs10743938:T>A passed quality control and 
its association with caffeine had a P-value of 1.1e-7 (Supplementary Table 3-2). 
Further, the SNPs for quinine, caffeine, and SOA are common expression 
quantitative loci (eQTL) for five bitter taste receptor genes (TAS2R14, TAS2R20, 
TAS2R31, TAS2R43, TAS2R64P) on chromosome 12, and the expression of other 
bitter taste receptors in the same region is regulated by one or two of these three 
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SNPs, e.g. the expression of TAS2R46 is only regulated by the SOA and quinine 
associated SNP rs67487380. The DB-associated SNP rs10261515 influences the 
expression of the bitter taste receptor genes, TAS2R4 and TAS2R5, on chromosome 
7. T2R4 is more likely to a receptor for DB because the allele (rs10261515 G allele) 
for weaker DB intensity rating is associated with a lower expression level of TAS2R4 
and the opposite (higher) for TAS2R5. In addition, DB can activate T2R4 but T2R5 in 
cell-based functional analysis. Results from the cell-based functional analysis do not 
necessarily agree with the results from the bioinformatics functional analysis. For 
example, the quinine-associated SNP rs10772420 is a missense variant within 
TAS2R19 and it regulates both gene expression and DNA methylation of TAS2R19, 
but T2R19 does not respond to quinine. We note that neither of these bioinformatics 
and cell-based functional analyses were based on human taste tissues. 
 
Table 3-3. Bioinformatics and cell-based functional studies of the genetic 
variants associated with bitter taste perception. 
Trait Index SNP 
GENCODE 
genes 
Non-synonymous 
SNPs in LD (r2 ≥ 0.8) 
with index SNP 
eQTLa mQTLb 
Cell-based functional 
analysisc 
Quinine rs10772420 TAS2R19 rs10772420 in 
TAS2R19 
TAS2R10, 
TAS2R14, 
TAS2R19, 
TAS2R20, 
TAS2R31, 
TAS2R43, 
TAS2R50, 
TAS2R64P 
TAS2R19 T2R4, T2R7, T2R10, 
T2R14, T2R31, T2R39, 
T2R40, T2R43, T2R46 
Caffeine rs2597979 PRR4, 
TAS2R31 
rs10743938 in 
TAS2R31 
TAS2R14, 
TAS2R15, 
TAS2R20, 
TAS2R31, 
TAS2R43, 
TAS2R45, 
TAS2R64P   
TAS2R19, 
TAS2R50  
T2R7, T2R10, T2R14, 
T2R43, T2R46 
SOA rs67487380 PRR4  TAS2R10, 
TAS2R12, 
TAS2R14, 
TAS2R15, 
TAS2R19, 
TAS2R20, 
TAS2R31, 
TAS2R43, 
TAS2R46, 
TAS2R64P  
 T2R46 
DB rs10261515 KIAA1147  TAS2R4, 
TAS2R5 
 T2R4, T2R8, T2R10, 
T2R13, T2R30, T2R39, 
T2R43, T2R46 
PROP rs10246939 MGAM, 
TAS2R38 
rs713598, rs1726866 
and rs10246939 in 
TAS2R38 
TAS2R5, 
TAS2R38 
  T2R4, T2R38 
a The genotype of the index SNP and/or correlated SNPs (r2 ≥ 0.8) is associated with the expression of these bitter taste 
receptor genes.  
b The genotype of the index SNP and/or correlated SNPs (r2 ≥ 0.8) is associated with the methylation of DNA fragments 
within these bitter taste receptor genes. 
c Bitter taste receptors shown to respond to bitter substances in cell-based functional analysis using human embryotic kidney 
cells [165, 166]. 
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Discussion 
In this study of bivariate GWAS on human taste perception, we identify two 
putative novel associations, including rs67487380 on chromosome 12 for SOA-
elicited bitter taste and rs10261515 on chromosome 7 for DB-elicited bitter taste. In 
addition, we provide the first independent replication of an association on 
chromosome 12 for caffeine bitterness (rs2597979) and confirm the previously 
reported associations for quinine bitterness (rs10772420 on chromosome 12) and 
PROP bitterness (rs10246939 on chromosome 7). All variants are located within the 
bitter taste receptor clusters on chromosomes 7 and 12, highlighting the importance 
of these two regions in the genetics of bitter taste. Further, we show evidence of 
pleiotropy for those variants on chromosome 12 and the functional importance of the 
DB-associated SNP.  
This is the first GWAS study to identify a SNP (rs67487380 on chromosome 
12) association with human perception of SOA. In mice, a major locus for SOA 
perception (soa) was reported in the early 1990s [167]. Interestingly, the mouse soa 
locus also affects the perception of other bitter substances, including quinine, DB, 
PROP, but not caffeine [168, 169]. Here we show that rs67487380 is also associated 
with the perception of quinine and DB, but not caffeine or PROP (P > 0.05). SOA 
activates human T2R46 but no other T2Rs in heterologous expression assays [166]. 
It is possible that rs67487380 regulates the perception of SOA through its effect on 
mRNA expression because the G allele for weaker SOA intensity is also associated 
with a lower expression level of TAS2R46. Nevertheless, rs67487380 could still be a 
proxy for true causal variants.  
The finding of the novel association between DB and the SNP rs10261515 
suggests that there may be a second locus on chromosome 7 that affects human 
bitter taste perception (the first is the locus within TAS2R38 for PROP). 
Heterologous expression studies using human embryotic kidney (HEK) cells 
transfected with TAS2Rs have shown that DB activates T2R4 but no other bitter 
taste receptors in this region (e.g. T2R3, T2R5, and T2R38) [165]. In addition, the 
human T2R4 is the ortholog of mouse T2R8, which also responds to DB [141]. Our 
functional annotation results provide further support for T2R4 as a DB bitter taste 
receptor, since the allele (rs10261515 G allele) for a lower perceived intensity of DB 
is associated with lower expression level of TAS2R4 mRNA. 
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The SNP association for caffeine perception replicated a previous GWAS of 
608 Brazilian adults [38]. In that study the lead SNP accounted for 8.9% of the 
variance in caffeine sensitivity, compared with our estimate of 1.9%. Similarly, the 
quinine-associated SNP accounted for 23.2% of the variance in quinine sensitivity in 
the Brazilian study, which is four times of the effect estimated here. This difference in 
effect sizes is likely due to two main factors. First, the taste scores in the Brazilian 
sample were corrected for overall-taste-sensitivity (an average score of the 
perception of sweet, umami, sour, salty and bitter compounds), which removed 
~30% of the variance in the perception of caffeine and quinine. Without correction, 
rs10772420 accounted for 13.2% of the variance in quinine, and the caffeine 
association was not detected due to low power. Second, the Brazilian study used a 
detection threshold approach, which measures overall oral sensitivity, compared with 
our measure of bitter taste intensity. Regardless, both studies identified the same 
variants for caffeine, quinine as well as PROP, indicating that these are likely to be 
valid associations among human bitter taste perception and these T2R-rich regions 
of chromosomes 7 and 12. 
The functional annotation of the caffeine-associated SNP showed that the 
highly correlated SNP (rs10743938) is a missense mutation that could affect the 
function of T2R31. Although this is the first evidence linking this bitter taste receptor 
to the perception of caffeine, genetic variants in TAS2R31 have been shown to affect 
the perception of quinine [170] and acesulfame potassium [171] (a non-nutritive 
sweetener with bitter aftertaste). Prior cell-based functional studies [165] reported 
that caffeine does not activate T2R31 in heterologous expression assays; rather, it 
activates T2R7, -10, -14, -43, and -46, and that the summed expression level of 
these activated T2Rs increases with the perceived intensity of caffeine [50]. However, 
comparing results from bioinformatics and cell-based analyses can be limited by two 
major factors. Here, we report associations for the index (lead) SNP with the lowest 
P-value, but since this SNP is in a linkage disequilibrium block, the association could 
be driven by any variant within the block. Second, these cell-based functional assays 
[165] were conducted in heterologous systems (i.e. HEK cells transfected with 
TAS2Rs), which may not always recapitulate human sensory experience faithfully 
[172]. We observed a similar difference for quinine, with the lead quinine-associated 
SNP rs10772420 constituting a missense mutation in TAS2R19. Yet T2R19 does not 
respond to quinine in functional expression assays [165]. Therefore, a better method 
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to identify causal SNPs for the foreseeable future is to tightly integrate genetic-
perceptual association results with those of taste receptor cell-based assays using 
human taste tissues, such as taste buds or cultured human taste cells [173].  
This study provides the first evidence for antagonistic genetic pleiotropy in 
bitter taste. The two SNPs rs10772420 and rs2597979 have opposite effects on the 
perceived intensity of quinine and caffeine (Supplementary Figure 3-1; 
Supplementary Table 3-3) and this largely enhances the strengths of their 
associations (P-value) in the bivariate analysis (Figure 3-1b). As bitter-tasting 
substances (e.g. caffeine [174]) can have both beneficial and detrimental effects, the 
antagonistic pleiotropy may be an evolutionary consequence that avoids over and 
under consumption. 
The top SNPs for quinine, caffeine, and SOA were correlated (r2 = 0.08 – 0.43) 
and each could have various effects on one another. These correlations are due to 
the linkage disequilibrium between polymorphisms within bitter taste receptor genes 
on chromosome 12, which results in common haplotypes for nearby genes and long-
range haplotypes for more distant ones [175, 176]. Previous studies have revealed a 
complex bitter substance – receptor relationship, with one bitter compound activating 
multiple T2Rs and one T2R responding to multiple bitter substances [165, 166, 177]. 
Taken together, it is likely that the perception of a bitter taste can be mediated by 
multiple T2Rs, and SNPs identified in the present study could represent haplotypes 
that regulate several T2Rs together. We have attempted to illustrate this in Figure 
3-5 by taking the perception of quinine and caffeine as an example. The lead SNP 
for quinine (rs10772420) is correlated with several SNPs (the regional association 
plot in Figure 3-2a) that regulate the T2Rs for quinine (cell-based functional analysis 
results in Table 3-3). Also, the lead SNP for caffeine (rs2597979) is correlated with 
SNPs (Figure 3-2b) that regulate T2Rs for caffeine (Table 3-3). In addition, the 
common T2Rs for the two tastes are regulated by SNPs that are in linkage 
disequilibrium with the two lead SNPs. We note that the real regulatory network can 
be more complex than this, such that one T2R can be regulated by multiple SNPs. 
Whereas we used conditional analysis (Table 3-2) and plotted the SNP associations 
against the three tastes (Figure 3-3) to show that each of the lead SNPs represents 
the main signal in the linkage disequilibrium block, the clusters of nearby bitter 
receptors and many variants in high linkage disequilibrium create challenges in 
separating causal from non-causal variants. 
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Figure 3-5. Potential model of the SNP regulation of human bitter taste 
perception. Quinine can be detected by bitter taste receptors T2R4, -7, -10, -14, 
-31, -39, -40, -43, and -46 on chromosome 12, and caffeine can be detected by 
the T2R7, -14, -43, and -46 (as summarized in Table 3-3), which overlap the 
T2Rs for quinine. Here we assume that each T2R is regulated by a major SNP 
with the corresponding number. rs10772420 is associated with the perception 
of quinine via its correlated SNPs; rs2597979 is associated with the perception 
of caffeine via its correlated SNPs.  
 
Perceptual studies of bitter taste also have reported that individual differences 
in perceived bitterness from multiple compounds show positive correlations. Most 
relevant to the present work, past studies demonstrated a strong correlation of 
perceived bitter taste intensities among DB, SOA, and quinine [153]. This 
observation harkens to that reported in the present study for rs67487380 on 
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chromosome 12. Furthermore, individual differences in bitterness from SOA, caffeine 
and quinine were also observed, suggesting a linkage between SOA receptor 
variants and caffeine receptor variants [153]. This too reflects associations observed 
in the present data set. Perhaps, a linkage disequilibrium block accounts both for the 
genetic architecture as well as the bitterness perception associations.  
Prior work using pedigree segregation analysis has proposed that the 
perception of PTC (a structurally related chemical to PROP) is modulated by a 2-
locus model [135], but the location of a second locus has been unclear for nearly 30 
years. Here we found no support for an association with TAS2R1, which was 
suggested by a prior family-based linkage study [164], but identified a putative 
secondary locus within the DIRC3 gene on chromosome 2, which accounted for an 
additional 1.83% of the variance (4.58% of the genetic variance) in the perception of 
PROP paper. While we found no evidence for replication using three independent 
datasets – from one published study (i.e. the Brazilian sample) and two unpublished 
(the Silk Road and the Italian samples), we note that there are considerable 
differences across studies (e.g., sample age [all other studies used adults], ethnicity, 
and delivery method [the Brazilian study used PROP solution]), which may have 
influenced our ability to replicate their findings. We did a further search for this 
association using available data from an early linkage study [164], which used the 
same PROP paper, but were severely limited by the sparsity of markers, as none 
were close to the SNP identified in the present study. Ideally, we need to test for this 
association using the same methods and materials (i.e. the perceived intensity of 
saturated PROP paper measured from adolescents with European ancestry), but at 
this stage the signal does not appear to be sufficiently robust to be detected with 
alternative methods. 
The strengths of the present study include the use of the largest-to-date 
sample with multiple taste phenotypes from the same individuals, which increases 
the statistical power via bivariate association analysis. We show that the association 
signals (P-value) for quinine and caffeine (rs10772420 and rs2597979 respectively) 
were stronger in the bivariate compared with the univariate analysis, but the 
estimated effect size remains the same. The signal boosts in these already 
established associations serve as a proof of principle for using bivariate GWAS. We 
also show that, through the discovery of the association of DB, a signal can be 
enhanced when only one of two correlated traits is associated. This is useful for 
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identifying non-pleiotropic SNPs for correlated phenotypes. We used multiple levels 
of analysis (conditional on genotype and phenotype) as well as cluster plots to 
disentangle the pleiotropic nature of these SNPs with bitter tastes and provide 
additional support for the signals identified in the bivariate analyses. We attempted to 
obtain data to replicate every novel association. However, we were unable to test the 
association for SOA and DB, due to no other datasets being available. Given the 
enhancement in the known signals for both quinine and caffeine in the bivariate 
analyses, together with the post-hoc bioinformatics analyses, as well as prior 
functional analyses, we believe the SOA and DB hits are unlikely to be false 
positives. Further, findings from multivariate GWAS of other phenotypes, e.g. levels 
of plasma lipids [178], have been replicated in independent studies. The variants for 
SOA and DB account for less than 10% of the genetic variance (< 2% of trait 
variance) of their associated traits, suggesting that there are more variants with 
smaller effects. The remaining genetic variance could be partly due to rare variants 
because SNPs with an MAF smaller than 5% were excluded here and rare variants 
can have a large effect on complex traits [179]. 
In conclusion, this study reveals the influence of multiple variants on bitter 
taste and demonstrates the benefits of multivariate analysis over the conventional 
univariate GWAS. Recent advancement in the methodology of multivariate GWAS 
(i.e. MTAG [180]) could make multivariate analysis easier to apply because it uses 
individual summary level results from different studies and does not require 
correlated phenotypes to be collected from the same sample. Whereas our previous 
twin analysis (Chapter 2) provided strong evidence of pleiotropy for the perception of 
several bitter compounds (except for PROP), there are numerous causal models that 
could underlie this shared genetic aetiology. Identification of specific SNPs/genes 
involved offers a useful starting point for determining the biological pathways linking 
perception of bitter substances and for delineating of the mechanisms involved. 
Future studies integrating bioinformatics and functional analyses using human taste 
tissues will provide stronger evidence in identifying true causal variants, which could 
assist personalized nutrition and precision medicine. 
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4  
Understanding the Role of 
Bitter Taste Perception in 
Coffee, Tea and Alcohol 
Consumption through 
Mendelian Randomization  
 
 
Chapter modified from a manuscript submitted to Scientific Reports (June 2018). 
I presented the preliminary results at the Brisbane Life Scientist Symposium in 
November 2017 (see Supplementary Document for the abstract). 
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Chapter 4. Understanding the role of bitter taste 
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Abstract 
Coffee, tea and alcohol are widely consumed bitter beverages of high public 
health interest because they are implicated in various health conditions. 
Consumption behaviour of these beverages can be shaped by individual differences 
in bitter taste perception but findings from observational studies are unclear and 
provide no insight to causality. This study aimed to examine the causal relationship 
between perception of three bitter substances, propylthiouracil (PROP), quinine, and 
caffeine, and the consumption of coffee, tea, and alcohol. We applied a two-sample 
Mendelian randomization analyses. Genetic instruments for the perception of PROP 
(rs1726866), quinine (rs10772420) and caffeine (rs2597979) were obtained from a 
genome-wide association study of Australian Twins of European ancestry (sample 1; 
Chapter 3). These association of these variants with consumption of coffee, tea and 
alcohol were obtained from a population-based cohort study including up to 438,870 
UK Biobank participants of white-British ancestry (sample 2). The results showed 
that, with every 2-standard deviation change in the predicted taste perception, a 
higher perceived intensity of caffeine increased coffee consumption by 0.076 (P = 
1.6e-9) cups per day, whereas higher perceived intensities of PROP and quinine 
decreased coffee consumption by 0.034 (P = 7.2e-4) and 0.052 (P = 1.9e-7) cups 
per day. For tea consumption, an inverse relationship with each bitter taste was 
observed due to the negative correlation between coffee and tea intake. Higher 
perceived intensities of PROP and quinine increased tea consumption by 0.067 (P = 
3.7e-7) and 0.059 (P = 2.1e-8) cups per day, and a higher perceived intensity of 
caffeine decreased coffee consumption by 0.094 (P = 2.1e-8) cups per day. For 
alcohol, only the perception of PROP was associated, with every 2-standard 
deviation increase in the predicted perceived intensity leading to a lower alcohol 
intake (P = 5.9e-10). We present strong evidence that bitter taste perception is 
causally associated with intake of coffee, tea and alcohol, with the patterns of causal 
relationships varying by bitter stimulus. These results provide insights into the 
development and prevention of their addictive consumption behaviour and 
consequential health outcomes. 
Introduction 
Coffee, tea and alcohol are widely consumed beverages with bitter taste that 
most humans naturally dislike at first tasting. They have been implicated in both 
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beneficial and adverse health effects [174, 181]. Individual differences in 
metabolizing caffeine [182, 183] and ethanol [184-188] present in these beverages 
may shape their consumption, whereas the influence of taste factors remain unclear.  
The relationship between the perception of bitter compounds, such as 
propylthiouracil (PROP), quinine, and caffeine, and the consumption behaviour of 
these bitter beverages had been inconsistent across various studies [50-57, 189-
191]. As performing taste tests is a time-consuming process, these investigations 
likely lacked sufficient power to convincingly rule out moderate effects due to sample 
size limitations, which complicates causal inferences. However, these issues can be 
overcome by recent advances in taste genetics and statistical genetic methods. 
Heritabilities for the perceived intensity of PROP, quinine, and caffeine have 
been estimated to be 0.73, 0.40, and 0.36 in classical twin studies [41, 107]. 
Furthermore, candidate gene and genome-wide association studies (GWAS) have 
pinpointed precise genetic factors [37, 38], including SNPs in/near bitter taste 
receptor genes TAS2R38 for PROP, TAS2R19 for quinine, and TAS2R31 for 
caffeine. Identification of these genetic variants enables Mendelian randomization 
analysis (MR), a technique commonly used in disease epidemiology, to make causal 
inferences of an exposure on outcomes of interest using genetic variants (i.e. SNPs) 
as instrumental variables. Its fundamental principle is based on Mendel’s Law of 
Independent Assortment whereby genetic variants are shuffled at meiosis, 
conceptually mimicking a “natural” randomized trial [77, 192, 193]. Since genetic 
variants are randomized at birth at conception, they can be used as risk factor 
instruments that are generally free from confounding and reverse causality to 
evaluate the relationship of a risk factor on a specific outcome of interest [194, 195]. 
In this study, we investigate the causal relationship between bitter taste 
perception and the consumption of coffee, tea and alcohol through a MR framework. 
We use confirmed genetic markers for the perception of PROP (rs1726866), quinine 
(rs10772420) and caffeine (rs2597979) separately as genetic proxies for bitter taste 
perception and test their associations with the consumption of coffee, tea and 
alcohol among more than 400,000 participants in the UK Biobank cohort [78].  
Methods 
Study group description 
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The UK Biobank recruited 502,650 participants aged 37-73 years at 21 
centres across England, Wales and Scotland in 2006-2010 [78]. This study was 
under generic approval from the UK National Health Service National Research 
Ethics Service. Written informed consent was obtained from participants. 
Genetic data from UK Biobank 
All UK Biobank participants have been genotyped using the Affymetrix UK 
BiLEVE Axiom array or Affymetrix UK Biobank Axiom®  array comprising 805,426 
markers in the official release. Imputations were performed using IMPUTE2 and 
UK10K haplotype and Haplotype Reference Consortium (HRC) reference panels, as 
described elsewhere [78]. For the current analysis, all SNPs of interest were 
genotyped or imputed with high quality (minimum INFO score of 0.95) based on the 
HRC reference panel samples. Our present analyses focused on the population of 
white-British ancestry, as determined by similarity of ancestral principal component 
values (PC1, PC2) to those who self-reported and were classified as white-British 
[78]. Using this criterion, we identified 438,870 individuals of white-British ancestry. 
Genetic instruments for bitter taste 
Genetic proxies for perceived intensity of PROP, quinine and caffeine were 
identified from our GWAS (Chapter 3), which used a subset of the Brisbane 
Adolescent Twin study (n = 1757; aged 12-25; 54% females; all European ancestry) 
[72]. Taste phenotypes were collected between 2003 and 2014. Participants were 
asked to rate the perceived intensity of 6.0 x 10-4 M PROP, 1.81 x 10-4 M quinine, 
and 0.05 M caffeine on a general labelled magnitude scale (gLMS). All three SNP-
taste phenotype associations have also been confirmed in independent studies [35, 
36, 38]. 
Each of the three taste-associated SNPs was genome-wide significant and 
explained an appreciable amount of trait variation (rs1726866 accounted for 46% 
variance in PROP, P = 5.6e-198; rs10772420 accounted for 6% of the variance in 
quinine, P = 7.8e-23; rs2597979 accounted for 2% of the variance in caffeine, P = 
4.2e-8), rendering them suitable instruments for our MR analyses. All the SNPs 
satisfy the F-statistic > 10 criterion for being a strong instrument (Supplementary 
Table 4-1). In the GWAS, taste intensity ratings were square root transformed and 
then converted into Z-scores. Here, we assigned the effect allele (EA) to represent 
the allele associated with higher intensity ratings. The EA for rs1726866 (G allele), 
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rs10772420 (A allele), and rs2597979 (G allele) increased the intensity rating of 
PROP, quinine, and caffeine by 0.965, 0.337, and 0.264 standard deviations (SD), 
respectively. 
Beverage consumption phenotypes 
For bitter beverages consumption, we collated the following traits based on 
the touch-screen questionnaire completed by UK Biobank participants at the 
assessment centre. Amounts of coffee and tea consumption were quantified 
separately based on self-reported daily cups per day consumption, e.g. “How many 
cups of coffee do you drink each DAY? (including decaffeinated coffee)” and “How 
many cups of tea do you drink each DAY? (including black and green tea)”. For 
alcohol, participants were asked “About how often do you drink alcohol?” and to 
report on their drinking behaviour on a 6-point frequency scale (Never, Special 
occasions only, 1-3 times a month, 1-2 times a week, 3-4 times a week, Daily or 
almost daily). Participants who preferred not to answer were excluded from the 
analyses. For participants completing the assessment at multiple times (n > 1), we 
computed their average consumption.  
To assess risks of heavy-consumption, we separated light/non-drinkers from 
heavy drinkers according to the lower quartile and upper quartile of the consumption 
distribution. For coffee, light/non-drinkers were classified as participants with < 2 
cups per day and heavy drinkers as > 4 cups per day of coffee intake. The cut-offs 
were < 2 cups/day and > 5 cups/day for tea-drinking. For alcohol, non-drinkers were 
defined as individuals reporting no consumption of alcohol, while heavy-drinkers 
were individuals who consume more frequently than 3-4 times weekly. 
Statistical Analysis for beverage consumption in UK Biobank 
Associations between each bitter-taste SNP and  bitter beverage consumption 
were estimated through linear and logistic additive models using BOLT-LMM [196] 
(linear) and plink2 [197] (logistic). Covariates included age, sex and the first 10 
principal components (PC). Using genetic PCs, we identified 438,870 Europeans of 
white-British ancestry, described elsewhere [198]. The use of BOLT-LMM allows the 
use of a linear mixed model to adjust for cryptic relatedness, hence maximizing 
power as related individuals can be retained in the analyses. However, BOLT-LMM 
was only formulated for quantitative traits; for binary traits, such as drinker status, the 
software plink2 [197] was used after excluding related individuals.   
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Mendelian randomization analyses 
We applied a two-sample MR approach [193]. The SNP-taste perception 
estimates were derived from our GWAS of taste perception (Chapter 3) while the 
SNP-beverage consumption association was derived from an independent sample, 
the UK Biobank. The MR estimate of the effect of bitter taste perception on 
consumption traits can be calculated using the wald-type ratio estimator [77, 199]. 
The causal magnitude of association can then be estimated through 𝛽𝐼𝑉𝑊 =
𝛽𝑏𝑒𝑣 /𝛽𝑏𝑖𝑡𝑡𝑒𝑟, where 𝛽𝑏𝑒𝑣 refers to the magnitude of association on quantity of bitter 
beverages for each perception-increasing allele and 𝛽𝑏𝑖𝑡𝑡𝑒𝑟 refers to the magnitude of 
association for per-SD change in square-rooted perception score for each 
perception-decreasing allele. For the analyses on logistic traits (e.g. non- vs heavy-
drinkers), the equivalent causal odds ratio can be estimated using log 𝑂𝑅𝐼𝑉𝑊 =
𝑙𝑜𝑔 𝑂𝑅𝑑𝑟𝑖𝑛𝑘 𝑠𝑡𝑎𝑡𝑢𝑠 /𝛽𝑏𝑖𝑡𝑡𝑒𝑟  where 𝑙𝑜𝑔 𝑂𝑅𝑑𝑟𝑖𝑛𝑘 𝑠𝑡𝑎𝑡𝑢𝑠   refers to the (log) increase in 
drinker risk per perception-decreasing allele. The standard errors of our MR 
estimates were derived using the delta method. Estimates were then scaled 
(multiplied by 2) to reflect a 2-SD change in perception score. All statistical analyses 
were performed using in-house scripts written in the statistical package R. As we 
investigated 3 different bitter stimuli against 3 different beverages of interest in our 
analyses, we conservatively set our Bonferroni-corrected P-value to be 0.00556 
(0.05/9). We further assessed SNP associations with potential confounders through 
a look-up effort on publicly available GWAS summary results [200]. 
Results 
Descriptive  
Table 4-1 below summarizes the baseline characteristics including self-
reported measurements of bitter beverage consumption among 438,870 individuals 
that were included in our analyses. The genotype frequencies for each of the bitter 
SNPs are shown in Supplementary Table 4-2. 
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Table 4-1. Baseline characteristics of 438,870 individuals from the UK Biobank 
cohort included in the analyses. 
Variable Statistics Value based on 438,870 participants 
Age  Mean (SD) 56.5 (8.09) 
Sex N of males (%) 223,040 (45.8%) 
Height (cm) Mean (SD) 168.5 (9.28) 
BMI Mean (SD) 27.42 (4.78) 
Smoking N (%)  
    Ever smoked  194,764 (40.16%) 
Self-reported alcohol drinking 
frequency 
N (%)  
 Never  39,434 (8.1%) 
 Special occasions only  55,197 (11.35%) 
 1-3 times/month  56,299 (11.58%) 
 1-2 times/ week  123,195 (25.33%) 
 3-4 times/week  115,327 (23.71%) 
 Daily or almost daily  96,870 (19.91%) 
Coffee consumption Mean (SD)  
 Coffee (cups per day)  2.13 (2.11) 
Tea consumption Mean (SD)  
 Tea (cups per day)  3.51 (2.87) 
 
 
 
 
 
 
 
 
 
 
 
92 
Mendelian randomization estimates of bitter perception on coffee and 
tea consumption 
Associations between bitter SNPs and the consumption of bitter beverage are 
summarized in Supplementary Tables 4-3 (linear) and 4-4 (logistic). Instrumental 
variable estimates for per 2-SD unit increase in perceived bitterness on consumption 
quantity are shown in Figure 4-1a. We identified strong associations between 
genetically predicted higher perception for each bitter taste and coffee consumption 
(P < 1e-4). The magnitude of association for higher caffeine perception (rs2597979) 
is consistently in the opposite direction compared to perception of PROP (rs1726866) 
and quinine (rs10772420), providing evidence that higher perception of caffeine is 
causally associated with increased risk of being a heavy coffee drinker (P = 7e-
4;Figure 4-1b), with similar evidence for association with higher cups per day (P = 
5.2e-4), but higher perception of PROP and quinine results in lower coffee 
consumption. 
Genetically predicted higher PROP and quinine intensity was associated with 
increased tea consumption, with a change of 0.069 (P = 3.6e-8) and 0.055 (P = 9.8e-
6) cups per day per 2-SD increase in perception score. In contrast, higher caffeine 
perception leads to a decrease in tea consumption (beta = -0.091, P = 8.7e-9). 
Similar patterns of association were observed when comparing non-tea drinkers 
against heavy tea drinkers (see Figure 4-1b). All associations remained statistically 
significant upon Bonferroni correction. 
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 (a)
 
(b)
 
Figure 4-1. Causal effects of perceived bitterness of PROP, quinine, and 
caffeine on (A) the intake of coffee, tea, and alcohol and (B) the odd ratio of 
heavy coffee, tea, and alcohol drinker. 
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Conditional Mendelian randomization analyses to address inverse correlation 
between coffee and tea 
As each of the three bitter tastes had opposite effects on the intake of coffee 
and tea, we investigated whether this was driven by the negative correlation between 
coffee and tea intake in the UK Biobank (r = -0.3). To remove the covariance 
between coffee and tea intake, we performed conditional analyses by adjusting for 
cups per day of tea consumption when estimating the MR causal estimates on bitter 
perception of coffee, and vice versa. Our conditional analyses (Supplementary Table 
4-5) revealed that the association between predicted quinine and caffeine perception 
and coffee intake remained after conditioning for tea intake, and the association 
between predicted PROP and caffeine perception and tea intake remained after 
adjusting for coffee intake.  
When stratified by non-drinker status on tea (or coffee) for the association 
between bitter taste and coffee (or tea) (Supplementary Tables 4-6 and 4-7), the 
direction of effect was largely consistent with the unstratified model - with larger 
standard errors due to a loss of effective sample size. However, the magnitude of 
positive (negative) association for caffeine perception on coffee (tea) among non-tea 
(coffee) drinkers was larger than the unstratified model (e.g. beta_coffee among non-
tea drinkers = 0.248; as compared to 0.077 from the original model), suggesting a 
potential beverage preference based on caffeine perception. Complete results for the 
conditional and stratified analyses can be found in Supplementary Tables 4-5 to 4-7. 
Mendelian randomization estimates for alcohol intake 
The MR analysis of bitter taste perception on alcohol varied by stimuli (Figure 
4-1). For PROP, increased predicted intensity was associated with lower alcohol 
consumption (for a 2-SD increase in PROP intensity, beta = -0.038 frequency score, 
P = 5.9e-10). Our MR analyses reveal weak evidence that genetically predicted 
increased quinine perception is associated with higher alcohol consumption as the 
confidence interval overlaps zero. Genetically predicted caffeine perception was not 
associated with alcohol consumption (beta = -0.008, P = 0.3). For drinker status, 
direction of association was largely consistent (Figure 4-1b), but none of the 
associations between predicted bitter taste and drinking status were statistically 
significant after correcting for multiple testing. 
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Investigating sex differences on the causal association between bitter 
taste and bitter beverage consumption 
In light of previously suggested confounding effect of sex on the association 
between bitter perception and these beverages [54, 57, 189], we attempted to 
evaluate whether these differences were observed in our data, by performing our MR 
analyses separately for each sex (Supplementary table 4-8). We found no consistent 
evidence to support sex-difference, except for the association between caffeine 
perception and tea intake which appeared to be much stronger in females (for a 2-
SD increase in caffeine perception score, beta = -0.523 cups per day, P = 1.4e-10 in 
females and beta = -0.181 cups per day, P = 0.06 in males).  
Discussion 
We investigated the perception of different bitter compounds on beverage 
consumption in a large population-based cohort (UK Biobank) using a MR 
instrumental variable approach. To summarize, our MR analyses indicated that 
genetic prediction of higher perceived intensity of PROP and quinine decreased 
coffee consumption and that prediction of higher perceived intensity of caffeine 
increased coffee consumption; opposite relationships were observed for tea 
consumption. For alcohol, higher predicted intensity of PROP resulted in lower 
consumption but the perception of quinine and caffeine had no clear influence. 
These findings highlight a potential role of taste perception in consumption behaviour 
and that the underlying mechanisms are specific to each of the bitter tastes. 
Previous studies investigating the effect of PROP taster status on coffee 
consumption had conflicting findings. Many reported no association [51, 52, 55, 56], 
but one study of Polish elderly women showed that tasters consume coffee more 
frequently [54]. These data may be confounded by the use of coffee condiments as 
PROP tasters are more likely to drink coffee with milk, cream, and sweetener than 
PROP non-tasters [51]. Nevertheless, not only were these studies plagued by the 
caveats of observational study designs, they were also statistically underpowered 
due to low sample sizes (n < 500). Here we showed that the TAS2R38 genotype was 
associated with coffee intake among the large UK Biobank cohort, with increased 
predicted perceived intensity leading to a lower intake. The direction of association 
could be attributed to the inborn aversion towards bitterness, which is a defensive 
mechanism that prevents ingestion of poisonous food [3]. Here the effect size is 
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notably small, so the association could only be observed when the sample is large 
enough. 
Quinine is a commonly used stimulus to examine bitter taste response and it 
is also a source of bitterness in coffee [201]. However, previous work on the effect of 
quinine perception on coffee drinking is limited, with one study showing that coffee 
drinkers tend to be less sensitive to quinine [53]. Our results provide the first 
evidence that increased predicted perceived intensity of quinine leads to a lower 
coffee intake and a lower risk of being a heavy coffee drinker. The association is in 
the same direction as that of PROP but the effect of quinine is stronger, presumably 
because the perception of quinine could better reflect an individual’s sensation to 
general bitterness. 
Unexpectedly, for caffeine, the direction of effect was opposite to the other 
two bitter substances PROP and quinine. Caffeine intake has been related to 
caffeine perception. For example, a higher intake of caffeine is associated with lower 
sensitivity to caffeine [53], whereas caffeine daily users tend to rate caffeine, at a 
perceivable concentration, more bitter than non-daily users [50]. The present study 
suggests that an increased predicted perceived intensity of caffeine leads to a higher 
intake of coffee and a higher risk of being a heavy coffee drinker. Additionally, 
caffeine demonstrated the largest magnitude of association among the three bitter 
tastes. Caffeine is a non-volatile component of coffee and it contributes to the 
perceived strength, body and bitterness of coffee [202]. It is possible that caffeine 
adds an extra flavour to coffee for individuals with a stronger ability to perceive it, 
which further modifies their drinking behaviour. Nevertheless, caffeine metabolism 
still plays a major role in coffee consumption behaviour [182]. 
For the relationship between bitter taste perception and tea, conflicting 
findings have been found between PROP perception and the sensory acceptance of 
green tea [190, 191]. Here we showed that a higher predicted perceived intensity of 
PROP and quinine increased tea intake and a higher predicted perceived intensity of 
caffeine decreased the intake. These effects of bitter taste on tea consumption were 
in the opposite direction compared with those on coffee consumption, consistent with 
the negative correlation between coffee and tea intake in the UK Biobank cohort (r = 
-0.3). A negative relationship of same magnitude has also been reported in an 
Australian population sample (N = 3908) [203]. Our sensitivity analyses, which used 
the instrumental variable estimate on tea conditional on coffee (and vice versa), 
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provided more conservative results that tea intake was associated with PROP and 
caffeine and coffee intake was associated with quinine and caffeine. Similar results 
were observed in post-hoc analyses examining the effect of bitter taste on tea intake 
among non-tea drinkers and the effects on coffee among non-coffee drinkers, though 
the standard errors were larger due to a loss of effective sample size. We note that 
the tea drinking behaviour largely varies in the United Kingdom due to its mixed 
cultural backgrounds. Our findings were based on the intake of black and green tea, 
and the effects may differ for other tea types with different taste profiles. 
Apart from coffee and tea, earlier studies have also suggested alcohol elicits 
bitterness in humans [204, 205] and such bitter sensation can mediate consumption 
behaviour [206]. PROP taster status and the TAS2R38 genotype have been 
suggested to mediate alcohol consumption [57, 189, 206, 207], with inconsistencies 
being found between sexes. Our MR findings indicate that increased predicted 
perceived intensity of PROP leads to a lower intake but presented no evidence 
indicative of a difference between males and females. Through the stratified MR 
analyses by types of alcohol, we further showed that such association is mainly 
driven by red wine (Supplementary Table 4-9). We found no effect of quinine and 
caffeine perception on alcohol intake. Since quinine perception can be considered as 
taste response to general bitterness, the null association indicates that other taste, 
such as sweet taste perception [205, 206], may be a more important factor 
influencing alcohol consumption. 
The strengths of our study include the use of a two-sample approach in MR to 
avoid biased estimates [199]. Since the relationship between SNP instruments and 
the exposure of interest (bitter taste) is independent from the instrument with the 
outcome, this approach potentially avoids winner’s curse and weak instrument bias 
[193, 199]. Since taste perception can change overtime, our MR design of utilizing 
the SNP estimates on bitter taste perception during adolescence/early adulthood as 
an instrument allows us to evaluate the impact of taste factors on bitter beverage 
consumption in later life. Additionally, the use of a 2-SD change in taste perception 
allow us to assess the effect of changing from one taster status to another 
(equivalent to an interquartile change), without worrying about within-individual 
variation in taste perception as observed in earlier test-retest validations [40]. 
A major limitation for our study is the relatively small sample size (n = 1757) of 
the discovery sample used to estimate the SNP-bitter taste associations. However, 
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this limitation is unlikely to have substantially biased our finding as all of the SNPs 
used in this study have been replicated in other independent GWAS [35, 36, 38]. 
Despite our inability to perform sensitivity analyses that explore the validity of 
instrumental variables, particularly in relation to bias due to potential horizontal 
pleiotropy [199] due to having just one genetic instruments per trait, all of the SNPs 
(or their highly correlated SNPs) are missense variants in bitter taste receptors 
genes (Chapter 3). The biological evidence greatly reduces the chance for residual 
pleiotropy biasing our findings. 
The response amongst those invited to UK Biobank was ~5% and participants 
differ considerably from the underlying population with respect to socioeconomic 
position, health and survival [208]. This could introduce selection bias, including with 
genetic associations and MR analyses [209]. For example, non-response is related 
to genetic predictors of a number of mental health and lifestyle/behavioural 
outcomes [210]. This will not have affected the association of genetic variants with 
taste perception which was done in a cohort with a > 72% response rate [72], but if 
consumption of tea, coffee or alcohol are related to socioeconomic position the 
associations in UKB may be biased. For example, there is evidence of a positive 
association between socioeconomic position and alcohol consumption (i.e. higher 
consumption in those with higher education and socioeconomic position [211]). 
However, sensitivity analyses (Supplementary Table 4-10) evaluating the association 
between these bitter taste SNPs and proxies of socio-economic status (i.e. UK 
Biobank townsend deprivation index and number of vehicle in household) found no 
evidence of association. Hence, it is unlikely for our inference to have been affected 
by these selection biases. 
Given that the SNPs used as instrument variables explain appreciable 
amounts of variation in bitter taste perception as compared to bitter beverage intake, 
it is highly unlikely to manifest a bi-directional causal effect. However, we looked up 
the SNP associations with a list of behavioural and disease traits correlated to coffee 
consumption (e.g. diet behaviour, smoking, anorexia, and insomnia; Supplementary 
table 4-10) from on publicly available GWAS summary database [200] and found no 
association reaching statistical significance after adjusting for multiple testing. 
The use of the wald-type estimator to evaluate the causal effect has an 
intrinsic assumption that the exposure-outcome relationship is linear. For behavioural 
traits like coffee consumption, this assumption can be violated when we assess the 
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effect of bitter taste on individuals at the extreme end of the trait distribution (i.e. non-
tasters, or extremely sensitive tasters). Here, our stratified approach of making a 
separate hypothesis for i) amount of coffee consumed using cups per day and ii) 
non-drinker vs extreme drinker (or drinker for the case of alcohol traits) allow us to 
complement this investigation. It was shown that in most cases, the inference drawn 
for the cups per day (quantitative) phenotype was similar to those estimated on 
drinker status. Both results provide evidence against a quadratic relationship 
between bitter taste and bitter beverage consumptions. However, individual level 
data on both taste perception and beverage intake will be required to evaluate 
causal effects stratified at different consumption categories. 
Overall, our findings demonstrate that differences in bitter taste perception is 
causally associated with bitter beverage consumption behaviour. This delivers an 
important message that, in addition to inborn variations, factors altering taste 
perception, such as disease status (e.g. middle ear infection) and medical treatment 
(radiotherapy on brain and neck) [212], may also modify our dietary behaviour. Given 
the popularity of these bitter beverages, future studies are necessary to investigate 
the underlying biology of how altered perception can potentially contribute to their 
addiction, which may shed light on the prevention and have public health 
implications. 
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5  
Sweet Taste Perception is 
Associated with Body Mass 
Index at the Phenotypic and 
Genetic level  
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Abstract 
Investigations on the relationship between sweet taste perception and body 
mass index (BMI) have been inconclusive. Here we report a longitudinal analysis 
using a genetically informative sample of 1,576 Australian adolescent twins to 
explore the relationship between BMI and sweet taste. First, we estimated the 
phenotypic correlations between perception scores for four different sweet 
compounds (glucose, fructose, neohesperidine dihydrochalcone [NHDC], and 
aspartame) and BMI. Then, we computed the association between adolescent taste 
perception and BMI in early adulthood (reported 9 years later). Finally, we used twin 
modelling and polygenic risk prediction analysis to investigate the genetic overlap 
between BMI and sweet taste perception. Our findings revealed that BMI in early 
adulthood was significantly associated with each of the sweet perception scores, 
with the strongest correlation observed for aspartame with r = 0.09 (P = 0.007). 
However, only limited evidence of association was observed between sweet taste 
perception and BMI that was measured at the same time (in adolescence), with the 
strongest evidence of association observed for glucose with a correlation coefficient 
of r = 0.06 (P = 0.029) and for aspartame with r = 0.06 (P = 0.035). We found a 
significant (P < 0.05) genetic correlation between glucose and NHDC perception and 
BMI. Our analyses suggest that sweet taste perception in adolescence can be a 
potential indicator of BMI in early adulthood. This association is further supported by 
evidence of genetic overlap between the traits, suggesting that some BMI genes 
may be acting through biological pathways of taste perception.  
Introduction 
A high body mass index (BMI) is associated with increased risks for metabolic, 
cardiovascular and respiratory diseases and several types of cancer, such as breast 
and colorectal cancers  [214]. Obesity can arise as a result of genetic predisposition 
[215], metabolic problems [216], hormonal changes [217], physical activity [218], 
and/or eating behaviour [219]. The latter is heavily influenced by cognitive factors 
that allow individuals to assign a subjective reward value to specific kinds of foods 
[220]. One of these (cognitive) factors is taste perception, which is the sensory 
impression of food on the tongue.  
Among the five basic human taste qualities (i.e. sweet, bitter, sour, salty, and 
umami), sweetness is generally considered pleasant at moderate intensities and 
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favoured by most individuals [221]. Sweetness is detected by sweet taste receptors 
in the oral cavity, which send signals to the brain where taste sensation is elicited 
[222]. Sweet taste receptors are also expressed along the digestive system, 
including the pancreas, bladder, gastrointestinal, and adipose tissues [223], where 
they do not evoke sweet sensation but are involved in many physiological functions, 
including glucose homeostasis [223], insulin secretion [224], and adipogenesis [225]. 
Earlier studies investigating the association between BMI and sweet taste 
perception have presented inconsistent findings. Some studies reported that obese 
individuals perceive the same candy or sucrose solution as less sweet than their 
non-obese counterparts [5, 60]. However, a handful of other studies did not find a 
direct association between BMI and sweet taste perception or sensitivity [13, 58, 59].  
Twin studies have reported that individual differences in both sweet taste 
perception and BMI are partially attributable to genetic variation (h2 = 0.30 – 0.34 for 
sweet taste perception [Chapter 1]; h2 = 0.47 – 0.90 for BMI [226]) . Recent genome-
wide association studies (GWAS) of BMI identified an enrichment of associated 
genetic variants involved in the central nervous system (CNS) that might be linked to 
sweet taste perception. These include genetic variants in loci associated with insulin, 
glucose and adipogenesis regulation [79], as well as energy balance, regulation of 
appetite, and food intake preferences [215]. However, it is still unclear whether some 
genes are jointly responsible for both the regulation of sweet taste perception and 
BMI.  
In the present study, we used longitudinal and genetic data from a sample of 
1,576 young Australian twins to investigate the relationship between sweet taste and 
BMI. We first examined the association between sweet taste perception and BMI 
both measured during adolescence. Next, we examined whether adolescent taste 
perception predicted BMI later in life (9 years later). Finally, we assessed the genetic 
overlap between BMI and sweet perception using twin modelling and polygenetic risk 
scores approaches to determine whether the association between the two traits was 
due to shared genetic components.  
Materials and Methods 
Data 
Participants were adolescent and young adult twins and their singleton 
siblings from the Brisbane Adolescent Twin Study (BATS) [72], also referred to as 
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the Brisbane Longitudinal Twin Study (BLTS). They completed a taste test at around 
15.8 ± 2.6 years old and had their BMI measured at the clinic (two thirds) or self-
reported (one third). They reported their BMI again approximately 9 years later as 
part of a follow-up study. Descriptive statistics for the participants are displayed in 
Table 5-1. The study was conducted in accordance with the Declaration of Helsinki 
and informed consent was obtained from all adult participants and from parents for 
participants under age of 18. Approval for this study was obtained from the Human 
Research Ethics Committee of QIMR Berghofer Medical Research Institute. 
 
Table 5-1. Descriptive statistics of participants and their taste perception. 
  Early Age (12-26) Later Age (18-38) 
N of participants 1576 998 
  MZ pairs 205 101 
  DZ pairs 395 197 
  Siblings 376 402 
Age (years) 15.8 ± 2.6 25.2 ± 4 
Female 53.5% 61.1% 
Height (cm) 162.7 ± 8.2 171.8 ± 9.7 
Weight (kg) 54.9 ±11.6 70.9 ± 15.1 
BMI (kg/m2) 20.6 ± 3.5 23.8 ± 4.0 
Intensity rating    
  Glucose 31.2 ± 15.7  
  Fructose 31.9 ± 17.6  
  NHDC 34.4 ± 18.6  
  Aspartame 26.3 ± 16.0  
  gSweet 31.1 ± 15.0  
Data are presented as mean ± standard deviation. Intensity ratings are millimetre on a 
labelled magnitude scale. NHDC: neohesperidine dihydrochalcone. gSweet: general sweet 
intensity. 
 
 
The taste test included 10 different solutions, of which five were bitter, four 
were sweet (described below) and one was neutral (i.e. water, as control) [81]. The 
four sweet solutions included two sugars (0.60 M glucose and 0.30 M fructose) and 
two high-potency (low/non-caloric) sweeteners (8.0 x 10-5 M neohesperidine 
dihydrochalcone [NHDC] and 1.4 x 10-3 M aspartame). Each solution and the water 
control were presented twice (i.e. a total of 20 solutions) in colour-coded 2mL 
polypropylene microcentrifuge tubes with flip tops. The first ten tubes contained one 
presentation of each compound plus the water control and the next ten contained the 
same solutions in a different order. The order of all twenty tubes was the same for all 
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participants. Participants were instructed to: 1) open the tube, swish the solution in 
the mouth for five seconds and spit out, 2) rate the perceived intensity of the solution, 
3) rinse the mouth out four times with tap water and, 4) repeat steps 1 to 4 for each 
tube. Perceived intensity was rated on a general labelled magnitude scale (gLMS) 
[73] with labels of no sensation (0mm), barely detectable (2mm), weak (7mm), 
moderate (20mm), strong (40mm), very strong (61mm), and strongest imaginable 
(114mm). Participants marked a line on the scale where they thought the sensation 
fitted. The mean intensity ratings from duplicate presentations were used in this 
study. As Chapter 1 showed that a common genetic component accounted for most 
of the variance in intensity scores of each sweetener (71% for glucose, 77% for 
fructose, 64% for NHDC, and 59% for aspartame), here we calculated a general 
sweet intensity rating (gSweet) using the weighted mean of intensity ratings of the 
four sweeteners (Chapter 2). Intensity scores were square root transformed to 
approximate the normal distribution. 
Genotyping Quality Control 
Participants were genotyped using the IlluminaHuman610W-Quad bead chip. 
Standard quality control was performed on genotyped variants: single nucleotide 
polymorphism (SNP) with call rate < 0.95, deviation from Hardy-Weinberg 
equilibrium (HWE) p-value < 10−6 or minor allele frequency (MAF) < 0.01 were 
excluded [227]. To control for population stratification, we excluded individuals which 
lay beyond 6 standard deviations from the first 2 genotypic principal components 
centroid of the 1000 Genome European descent populations. Imputation was carried 
out based on the August 4, 2010 version of the publicly released 1000 Genomes 
Project European genotypes using MACH [228]. We implemented a filtering 
threshold of 0.3 on the r2 metric for each of the SNPs in-line with recommended 
practice in MACH, and a MAF > 0.01. 
Twin modelling 
Phenotypic and genetic correlations between measures of taste intensity and 
BMI were estimated using bivariate variance components modelling in the structural 
equation software package Mx, which utilises maximum likelihood estimation 
procedures [74]. Variance components modelling partitions the variation of a trait into 
genetic and environmental sources by leveraging the degree of genetic differences 
between monozygotic twins (MZ; share all genes) and dizygotic twins (DZ; share half 
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of genes) pairs. These known differences allow the estimation of additive genetic (A), 
common environment (C), and unique environment (E, which also includes 
experimental error and random noise) parameters in a variance components model 
(ACE). The comparative fit of models was assessed by calculating the Log-likelihood 
Ratio Test (LRT) statistics [229]. All the models were adjusted for sex and the 
participants’ corresponding age. 
Polygenic risk scores 
To complement the genetic correlation estimates, we also carried out a 
polygenic risk prediction analysis by computing polygenic risk scores (PGRS) of our 
trait of interest (in this case, BMI) and then using this genetic profile to predict 
another trait (i.e. taste perception) [230]. In short, the PGRS describes predicted 
phenotypic values that are genetically derived. It is computed by aggregating the 
estimated effects of many variants multiplied by the number of observed effect allele 
into a single score for each individual, to mimic a genetic proxy (profile scoring) for 
the underlying phenotypic trait. In our analysis, we used the association estimates 
from the latest GWAS meta-analysis summary statistics of BMI from the Genetic 
Investigation of Anthropometric Traits (GIANT) consortium including up to 339,225 
participants [79]. We extracted effect estimates of the SNPs that were computed 
based on participants (n = 322,154) of European ancestry only. This approach could 
yield increased power to detect genetic correlations due to the large sample size of 
the GIANT analysis. Given that the samples in this study were also part of the 
GIANT BMI GWAS, these GWAS estimates were recomputed after removing the 
overlapping samples. Next, we selected variants to compute the PGRS based on 10 
different P-value thresholds (< 0.00001, 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 
0.75). Linkage disequilibrium (LD) clumping was performed to remove redundant 
SNPs (r2 > 0.2) within a 500kb window for each of the variants in the PGRS. The 
computation of PGRS and LD clumping were carried out using PLINK [197] by 
multiplying the number copies of each effect allele with the reported magnitude of 
association and summing over all the relevant SNPs. Ambiguous SNPs with 
complementary strands (A/T, G/C) were removed. Specifically, the number of 
independent genetic variants for each of the thresholds were 2071, 8403, 27638, 
79871, 136195, 237876, 333747, 424237 and 511295 SNPs. Finally, we converted 
each of the PGRS to standard Z-scores (μ = 0 and σ = 1) and tested their 
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association with the different sweet taste perception scores using a linear mixed 
model: fitting the first three principal components derived from the genotypes, age 
and sex as covariates, and the family ID as random effect.  
The polygenic risk prediction approach carries a high multiple testing burden 
given that each of the PGRS is tested for their association with sweet taste 
perception. However, given that the different sweet taste perception are correlated 
between each other and that each of the PGRS are highly redundant, we estimated 
the number of independent tests using a matrix spectral decomposition algorithm 
[157]. This algorithm estimates the equivalent number of independent variables from 
a correlation matrix, by examining the ratio of observed eigenvalue variance to its 
theoretical maximum. The estimated number of independent test was 7 and thus a 
Bonferroni-corrected significance threshold was P = 0.05/7 = 0.007. 
Results 
We investigated whether sweet taste perception in adolescence was 
predictive of BMI in adolescence (15.8 ± 2.6 years old) and early adulthood (25.2 ± 
4.0 years old). In our regression analyses, we found an association between the 
perceived intensity of sweetness and BMI at the same age in adolescence, with 
glucose and aspartame showing significant correlations of r = 0.056 (P = 0.035) and 
r = 0.058 (P = 0.029) respectively (Table 5-2). When investigating whether sweet 
taste perception was predictive of early adulthood BMI, we found stronger 
associations with all sweet perception scores ranging from r = 0.07 for fructose to r = 
0.09 for aspartame (Table 5-2). Intensity ratings of water were used as a negative 
control, and, as expected, they were not associated with BMI. 
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Table 5-2. Summary of phenotypic and genetic correlations between taste 
intensity ratings and BMI. 
 
BMI same age 
 
BMI later age 
Phenotypic 
correlations 
rp ± s.e. P   rp ± s.e. P 
gSweet 0.05 ± 0.03 0.059   0.08 ± 0.03 0.012 
Glucose 0.06 ± 0.03 0.035   0.08 ± 0.03 0.020 
Fructose 0.04 ± 0.03 0.196   0.07 ± 0.03 0.034 
NHDC 0.04 ± 0.03 0.122   0.07 ± 0.03 0.025 
Aspartame 0.06 ± 0.03 0.029   0.09 ± 0.03 0.007 
H2O -0.02 ± 0.03 0.579   -0.03 ± 0.03 0.406 
Genetic correlations rg ± s.e. P   rg ± s.e. P 
gSweet 0.10 ± 0.06 0.092   0.16 ± 0.08 0.053 
Glucose 0.13 ± 0.06 0.030   0.21 ± 0.08 0.017 
Fructose 0.08 ± 0.06 0.173   0.14 ± 0.08 0.150 
NHDC 0.07 ± 0.06 0.260   0.10 ± 0.08 0.267 
Aspartame 0.12 ± 0.06 0.077   0.18 ± 0.08 0.090 
H2O 0.00 ± 0.06 0.955   -0.12 ± 0.08 0.172 
All values are calculated using bivariate variance components modelling in the structural 
equation software package Mx. Genetic correlations are calculated from bivariate AE model as C 
components can be dropped without worsening the model fit (P = 0.28 - 0.87 for each trait). 
gSweet: general sweet intensity. NHDC: neohesperidine dihydrochalcone. s.e.: standard error.  
Estimates in bold are statistically different from 0. 
 
 
Using twin modelling, we found a positive genetic correlation between 
perceived intensity of all the tastes and BMI at same and later age. However, only 
the perceived intensity of glucose showed a significant association (same age: rg = 
0.13, P = 0.03; later age: rg = 0.21, P = 0.017) (Table 5-2). The environmental 
correlations were not significantly different from zero (data not shown).  
To further assess the genetic overlap between BMI and sweet taste 
perception, we carried out a polygenic risk prediction analysis. Based on the GWAS 
of BMI from the GIANT consortium, we computed individual BMI PGRS including a 
different number of variants based on P-value thresholds and tested their association 
with sweet taste perception and BMI itself. As anticipated, each of the PGRS were 
strongly associated with BMI (e.g. the PGRS based on SNPs with a P-value < 0.2 in 
the GIANT GWAS had an r = 0.2; P < 1.0 x 10-15) (Supplementary Figure 5-1). 
Through this approach, we found a significant genetic correlation between BMI and 
NHDC (Figure 5-1) but not with glucose as with the twin modelling analysis.  
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Figure 5-1. Results of the polygenic risk prediction. The bars correspond to the 
association between each of the polygenic risk scores (PGRS) of BMI 
computed based on the specified P-value thresholds (< 0.00001, 0.001, 0.01, 
0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75) and the different sweet taste intensity scores. 
P-values of the association are shown in the logarithmic scale in the upper 
part of the figure while spearman correlations (r) are shown in the bottom part. 
Red dotted line shows the nominal P-value (0.05) on –log10 scale. Blue dotted 
line shows the significance threshold after accounting for multiple testing. As 
an example, the first bar should be interpreted as the correlation between a 
genetically-predicted BMI value based on SNPs with a P-value < 1.0 x 10-5 in 
the GIANT BMI GWAS and glucose. gSweet: general sweet intensity. NHDC: 
neohesperidine dihydrochalcone. 
 
Discussion 
We found that the perceived intensity of sweet solutions measured during 
adolescence was positively associated with BMI measured at the same age, and that 
the association was stronger with BMI measured 9 years later. We also found 
evidence of a positive genetic correlation of glucose and NHDC with BMI. 
In contrast to findings from previous cross-sectional studies, which showed 
negative associations [5, 60] or no associations between sweet taste perception and 
BMI [13, 58, 59], we found a subtle but positive association with BMI measured at 
the same age. The differences may result from variation in study designs and 
sample demographics. Bartoshuk et al. [60] reported a negative association between 
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perceived sweetness of a candy and BMI in a large sample of college students (n = 
3700) whereas the taste measures in our study were adolescents’ intensity ratings of 
sweet solutions. Overberg et al. [5] collected data from adolescents as well as 
children (age ranged from 6 to 18) and they reported a negative association by 
dichotomising participants into either obese (BMI > 97th percentile) or normal weight 
(BMI < 90th percentile). In our study, BMI was defined as a continuous variable, 
which provided us more robust estimates with respect to the magnitude and direction 
of the correlation. In addition, studies [13, 58, 59] that showed no association 
typically have relatively small sample sizes (n < 100), which suggests that larger 
samples are necessary to detect a significant association.  
Our finding that sweet taste perception has a higher association with BMI at a 
later age (as compared to BMI obtained at the same time of taste perception 
measurement) yields several possible explanations. The first could be the cumulative 
effect of sweet preferences. Individual differences in sweet perception may gradually 
contribute to a bigger variation in preferences for sweetness, which directly influence 
sweet food consumption, and further lead to a bigger variation in BMI later in life. 
Secondly, during adolescence, diet preferences are strongly influenced by cultural 
practise and familial influences [231], rather than the true taste preferences. Also, 
BMI at a young age is susceptible to body and hormonal changes rather than sweet 
food consumption, compared to that in a later age when body mass change 
becomes more stable.  
Our two genetic approaches independently identified significant correlations 
between BMI and sweet taste perception; one with glucose and the other with NHDC. 
Nevertheless, these correlations were all positive regardless of taste stimuli and the 
underlying modelling approaches. In the context of our study, the twin modelling and 
PGRS analyses complement each other in the sense that the PGRS models the 
cross-trait genetic overlap based on common genetic variants, while conventional 
twin models incorporate a larger spectrum of information including undiscovered 
causal SNPs and rare variants in determining co-heritability.  
The genetic overlap we observed tends to agree with the literature. Simple 
carbohydrates (sugars) as well as complex carbohydrates (oligosaccharides and 
polysaccharides) are the main source of energy for the human body, and over-
consumption of these sweet compounds can result in weight gain as excess energy 
intake is transformed and stored as body fat [232]. While the GIANT consortium 
 
 
111 
identified several BMI-associated genes with putative functions in the brain [79], 
some of those genes could be responsible for sweet taste perception by influencing 
dietary behaviour. Similarly, there is evidence that individual differences in taste 
responses are due to differences in signal processing in the CNS [138]. Other 
pathways may also contribute to the genetic overlap between sweet perception and 
BMI. For example, the neurobiology of food reward might help explain why the use of 
non-caloric sweeteners can result in weight gain without affecting calorie intake [233]. 
Lastly, apart from the neurological and possible mechanisms explained above, sweet 
taste receptors in the mouth and guts can also regulate energy metabolisms through 
various mechanisms, such as their effects on insulin secretion [223, 224]. Sweet 
taste perception appears to play an important role in regulating BMI; however, in this 
study we were not able to prove the directionality of this association.  
The strengths of our study included that the twin data allowed us to estimate 
the genetic and environmental contributions to the correlation between sweet taste 
and BMI. Also, the polygenic risk score of BMI derived from common variants 
provided further support for the genetic correlation between the two and made our 
findings more robust. Lastly, the longitudinal data for BMI measured 9 years apart 
allowed us to test the long-term effects of sweet taste perception on BMI. We must 
also acknowledge some limitations. For example, the effective sample size (Nsame age 
= 1576 and Nlater age = 998) could be considered small for a twin study, and the use of 
self-reported BMI might potentially introduce some modest bias, as it has been 
pointed out that participants tend to slightly overestimate their height and 
underestimate their weight [234].  
In conclusion, we showed that adolescent sweet taste perception is 
associated with BMI at both adolescence and early adulthood, and that this 
association is partly explained through their genetic overlap. Identification of the 
shared genetic architecture could improve our understanding of the genetic 
pathways underlying both sweet taste perception and weight gain. As we obtain 
more study samples in the future, we can use the SNPs that strongly associate with 
sweet taste perception as genetic instruments to make causal inference (i.e. 
Mendelian randomization studies [Chapter 4]) about the effect of sweet taste 
perception on weight gain and diet-related disorders, which may provide insights into 
the prevention and treatment. 
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Abstract 
Functional neuroimaging studies have identified brain regions associated with 
human taste perception, but only a few studies investigated the associations with 
brain structure. Here, in this exploratory study, we examined the association 
between the volumes of 82 brain regions of interest (ROI) and the perceived 
intensities of sweet (glucose, fructose, aspartame, and neohesperidin 
dihydrochalcone) and bitter (propythiouracil [PROP], quinine, and caffeine) 
substances in a large Australian healthy cohort (n = 559). We showed that the 
volumes of 3 cortical (right cuneus gyrus, left transverse temporal gyrus, right inferior 
temporal gyrus) and one subcortical structure (both left and right caudate) were 
associated with more than one tastes (P < 0.05) and tended to be associated with 
both sweet and bitter tastes in the same direction, suggesting that these brain 
regions could be broadly tuned for taste sensation. A further 11 ROIs were 
associated with a specific taste, suggesting that these brain regions may be more 
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narrowly turned (P < 0.05; sweetness: left pars triangularis, left banks of the superior 
temporal sulcus, left caudal anterior cingulate cortex, posterior cingulate cortex; 
PROP: right isthmus cingulate cortex, right thalamus, right pars orbital cortex [only 
after adjusting for TAS2R38 genotype]; caffeine: right superior fontal gyrus, right 
hippocampus; quinine: left entorhinal cortex, left amygdala). Using brain imaging and 
quinine ratings available from the Human Connectome Project (n = 1101), we 
replicated the association between the left entorhinal cortex volume and quinine 
bitterness (r = -0.06, P = 2.0 x 10-2). This study provides the first evidence that, even 
in healthy people, variation in brain structure is associated with taste intensity ratings, 
and provides new insights into the role of the brain structure in taste perception. 
Introduction 
Our brain plays a significant role in taste perception. When we eat, food 
chemicals are detected by taste receptors in the oral cavity and signals are sent via 
gustatory nerves to the brain where taste sensation is generated so we know what 
we eat and whether we like it or not [61]. Positron emission tomography (PET) and 
functional magnetic resonance imaging (fMRI) studies show that there are areas in 
the human brain that both respond to taste and are homologous to those found in 
other primates [62]. However, identification of these taste-responsive brain regions 
has been inconsistent across studies [64], and this may be due to the use of different 
taste stimuli and tasks performed, as the brain response can be valence-specific [65] 
or intensity-specific [66], or, more importantly, the small sample size (n < 100). 
Therefore, more knowledge is required to construct the gustatory pathway in the 
human brain. 
Structural variations of specific brain regions relate to human senses, such as 
olfaction [67] and vision [68], and recent evidence suggests that volumetric 
differences also associate with taste. People with eating disorders, e.g. anorexia 
nervosa, had larger left gyrus rectus grey matter [69, 70], and there was an 
association between its size and the sucrose pleasantness among both patients and 
healthy controls. Furthermore, structural alterations (e.g. removing parts of the brain) 
can modify perceived intensity of taste [71]. These findings suggest a new direction 
to investigate the linkage between brain regions and taste. Here, using a large 
population sample (n = 559), we conducted an exploratory study to investigate 
whether there was an association between brain structure and taste perception. 
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Methods and Materials 
Sample 
Participants were a subset of the Brisbane Adolescent Twin Study (BATS) 
[72], consisting of 59 complete monozygotic and 107 complete dizygotic twin pairs 
and 285 unpaired twins or singleton siblings, from 361 families. The sample included 
351 females and 208 males and all of them were right-handed and healthy. 
Participants completed taste test at the mean age of 16.7 (± 2.7 standard deviations 
[SDs]) years, and were MRI scanned approximately 5.0 (± 1.5 SDs) years later 
(mean age at scan = 21.7 ±  3.2 SDs years), as part of the Queensland Twin 
IMagining (QTIM) study [235]. Prior to scanning, participants were screened for 
neurological and psychiatric conditions, including loss of consciousness for more 
than 5 minutes, and general MRI contraindications. Zygosity of same-sex twin pairs 
was determined using a commercial kit (AmpFISTR Profiler Plus Amplification Kit, 
ABI) and later confirmed by genome-wide single nucleotide polymorphism 
genotyping (Illumina Human610-Quad BeadChip). This study was approved by 
Human Research Ethics Committees at the University of Queensland, QIMR 
Berghofer Medical Research Institute, and UnitingCare Health. Written consent was 
obtained from both the participants and their parents (the latter not required for those 
18 years and over). 
Taste Test 
The taste test has been described in previous chapters.  Briefly, participants 
were instructed to taste five bitter (6.0 x 10-4 M propylthiouracil [PROP], 2.0 x 10-4 M 
sucrose octaacetate [SOA], 1.81 x 10-4 M quinine, 0.05 M caffeine, and 4.99 x 10-6 M 
denatonium benzoate [DB]) and four sweet (0.60 M glucose, 0.30 M fructose, 8.0 x 
10-5 M neoherperidine dihydrochalcone [NHDC], and 1.4 x 10-3 M aspartame) 
solutions and to rate their perceived intensities using a general Labelled Magnitude 
Scale (gLMS). Here we used a general sweet factor score, which is a weighted 
mean accounting for most of the variance in the perceived intensity of the four sweet 
tastes (71% for glucose, 77% for fructose, 64% for NHDC, and 59% for aspartame; 
Chapter 2), and ratings for three bitter solutions: PROP, a widely studied bitterness 
phenotype that approximately half of its variance is due to the genetic variation within 
the bitter taste receptor gene TAS2R38 [107]; quinine, a commonly used bitter agent 
to test perceived bitterness and aversiveness; caffeine, a basic ingredient of the 
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most popular bitter drink, coffee, and can have various impacts on brain [236]. 
Ratings for SOA and DB were not included because they were less common taste 
phenotypes, but their results are provided in the supplementary documents. 
Brain Imaging 
Structural T1-weighted 3D brain images were acquired using a 4T Bruker 
Medspec (Bruker, Germany) whole-body MRI system paired with a transverse 
electromagnetic (TEM) head coil (TR = 1500 ms, TE = 3.35 ms, TI = 700 ms, 240 
mm FOV, 0.9 mm slice thickness, 256 or 240 slices depending on acquisition 
orientation (86% coronal [256 slices], 14% sagittal [240 slices]) and corrected for 
intensity inhomogeneity with SPM12 before analysis (Wellcome Trust Centre for 
Neuroimaging, London, UK; http://www.fil.ion.ucl.ac.uk/spm). Volumes of the 82 
regions of interest (ROIs), including 34 gyral-based regions from the Desikan-Killiany 
atlas [237] plus 7 subcortical volumes from each hemisphere, were extracted using 
FreeSurfer (v5.3; http://surfer.nmr.mgh.harvard.edu/) as previously reported [238]. 
Cortical reconstructions and ROI labelling were checked using the procedures of the 
Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) consortium 
(enigma.ini.usc.edu), with incorrectly delineated cortical structures excluded from the 
analysis. Descriptive statistics of these brain and taste phenotypes are provided in 
Supplementary Table 6-1. 
Statistical Analysis 
Statistical analyses were performed using a linear mixed model implemented 
in the R package ‘hglm’ [239]. Prior to analysis taste intensity ratings were regressed 
by age at taste test, sex, and history of otitis media, which were shown to associate 
with taste ratings [107]. Brain phenotypes were regressed by age at brain scan, sex, 
and total brain volume (‘BrainSeg’ in FreeSurfer). Taste and brain phenotypes 
greater or smaller than mean ± 3 SDs were considered as outliers and removed 
from the analysis (up to 40 outliers; see Supplementary Tables for details). 
Covariates included the fixed effect of the time interval between the taste test and 
brain scan and the random effect of the family relationship matrix with values of 1, 
0.5, and 0 assigned to monozygotic twins, dizygotic twins/siblings, and unrelated 
individuals. Analyses of PROP were further adjusted for the TAS2R38 genotype. 
Given that the 4 taste phenotypes are correlated (Chapter 2) and so are the 82 brain 
phenotypes [240], we used a matrix spectral decomposition algorithm [157] to 
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estimate the number of independent phenotypes to be 3 taste and 55 brain 
phenotypes. A Bonferroni-corrected significance threshold was set at P = 0.05/(3 x 
55) = 3.2 x 10-4. 
Results 
While no association reached the corrected threshold (presented as a 
heatmap in Figure 6-1 [See Supplementary Tables 6-2 to 6-5 for details]), we found 
several patterns for these associations. ROIs from both hemispheres tended to 
associate with a taste in the same direction. Using the conventional threshold of P < 
0.05, the sweetness factor was associated with 6 ROIs and bitter tastes were 
associated with 4 to 7 ROIs. The volumes of 3 cortical regions (right cuneus gyrus, 
left transverse temporal gyrus, right inferior temporal gyrus) and 2 subcortical 
regions (left and right caudate) were associated with more than one taste and tended 
to be associated with both sweet and bitter tastes. The cortical associations were all 
positive – larger volumes being associated with increased taste intensity ratings, 
whereas large left and right caudate volumes were associated with decreased taste 
intensity ratings. 
Eleven regions were associated with only one taste (P < 0.05). These 
included 4 cortical regions in the left hemisphere being associated with sweet 
perception (3 positive associations with pars triangularis, caudal anterior cingulate 
cortex, and posterior cingulate cortex volumes and a negative association with banks 
of the superior temporal sulcus), 3 ROIs in the right hemisphere being associated 
with PROP perception (2 positive associations with pars orbital cortex [only after 
adjusting for the TAS2R38 genotype] and thalamus volumes and one negative 
association with isthmus cingulate cortex), 2 ROIs in the right hemisphere being 
association with caffeine perception (a positive association with hippocampus 
volume and a negative association with superior frontal gyrus volume), and 2 ROIs in 
the left hemisphere being associated with quinine perception (a positive association 
with amygdala volume and a negative association with entorhinal cortex volume). 
We note that the TAS2R38 genotype was not associated with any ROIs (P > 0.05), 
and while the number of ROIs associated with PROP perception increased from 2 to 
3 after adjusting for the TAS2R38 genotype (Supplementary Tables 6-5 and 6-6), the 
overall association pattern did not change much. 
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We further compared the associations with quinine perception with those from 
the Human Connectome Project (HCP) S1200 release [80], which included the same 
brain phenotypes and perceived intensity ratings of only one taste solution (i.e. 1.0 x 
10-3 M quinine solution, which was 10 times more concentrated than ours) from 1101 
adults with mainly European ancestry (Figure 6-1 and Supplementary Table 6-7). We 
found five associations (P < 0.05; all negative) with cortical regions in HCP, two of 
which were also associated in QTIM. The negative association between the left 
entorhinal cortex volume and quinine perception in QTIM (r = -0.12, P = 3.7 x 10-3) 
was replicated in HCP (r = -0.06, P = 2.0 x 10-2) (Figure 6-2). Analyzing the two 
datasets together gave a stronger association (r = -0.08, P = 1.2 x 10-3). In contrast, 
an inverse association between the left transverse temporal gyrus and quinine was 
observed in HCP (QTIM: r = 0.11, P = 6.9 x 10-3; HCP: r = -0.07, P = 3.8 x 10-3). 
Although the other 3 associated ROIs in HCP (right lateral occipital gyrus and 
bilateral orbitofrontal cortex) showed no association in QTIM, their direction of 
association tended to be the same. 
Discussion 
In this exploratory study, we showed that the volumes of 5 ROIs (right cuneus 
gyrus, left transverse temporal gyrus, right inferior temporal gyrus, and caudate from 
each hemisphere) were associated with both sweet and bitter tastes, suggesting that 
these brain structures could be more broadly tuned for taste sensation. In particular 
for cuneus and caudate, responses to a more general taste (i.e. not only for 
sweetness and bitterness but also for sourness and saltiness) have been reported in 
fMRI [64] and electroencephalogram (EEG) [241] studies, respectively. Transverse 
temporal gyrus, also known as Heschl’s gyrus, is the primary auditory cortex. A 
larger transverse temporal gyrus volume, bilaterally, has been associated with 
increased perceived intensity of hearing [242]. Here we provide evidence that the 
volume of transverse temporal gyrus also relates to the perceived intensity of taste.  
Among the 11 associations for more narrowly tuned ROIs found in QTIM, the 
association between left entorhinal cortex and quinine was robustly replicated in the 
HCP dataset. The entorhinal cortex is involved in learning of food avoidance, though 
lesions of entorhinal cortex in rats affect the learning of odour aversion [243] rather 
than taste [244]. Further investigation of this brain region in humans will help 
interpret our finding. We could not find a perfect explanation for the inverse 
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association between quinine and transverse temporal gyrus in HCP, but this could 
be due to differences between the two studies, such as the concentration of quinine 
solution (QTIM:  1.81 x 10-4 M vs HCP: 1.0 x 10-3 M).  
Regarding the volume of the primary (anterior insula and frontal operculum) 
and the secondary (orbitofrontal cortex) gustatory cortices, we found no association 
for insula in both QTIM and HCP, but there was evidence of associations for regions 
overlapping the frontal operculum (i.e. pars orbitalis and pars triangularis) in QTIM 
and for lateral orbitofrontal cortex in HCP. We note that, in QTIM, the test-retest 
reliability for insula (r = 0.57 and 0.32 for left and right) was low compared to other 
ROIs [240]. In the present study, we did not observe an association between 
sweetness and left gyrus rectus (medial orbitofrontal cortex), whose volume was 
previously linked to sucrose pleasantness [69, 70]. This is consistent with functional 
studies that, when tasting a sucrose solution, neural responses in medial 
orbitofrontal cortex appears to correlate with pleasantness rather than intensity 
ratings [66]. 
A limitation of our study is that the taste and brain phenotypes were collected 
at different times in QTIM. We included the time interval as a covariate to control for 
this, and found no significant effects (P > 0.05) for any of the associated regions, 
except for the right inferior temporal gyrus (P ~ 3e-3) where a longer time interval 
leads to a larger volume. Our findings may also be limited by the use of brain ROI 
measures, because an ROI covers a pre-defined brain region, which may contain 
areas that are not related to taste. Future vertexwise analyses could help pinpoint 
associated brain regions. Further, except for Quinine, which was collected as part of 
the HCP, there is no other dataset available that has both brain imaging and taste 
phenotypes, so it was not possible to replicate associations for any of the other taste 
phenotypes. 
This is the first large-scale study showing that taste perception is associated 
with the volumes of specific brain regions among healthy individuals. Whether there 
is a causal relationship between taste and brain structure can be tested using a two-
sample Mendelian randomization. This is similar to what we have done in Chapter 4 
with the outcome phenotypes of beverage intake replaced by brain volumes. The 
associations between taste-associated SNPs (from Chapter 3) and brain volumes 
can be obtained from the well-powered cohorts from the ENIGMA Consortium [245] 
and UK Biobank Imaging Study [246], each of which collected brain imaging data 
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from more than 30,000 and 20,000 participants, respectively. The results could not 
only be used to validated our findings but also elucidate the effect of brain structure 
on shaping taste perception and vice versa. 
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Figure 6-1. Heatmap showing 
correlations between taste 
perception and brain structure 
volumes in QTIM (n = 559) and 
HCP (n = 1101). In QTIM, 
Sweetness scores are 
associated with 6 brain regions. 
PROP scores are associated with 
2 regions (increases to 3 regions 
after adjusting for the TAS2R38 
genotype; Supplementary Table 
6-6). Caffeine and quinine scores 
are associated with 6 and 7 
regions respectively. The 
volumes of right cuneus and left 
transverse temporal gyri are 
positively associated with both 
sweetness and two of the bitter 
tastes. The volumes of right 
inferior temporal gyrus and 
caudate in each hemisphere are 
associated with quinine and 
caffeine. In HCP, quinine scores 
are associated with 5 brain 
regions and the association with 
left entorhinal cortex is in the 
same direction with that in QTIM, 
whereas the association with left 
transverse temporal gyrus is in 
the opposite direction. L and R 
indicate the volume of left and 
right hemisphere of the brain 
respectively. Only correlation 
coefficients with P-value < 0.05 
are shown. 
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Figure 6-2. Scatter plots showing the association between quinine intensity 
rating and entorhinal cortex volume in QTIM (n = 558) and HCP (n = 1101). 
Every SD increase in quinine intensity rating is associated with 0.12 and 0.06 
SD decrease in entorhinal cortex volume in QTIM and HCP, respectively.  No 
point is covered by the legend. 
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Chapter 7. General Discussion 
This work extends our understanding of individual differences in human taste 
perception of sweetness and bitterness by showing their relationships with genes, 
dietary behaviour, and brain morphology. We applied quantitative and statistical 
genetic methods (including variance component modelling, GWAS, Mendelian 
randomization, polygenic risk score prediction, and mixed-effect linear regression) on 
the largest-to-date genetically informative twin sample with multiple taste and brain 
phenotypes (n = 1999 Australian twins and siblings) and data from the UK biobank 
cohort (N = 438,870) and HCP (n = 1101). We estimated the heritability of sweet 
taste perception and the genetic association between sweet and bitter tastes. We 
identified novel loci associated with bitter tastes and revealed their pleiotropy. We 
demonstrated the effect of taste perception on beverage intake and BMI. Lastly, we 
showed the association between taste and the volume of specific brain regions. Key 
findings from each chapter are summarized in Table 7-1.  
 
Table 7-1. Summary of key findings from each chapter. 
Chapter Aims Findings 
1. A common genetic 
influence on 
human intensity 
ratings of sugars 
and high-potency 
sweeteners. 
- Estimate heritability of     
perceived intensity 
ratings of sugars and 
high-potency 
sweeteners. 
- Investigate their genetic 
overlap. 
 h2 = 0.31 for glucose. 
 h2 = 0.34 for fructose. 
 h2 = 0.31 for NHDC. 
 h2 = 0.30 for aspartame. 
 A common genetic factor accounts for more 
than 75% of the genetic variance in each sweet 
taste. 
2. Is the association 
between sweet and 
bitter perception 
due to genetic 
variation? 
- Investigate the source of 
association between the 
perceived intensity of 
sweetness (a factor 
score of glucose, 
fructose, NHDC, and 
aspartame) and 
bitterness (PROP, SOA, 
quinine, and caffeine). 
 The sweetness is moderately correlated with 
SOA, quinine, and caffeine (rp = 0.35 – 0.40). 
 A shared genetic factor accounts for 8% of the 
variance in sweetness and 17% – 37% of the 
variance in SOA, quinine, and caffeine (rg = 
0.46 – 0.51). 
 The association between sweetness and PROP 
becomes evident after adjusting for the 
TAS2R38 diplotype (rp increases from 0.22 to 
0.32 and rg increases from 0.18 to 0.40).  
3. Joint analysis 
strengthens the 
role of bitter 
receptor clusters 
on chromosomes 7 
and 12 in human 
bitter taste 
- Identify variants with 
small effects (< 5%) on 
bitter taste using 
bivariate GWAS. 
 Two putative novel associations within clusters 
of bitter taster receptor genes on chromosomes 
7 and 12 for DB (rs10261515, r2 = 0.93%, 
univariate PDB = 2.5e-4, bivariate PDB-Quinine = 
3.1e-8) and SOA (rs67487380; r2 = 1.63%, 
univariate PSOA = 3.8e-7, bivariate PSOA-Quinine = 
5.4e-13, bivariate PSOA-caffeine = 4.5e-8) 
 
 
125 
respectively. 
 Independent replication for an association for 
caffeine on chromosome 12 (rs2597979, r2 = 
1.91%, P = 4.2e-8). 
 Top SNPs for quinine, SOA, and caffeine on 
chromosome 12 are pleiotropic to the 
perception of quinine, caffeine, SOA, and DB. 
4. Understanding the 
role of bitter taste 
perception in 
coffee, tea and 
alcohol 
consumption 
through Mendelian 
randomization 
- Investigate the causal 
relationship between 
perceived bitterness of 
PROP, quinine, and 
caffeine and the intake 
of bitter beverages 
coffee, tea, and alcohol. 
 With every 2-SD change in the predicted 
bitterness, a higher perceived intensity of 
caffeine increases coffee consumption by 0.076 
(P = 1.6e-9) cups per day, whereas higher 
perceived intensities of PROP and quinine 
decrease coffee consumption by 0.034 (P = 
7.2e-4) and 0.052 (P = 1.9e-7) cups per day. 
 For tea consumption, a higher perceived 
intensity of caffeine decreases coffee 
consumption by 0.094 (P = 2.1e-8) cups per 
day, and higher perceived intensities of PROP 
and quinine increase tea consumption by 0.067 
(P = 3.7e-7) and 0.059 (P = 2.1e-8) cups per 
day. The opposite effects of bitter tastes are 
due to the negative correlation between coffee 
and tea intake. 
 For alcohol, only the perception of PROP is 
associated, with every 2-SD decrease in the 
predicted perceived intensity leading to a 
higher frequency of alcohol intake (beta = 
0.038, P = 5.9e-10). 
5. Sweet taste 
perception is 
associated with 
body mass index at 
the phenotypic and 
genetic level 
- Investigate the 
associations between 
sweet tastes (glucose, 
fructose, NHDC, and 
aspartame) and BMI 
measured (1) at the 
same time (in 
adolescence) and (2) 9 
years later (young 
adulthood). 
- Estimate their genetic 
associations using 
variance components 
analysis and polygenic 
risk score prediction. 
 Suggestive associations between sweet tastes 
and BMI measured at the same time:  
Glucose, rp = 0.06, P = 0.035. 
Fructose, rp = 0.04, P = 0.196. 
NHDC: rp = 0.04, P = 0.122. 
Aspartame, rp = 0.06, P = 0.029. 
 Stronger associations between sweet tastes 
and BMI measured 9 years later: 
Glucose, rp = 0.08, P = 0.020. 
Fructose, rp = 0.07, P = 0.034. 
NHDC: rp = 0.07, P = 0.025. 
Aspartame, rp = 0.09, P = 0.007. 
 The associations with glucose and NHDC are 
partly due to genetics. 
6. Is there an 
association 
between brain 
structure and 
perceived intensity 
of sweet and bitter 
tastes? 
- Explore the associations 
between the volume of 
82 brain regions of 
interest and perceived 
intensity of sweetness 
and bitterness of PROP, 
quinine, and caffeine in 
QTIM (n = 559) and 
QTIM (n = 1101). 
 Four brain regions (right cuneus gyrus, right 
inferior temporal gyrus, left transverse temporal 
gyrus, and both left and right caudate volumes) 
are nominally associated with the perceived 
intensities of both sweet and bitter tastes in 
QTIM. 
 The negative association between quinine 
perception and the entorhinal gyrus volume is 
found in both QTIM and HCP. 
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Heritability of sweet taste perception 
We showed that the heritabilities of the perceived intensity for both sugars 
and artificial sweeteners are approximately 0.3 (Chapter 1), which is smaller than 
that for sourness (h2 = 0.5) [42] and bitterness (h2 ~ 0.7 for PROP/PTC and ~ 0.4 for 
other bitter tastes [40, 41]) and larger than saltiness (h2 = 0) [42, 43]. Our large twin 
cohort overcame the power issue present in other studies [41, 43] and allowed us to 
use variance components modelling to provide this first solid estimate of the degree 
of genetic effect on sweet taste perception. 
Previous studies sequencing sweet taste receptor genes and genes involved 
in the sweet perception pathway suggested that variants within/nearby TAS1R3 [82] 
and GNAT3 [83] respectively account for 16% and 13% of the variance of sucrose 
sensitivity, but such large amounts of variance explained were likely overestimated. 
If these variants accounted for a total of 29% of the variance, which is over 85% of 
the total genetic variance of sweet taste, they should be easily replicated and widely 
reported, which is not the case. Besides, those associations were found using a 
small sample (n ≥ 160) with mixed ethnicities (Caucasians, Asians, and African-
Americans) without replication. We looked up these associations in our Australian 
Caucasian twin sample (n = 1757) and a U.S. Caucasian twin sample (n = 686) and 
found no replications, except for a nominal association between rs307355 and 
sucrose intensity in the U.S. sample (P = 0.03; Table 7-2). This suggests that the 
effects of these genes could be specific to sensitivity ratings rather the intensity 
ratings, or, their effects are simply too small so a large sample is required for 
replication. Additionally, genes apart from the sweet taste receptor system may also 
play a significant role, such as genes with putative functions in the brain that regulate 
BMI could also be responsible for sweet taste perception as suggested in Chapter 5. 
Nevertheless, we note that variants within TAS1R3 are found to be associated with 
sweet preference [84, 85] and the risk of dental caries [247] in adults, rather than 
with sweet perception. 
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Table 7-2. Associations (P-values) between variants within TAS1R3 and GNAT3 
and sweet taste phenotypes in the QIMR Berghofer and the Monell samples. 
 
QIMR (n = 1757 Australian twins and siblings) Monell (n = 686 U.S. twins) 
SNP 
Glucose 
Intensity 
Fructose 
Intensity 
Aspartame 
Intensity 
NHDC 
Intensity 
gSweet 
Sucrose 
Intensity 
Sucrose 
Sweetness 
Sucrose 
Liking 
TAS1R3 
        
  rs307355 0.64 0.21 0.69 0.56 0.37 0.03* 0.14 0.24 
  rs35744813 0.61 0.20 0.39 0.57 0.36 0.38 0.20 0.40 
GNAT3 
        
  rs7792845 0.99 0.37 0.80 0.81 0.70 0.28 0.31 0.32 
  rs940541 0.52 0.67 0.36 0.83 0.70 0.47 0.42 0.76 
  rs1107660 0.69 0.89 0.14 0.97 0.61 0.40 0.35 0.82 
  rs1107657 0.71 0.93 0.15 0.92 0.64 0.39 0.39 0.83 
  rs1524600 0.45 0.88 0.68 0.91 0.70 0.81 0.91 0.22 
  rs6467217 0.45 0.84 0.64 0.91 0.68 0.81 0.91 0.22 
  rs6970109 0.45 0.84 0.64 0.91 0.68 0.79 0.85 0.32 
  rs6975345 0.53 0.89 0.59 0.99 0.68 0.63 0.86 0.49 
  rs10242727 0.49 0.86 0.51 0.96 0.63 0.63 0.86 0.49 
  rs6467192 0.30 0.91 0.38 0.98 0.55 0.74 0.93 0.42 
  rs6961082 0.73 0.15 0.99 0.15 0.65 0.84 0.98 0.38 
Only one association has P < 0.05, followed by *. Associations are calculated using GEMMA, as used in Chapter 3. 
 
Genetic architecture of sweet and bitter taste 
In Chapter 1 we found a common genetic factor accounting for most of the 
genetic variance for each of the four sweet taste phenotypes, with specific sweet 
taste genetic factors accounting for < 25% of the total genetic variance. A different 
genetic architecture was found for bitter taste, with the unique/specific genetic 
factors for quinine and caffeine accounting for 50% and 35% of the total genetic 
variance, respectively (Chapter 2). These results suggest that humans have more 
specialized genetic pathways for the perception of different bitter substances 
compared with sweet substances, but more supporting evidence at the molecular 
level is required. 
In Chapter 3 we showed that bitter taste receptor genes played a key role for 
the genetic covariances between bitter tastes as they appeared in the top 
associations for each bitter taste and that the top SNPs for quinine, caffeine, and 
SOA had pleiotropic influences on the perception of quinine, caffeine, SOA, and DB. 
Interestingly, while we found a strong positive genetic association between the 
perception of quinine and caffeine (rg = 0.68; Chapter 2), the top SNP for quinine 
(rs10772420) was inversely associated with the perception of quinine and caffeine 
(Chapter 3), so was the top SNP for caffeine (rs2597979). This indicates that these 
top SNPs actually reduce the strength of genetic association between the perception 
of quinine and caffeine. Nevertheless, we note that these top SNPs are within a large 
linkage disequilibrium block and could be proxies of the true causal SNPs, which 
might not have such obvious opposite influences on the two tastes. 
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If the peripheral receptor system accounted for the genetic covariance 
between bitter tastes, it might also partly account for the genetic association between 
sweet and bitter tastes (Chapter 2) because both sweet and bitter receptors are 
from the GPCR family, which share downstream signalling molecules [136, 137]. In 
addition, genetic variants in the bitter taste receptor genes could also influence 
sweet taste perception, such as the effect of TAS2R31 on the perception of a non-
nutritive sweetener acesulfame potassium [171]. 
Taste, diet, and health 
Previous findings of the relationship between taste and other phenotypes 
were mostly reported in cross-sectional studies, which cannot make causal 
inferences. Using Mendelian randomization (Chapter 4), we demonstrated that bitter 
taste perception is causally associated with the intake of bitter beverages. This work 
could not be done without the identification genetic variants for PROP, quinine, and 
caffeine (Chapter 3). Further in a longitudinal study (Chapter 5) we showed that 
adolescent sweet perception is a predictor of early adult BMI. These findings 
together highlight the importance of taste perception in dietary behaviour. The causal 
relationship indicates that factors modifying taste perception can have further impact 
on diet and health and could support the previous findings that the primary cause of 
morbidity in 20% of cancer patients is malnutrition rather than malignancy [248, 249], 
as cancer treatments (e.g. chemo- and radiotherapies) can modify sensory 
perception [250] that further leads to a decrease in dietary intake and the 
development of food aversion [251]. Our efforts to explore the mechanisms 
underlying individual differences in taste could provide strategies to recover altered 
taste and prevent the unexpected negative impact on quality of life.  
A peep into the human gustatory circuit from a different angle 
We used the largest-to-date cohorts with both brain and taste phenotypes (n = 
559 and 1101 in QTIM and HCP, respectively) to show that taste perception is 
associated with the volume of specific brain regions (Chapter 6). However, the 
association pattern we found varies from what has been reported in functional 
imaging studies [63, 64]. For example, the entorhinal cortex, which was associated 
with quinine perception in both QTIM and HCP, was not reported in the two largest 
meta-analyses of functional imaging studies [63, 64]. Also, the repeatedly reported 
gustatory region – insula cortex – was not associated in our work. These 
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inconsistencies suggest that the associated brain regions we found may play a 
different role in taste perception compared to those identified in functional imaging 
studies. For example, neurons in these regions could function consistently (e.g. 
connecting taste cortices) regardless of tasting status so there is no obvious change 
in the neuronal activity. Additionally, the associations we found were weak (rp ~ 0.1) 
and were not significant when using a more stringent (Bonferroni-corrected) 
threshold, indicating that the power of our sample remains too small. Alternatively, 
this could suggest that other brain phenotypes, e.g. tissue density [252], should be 
investigated when exploring brain gustatory circuit. 
Limitations and future directions 
 In addition to the limitations discussed in each chapter, there are general 
limitations to this work. The primary sample we used included only healthy 
Caucasians living in Australia and most taste data were collected at age 14. 
Although this implies that our findings may only apply to this specific population, it 
indicates that they are less likely to be influenced by potential confounding factors 
such as age [14], race [24], ethnicity [23], and health status [25]. Additionally, there 
was no significant sex effect on taste perception (except for aspartame [Chapter 1] 
and SOA [40]) in our adolescent sample, whereas previous studies reported sex 
differences in younger [13, 15] and older groups [17]. Nevertheless, this work can 
serve as a starting point for future studies with different sample characteristics to 
investigate taste genetics. 
 Our sample contained multiple sweet and bitter taste phenotypes, but no data 
was available for other taste modalities (e.g. sourness, saltiness, and umami taste). 
Therefore, we could not test whether the common genetic factor for sweet and bitter 
tastes (Chapter 2) is also for the perception of umami taste, whose receptors are 
also members of the GPCR family [131, 139], and not for sour and salty tastes, 
whose receptors are believed to be ion channels [132, 134]. A more complete picture 
of the genetic covariances across taste modalities can be examined using the twin 
sensory data collected by the Monell Chemical Senses Center (n > 1000 and 
increases every year) [41]. The dataset includes taste ratings on sweet (sucrose), 
bitter (PTC and quinine), sour (citric acid), salty (sodium chloride and potassium 
chloride) solutions, and more (e.g. vegetable juice). Additionally, each taste stimulus 
was rated for not only perceived intensity but also sweetness, bitterness, sourness, 
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saltiness, burn, and liking. This informative twin dataset will further allow testing the 
relationship between different qualities of the same taste, e.g. whether the 
association between sweetness, intensity, and liking of a sucrose solution is due to 
genetic covariance.  
Sample size is a major obstacle hindering the progress of taste genetics 
because both twin modelling and GWAS require large power to show a significant 
effect particularly when the effect size is small (e.g. lower heritability and genetic 
variants with small effects). Genetically informative data on taste are relatively limited 
compared to disease traits or other sensory traits, such as vision [253-255] or 
hearing [256-258]. This is presumably due to impaired taste having no immediate 
threat to life, or to a lesser extent.  A foreseeable solution to the power issue is to 
form a “Taste Genetics” consortium. It has been a trend to bring research groups 
with similar interests together and there has been many successful genetic 
discoveries through consortium collaboration, e.g. the Enhancing Neuro Imaging 
Genetics through Meta-Analysis (ENIGMA) Consortium [245] and the Psychiatric 
Genomics Consortium (PGC) [259]. There are a few genetically informative cohorts 
on taste perception, including the American [41], the Brazilian [38], the Australian 
(ours), and the Silk Road and the Italian samples (see Chapter 3). Bringing these 
data together for meta-analysis or mega-analysis would provide enhanced power to 
identify loci that could not be found in each sub-sample. We note that taste 
phenotypes vary between studies so it will be easier to accumulate data on more 
common phenotypes (e.g. perception of PROP, quinine, caffeine, sucrose), whereas 
others will rely on new data collection, such as the perception of SOA and DB. 
Integrating genomic data with metabolomics data will provide a deeper 
understanding of the biological pathways of human taste perception. GWAS points 
out top signals, which are not necessarily the causal SNPs or within the responsible 
genes. Additional information of the identified SNPs can be obtained from analyses 
of metabolomic data such as eQTL or mQTL results. For example, GTEx [163] and 
Haploreg [160] are web-based tools for functional annotating the SNPs of interest, 
which we used to link the novel association for DB to the bitter taste receptor T2R4 
in Chapter 3. Other tools, such as PrediXcan [260] and MetaXcan [261], are 
developed to use GWAS summaries to impute gene expression levels for prioritizing 
associated genes. Furthermore, there are tools that employ GWAS and eQTL 
summaries to perform multi-SNP Mendelian randomization, such as SMR [262] and 
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gSMR [263], to test causal associations between the gene expression levels and 
traits of interests. These approaches help target the right genes for follow-up 
functional validation in cell-based assays or animal models. Besides, it is very 
important to choose right tissues/cells for functional validation because the same 
protein can have various functions in different tissues, e.g. T2R38 is responsible for 
perception in the mouth and immune response in the airway [264, 265]. Streamlining 
these steps can accelerate research discovery not only for taste but overall medical 
and biological sciences. 
Mendelian randomization is not ready to test the effect of taste other than the 
perception of PROP/PTC, quinine, and caffeine because this method relies on strong 
and reliable SNP associations, which are often discovered in GWAS, to be used as 
genetic instruments/proxies. However, since there has been hundreds of studies 
showing the relationships between PROP/PTC perception and dietary behaviour [34] 
and diseases [17] plus we showed the effects of quinine and caffeine on beverage 
intake in Chapter 4, it would be useful to do a phenome-wide Mendelian 
randomization to investigate the effect of these tastes on diet-related phenotypes, 
such as the intake of sugar, salt, and the risk of being overweight [266], 
cardiovascular diseases, and even cancer [267]. The SNP associations for these 
traits can be acquired from the Gene Atlas [200] and the Global Biobank Engine 
[http://gbe.stanford.edu], which contain genetic associations for hundreds of traits of 
UK Biobank participants. The outcomes will not only expand our understanding of 
the casual effect of taste but also provide hints to direct taste research, with 
potentially higher success/return rates.  
Conclusion 
This work contributes to the literature of taste sciences by expanding current 
knowledge in its genetics and relationships with diet and brain morphology. It also 
reveals existing obstacles and brings out new directions to pursue. We believe that 
taste research is promising in terms of personalized nutrition and medicine and the 
prevention of public health issues, which will benefit human beings and build a 
healthy world for tomorrow.  
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Supplementary Documents 
Chapter 1  
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Chapter 2  
 
Supplementary Table 2-1. Number of families before and after data screening. 
Family Type Initial After screening a 
MZ twin pairs 234 189 
MZ twin pairs + sibling(s) b 82 54 
DZ twin pairs 491 380 
DZ twin pairs + sibling(s) b 95 72 
Non-twin singletons/unpaired twins 150    320 c 
46% of the sample had suffered a middle ear infection and it was included as a covariate in all analyses. 27% of the sample 
had a history of head injury but it had no effect on all intensity ratings and thus was not included (Chapter 1).  
a Participants were excluded if they scored water as moderate or higher taste (> 20 mm on gLMS), had large differences 
between presentation one and two and had overly high or low total average scores (Chapter 1).   
b Families with a twin pair and one or two siblings.   
c The number of non-twin singletons/unpaired twins increases after cleaning as some twin pair families lose one twin during the 
screening procedure. 
 
 
Supplementary Table 2-2. Taste intensity characteristics of denatonium 
benzoate. 
Mean ± SD a 79.5+24.8 
  Twin Correlations b 
  rMZ (95% CI) 0.41 (0.3, 0.51) 
  rDZ (95% CI) 0.19 (0.1, 0.28) 
  Heritability (95% CI) 0.43 (0.33, 0.52) 
  Correlations (95% CI) 
  Full Sample 
 
    PROP 0.29 (0.25, 0.34) 
    SOA 0.63 (0.6, 0.66) 
    Quinine 0.58 (0.55, 0.61) 
    Caffeine 0.62 (0.59, 0.65) 
    gSweet 0.43 (0.4, 0.47) 
   TAS2R38 adjusted c 
    PROP 0.37 (0.33, 0.41) 
    SOA 0.63 (0.6, 0.66) 
    Quinine 0.6 (0.56, 0.63) 
    Caffeine 0.63 (0.6, 0.65) 
    gSweet 0.44 (0.4, 0.48) 
   AVI/AVI excluded d 
    PROP 0.45 (0.4, 0.49) 
    SOA 0.62 (0.58, 0.65) 
    Quinine 0.57 (0.53, 0.61) 
    Caffeine 0.6 (0.56, 0.64) 
    gSweet 0.41 (0.36, 0.46) 
Mean and standard deviation, MZ and DZ twin correlations, heritability estimate for perceived intensity ratings (millimeters on a 
labeled magnitude scale) of denatonium benzoate and phenotypic correlations with PROP, SOA, quinine, caffeine and a 
general sweetness factor (gSweet).  
a n = 1882. 
b 238 MZ and 446 DZ twin pairs. Estimates are from univariate AE models. 
c TAS2R38 diplotype, available for n = 1756, was tested in a partial dominant model. 
d N reduced to 1229 when TAS2R38 AVI/AVI diplotype excluded 
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Supplementary Table 2-3. Kurtosis and skewness of taste intensity ratings 
before and after square root transformation. 
  Kurtosis Skewness 
  
Original 
Sqrt 
transformed Original 
Sqrt 
transformed 
PROP 2.3963 1.9849 0.6164 -0.0931 
SOA 2.5823 2.6556 0.3702 -0.1761 
Quinine 2.8460 2.7351 0.5484 -0.1110 
Caffeine 2.7097 2.5954 0.5125 -0.0202 
Denatonium Benzoate 2.2380 3.2557 -0.4214 -0.8116 
gSweet 5.0308 3.2773 1.1864 0.4587 
The square root transformation approximates the intensity rating of gSweet to a normal distribution and does not worsen the 
distributions of those for PROP, SOA, quinine and caffeine. 
 
 
Supplementary Table 2-4. Model fit of the Cholesky multivariate modelling for 
perceived intensity ratings of PROP, SOA, quinine, caffeine and gSweet. 
  Model -2LL df AIC Δ-2LL Δdf p 
Full sample 
(n = 1901) 
ACE 23236.74 9377 4482.743 
   
AE  23242.78 9392 4458.779 6.036 15 0.98 
CE 23343.004 9392 4559.004 106.261 15 8.39e-16 
E  23676.959 9407 4862.959 440.216 30 1.96e-74 
TAS2R38 
adjusted a 
(n = 1756) 
ACE 20216.56 8661 2894.561 
   
AE 20225.1 8676 2873.103 8.542 15 0.9 
CE 20257.308 8676 2905.308 40.747 15 3.50e-4 
E  20428.84 8691 3046.84 212.279 30 2.44e-29 
AVI/AVI 
excluded 
(n = 1229) 
ACE 14413.51 6047 2319.511 
   
AE 14424.27 6062 2300.269 10.758 15 0.77 
CE 14462.502 6062 2905.308 48.991 15 1.76e-5 
E 14632.462 6077 2478.462 218.951 30 1.33e-30 
Abbreviations: degrees of freedom (df); -2 times the log-likelihood (-2LL); Akaike’s information criterion (AIC).  
All models are fitted versus Cholesky full ACE model. Best models are shown in bold.  
a TAS2R38 diplotype was tested in a partial dominant model. 
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Supplementary Table 2-5. Absolute variance (95% confidence intervals) in 
perceived intensities of PROP, SOA, quinine, caffeine, and the general sweet 
intensity accounted for by each genetic (A) and environmental (E) factor in 
Cholesky AE model. 
a. Full sample 
  A1 A2 A3 A4 A5 
PROP 0.72 (0.64, 0.81) 
    
SOA 0.02 (0.01, 0.05) 0.36 (0.27, 0.45) 
   
Quinine 0.01 (0, 0.02) 0.19 (0.11, 0.27) 0.20 (0.13, 0.27) 
  
Caffeine 0.03 (0.01, 0.06) 0.17 (0.10, 0.25) 0.02 (0, 0.05) 0.12 (0.07, 0.17) 
 
gSweet 0.01 (0, 0.03) 0.08 (0.03, 0.15) 0.02 (0, 0.06) 0 (0, 0.02) 0.24 (0.16, 0.31) 
  E1 E2 E3 E4 E5 
PROP 0.27 (0.23, 0.32) 
    
SOA 0.09 (0.05, 0.15) 0.49 (0.42, 0.58) 
   
Quinine 0.12 (0.07, 0.18) 0.08 (0.05, 0.13) 0.38 (0.33, 0.45) 
  
Caffeine 0.08 (0.04, 0.14) 0.15 (0.1, 0.21) 0.06 (0.04, 0.10) 0.35 (0.30, 0.40) 
 
gSweet 0.06 (0.02, 0.11) 0.01 (0, 0.03) 0.02 (0.01, 0.05) 0.02 (0, 0.03) 0.49 (0.43, 0.57) 
n = 1901. A2, shown in bold, is the only common genetic factor for gSweet and the bitter compounds SOA, quinine, caffeine. 
 
b. Adjusted for TAS2R38 diplotype. 
  A1 A2 A3 A4 A5 
PROP 0.20 (0.15, 0.25) 
    
SOA 0.05 (0.01, 0.10) 0.34 (0.26, 0.43) 
   
Quinine 0.07 (0.02, 0.13) 0.14 (0.08, 0.22) 0.16 (0.10, 0.22) 
  
Caffeine 0.08 (0.03, 0.15) 0.13 (0.07, 0.20) 0.01 (0, 0.04) 0.12 (0.07, 0.17) 
 
gSweet 0.05 (0.01, 0.11) 0.06 (0.02, 0.12) 0 (0, 0.03) 0 (0, 0.02) 0.24 (0.15, 0.32) 
  E1 E2 E3 E4 E5 
PROP 0.30 (0.26, 0.35) 
    
SOA 0.08 (0.04, 0.13) 0.49 (0.42, 0.57) 
   
Quinine 0.12 (0.07, 0.18) 0.08 (0.05, 0.13) 0.40 (0.34, 0.46) 
  
Caffeine 0.09 (0.05, 0.15) 0.14 (0.09, 0.20) 0.06 (0.03, 0.09) 0.34 (0.30, 0.39) 
 
gSweet 0.04 (0.02, 0.08) 0.01 (0, 0.04) 0.03 (0.01, 0.06) 0.01 (0, 0.04) 0.49 (0.43, 0.57) 
n = 1756. The genetic variance in PROP reduces from 0.72 to 0.20 after adjustment whereas its environmental variance 
remains. The total genetic and total environmental variances in SOA, quinine, caffeine, and gSweet do not change after 
adjustment. Both A1 and A2, shown in bold, are common genetic factors for intensity ratings of sweet and bitter tastes. 
TAS2R38 diplotype was tested in a partial dominant model. 
 
c. TAS2R38 AVI/AVI excluded. 
  A1 A2 A3 A4 A5 
PROP 0.37 (0.31, 0.43) 
    
SOA 0.07 (0.03, 0.12) 0.31 (0.23, 0.39) 
   
Quinine 0.07 (0.03, 0.12) 0.14 (0.08, 0.22) 0.16 (0.1, 0.23) 
  
Caffeine 0.09 (0.05, 0.15) 0.09 (0.04, 0.15) 0.01 (0, 0.05) 0.15 (0.10, 0.21) 
 
gSweet 0.04 (0.01, 0.09) 0.08 (0.03, 0.15) 0 (0, 0.03) 0 (0, 0.02) 0.27 (0.17, 0.36) 
  E1 E2 E3 E4 E5 
PROP 0.26 (0.22, 0.31) 
    
SOA 0.13 (0.08, 0.19) 0.46 (0.40, 0.53) 
   
Quinine 0.17 (0.11, 0.24) 0.05 (0.03, 0.09) 0.37 (0.32, 0.43) 
  
Caffeine 0.12 (0.07, 0.19) 0.14 (0.09, 0.19) 0.06 (0.03, 0.09) 0.33 (0.29, 0.39) 
 
gSweet 0.05 (0.02, 0.10) 0 (0, 0.02) 0.03 (0.01, 0.06) 0.01 (0, 0.04) 0.49 (0.42, 0.57) 
n = 1229. Participants with TAS2R38 AVI/AVI diplotypes were excluded. The genetic variance in PROP reduces from 0.72 to 
0.37 after adjustment whereas its environmental variance remains. The total genetic and total environmental variances in SOA, 
quinine, caffeine, and gSweet do not change after adjustment. Both A1 and A2, shown in bold, are common genetic factors for 
intensity ratings of sweet and bitter tastes. Both A1 and A2, shown in bold, are common genetic factors for intensity ratings of 
sweet and bitter tastes.  
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Supplementary Table 2-6. Genetic variance accounted for by each genetic 
factor in the Cholesky AE models. 
  
A1 A2 A3 A4 A5 
Full Sample 
PROP 100%      
SOA 6.2% (1.9, 12.5) 93.8% (87.5, 98.2)    
Quinine 1.4% (0, 5.2) 45.8% (31.3, 61.2) 52.8% (37.3, 67.7)   
Caffeine 9.3% (3.4, 17.5) 49.0% (34.0, 64.5) 5.9% (0.5, 15.8) 35.8% (22.7, 49.8) 
 
gSweet 3.2% (0.3, 8.7) 23.4% (10.3, 41.5) 4.4% (0, 15.8) 0.1% (0, 6.2) 68.9% (51.5, 83.3) 
 
     
TAS2R38 
Adjusted a 
PROP 100%     
SOA 12.3% (3.4, 24.5) 87.7% (75.5, 96.6)    
Quinine 17.8% (6.7, 31.5) 39.3% (25.1, 55.6) 42.9% (27.7, 58.1)   
Caffeine 23.5% (10.2, 39.9) 38.2% (23.6, 54) 3.1% (0, 11.6) 35.2% (22.4, 49.1) 
 gSweet 15.1% (4.7, 29.9) 16.4% (5.8, 32.2) 0.8% (0, 8.5) 0% (0, 0) 67.7% (49.9, 82.5) 
 
     
AVI/AVI 
excluded 
PROP 100%     
SOA 17.7% (8.8, 28.1) 82.3% (71.9, 91.2)    
Quinine 18.6% (9.6, 28.8) 38.1% (24.5, 54.1) 43.3% (27.8, 58.3)   
Caffeine 26.7% (15.5, 39.6) 25.2% (13.1, 38.6) 4.2% (0, 13.9) 43.9% (31.5, 57.6) 
 gSweet 11.2% (4.1, 20.9) 20% (8.3, 37.3) 0.2% (0, 8.7) 0.3% (0, 6.2) 68.4% (47.0, 83.2) 
a TAS2R38 diplotype was tested in a partial dominant model. 
 
 
Supplementary Table 2-7. Standardized variance (95% confidence intervals) in 
perceived intensities of PROP, SOA, quinine, caffeine, and glucose or fructose 
accounted for by each genetic (A) and environmental (E) factor in Cholesky AE 
model adjusted for the TAS2R38 diplotype. 
a. Glucose 
  A1 A2 A3 A4 A5 
PROP 40% (31, 49) 
    SOA 5% (1, 11) 36% (27, 43) 
   Quinine 7% (2, 13) 15% (9, 22) 16% (10, 22) 
  Caffeine 8% (3, 15) 13% (7, 20) 1% (0, 4) 12% (7, 17) 
 Glucose 4% (1, 9) 3% (1, 8) 0% (0, 3) 1% (0, 5) 26% (17, 34) 
  E1 E2 E3 E4 E5 
PROP 60% (51, 69) 
    SOA 8% (4, 14) 51% (44, 59) 
   Quinine 12% (7, 18) 9% (5, 13) 41% (35, 48) 
  Caffeine 9% (5, 15) 14% (10, 21) 6% (3, 10) 35% (30, 40) 
 gSweet 3% (1, 7) 2% (0, 5) 3% (1, 6) 1% (0, 3) 58% (50, 66) 
n = 1756. 
 
b. Fructose 
 
A1 A2 A3 A4 A5 
PROP 40% (31, 49) 
    SOA 5% (1, 11) 36% (27, 43) 
   Quinine 7% (2, 13) 15% (9, 22) 16% (10, 22) 
  Caffeine 8% (3, 15) 13% (7, 20) 1% (0, 4) 12% (7, 17) 
 Fructose 4% (1, 10) 5% (1, 10) 1% (0, 5) 0% (0, 4) 25% (15, 33) 
 
E1 E2 E3 E4 E5 
PROP 60% (51, 69) 
    SOA 8% (5, 14) 51% (44, 59) 
   Quinine 12% (7, 18) 9% (5, 13) 41% (35, 48) 
  Caffeine 9% (5, 15) 15% (10, 21) 6% (3, 9) 35% (30, 40) 
 Fructose 2% (1, 6) 1% (0, 2) 2% (0, 5) 1% (0, 4) 59% (51, 68) 
n = 1756. 
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Supplementary Table 2-8. Phenotypic correlations between taste intensities 
and IQ, personality and emphasis scores estimated from bivariate ACE models. 
  IQ 
Neuroticis
m 
Extraversio
n 
Openness 
Agreeablene
ss 
Conscientiousne
ss 
Emphasis 
PROP -0.11* 0.04 0.02 -0.05 -0.07* -0.03 -0.02 
SOA -0.15* 0.07* 0.03 -0.07*+ -0.06*+ -0.04 -0.02 
Quinine -0.14* 0.07* 0.05 -0.05 -0.04 -0.05 0 
Caffein
e 
-0.13* 0.07* 0.02 -0.04 -0.06*+ -0.04 -0.02 
gSweet -0.07* 0.05 0.02 0.00 -0.03 -0.05 0 
n = 1244~1256. *p < 0.05 before correction for multiple testing. +Insignificant after adjusting for IQ. 
 
 
Supplementary Table 2-9. Standardized variance in five taste traits in 
Choleskly AE models adjusted for the TAS2R38 diplotype and further adjusted 
for IQ, neuroticism, openness and agreeableness. 
a. IQ 
  A1 A2 A3 A4 A5 
PROP 38% (28, 46) 
    SOA 8% (3, 15) 31% (22, 38) 
   Quinine 3% (0, 8) 15% (8, 23) 16% (9, 23) 
  Caffeine 9% (4, 17) 12% (6, 19) 2% (0, 6) 14% (9, 19) 
 gSweet 11% (5, 19) 4% (1, 9) 2% (0, 9) 0% (0, 2) 21% (11, 29) 
  E1 E2 E3 E4 E5 
PROP 62% (54, 72) 
    SOA 8% (4, 14) 53% (46, 62) 
   Quinine 16% (11, 23) 8% (4, 12) 42% (36, 48) 
  Caffeine 9% (5, 14) 14% (9, 19) 5% (3, 8) 35% (30, 41) 
 gSweet 3% (1, 7) 2% (0, 5) 2% (0, 4) 2% (0, 5) 54% (46, 62) 
n = 1282.  
b. Neuroticism 
 
A1 A2 A3 A4 A5 
PROP 37% (27, 46) 
    SOA 7% (2, 13) 30% (22, 38) 
   Quinine 4% (0, 9) 14% (8, 22) 16% (9, 23) 
  Caffeine 9% (3, 16) 11% (5, 18) 1% (0, 5) 13% (8, 19) 
 gSweet 9% (4, 17) 3% (0, 8) 2% (0, 8) 0% (0, 3) 22% (12, 30) 
 
E1 E2 E3 E4 E5 
PROP 63% (54, 73) 
    SOA 10% (5, 15) 54% (46, 62) 
   Quinine 16% (10, 23) 8% (4, 12) 43% (37, 49) 
  Caffeine 9% (5, 15) 15% (10, 21) 6% (3, 9) 36% (31, 42) 
 gSweet 4% (1, 8) 3% (1, 7) 2% (0, 4) 3% (1, 6) 52% (45, 60) 
n = 1277. 
c. Agreeableness 
  A1 A2 A3 A4 A5 
PROP 38% (29, 47) 
    SOA 7% (2, 13) 30% (21, 37) 
   Quinine 4% (1, 9) 14% (7, 22) 16% (9, 23) 
  Caffeine 9% (3, 16) 11% (5, 18) 1% (0, 5) 13% (8, 19) 
 gSweet 9% (4, 17) 3% (0, 9) 2% (0, 8) 0% (0, 3) 22% (12, 30) 
  E1 E2 E3 E4 E5 
PROP 62% (53, 71) 
    SOA 10% (5, 15) 54% (46, 62) 
   Quinine 16% (10, 23) 8% (4, 12) 43% (37, 49) 
  Caffeine 9% (5, 14) 15% (10, 21) 6% (3, 9) 36% (31, 42) 
 gSweet 4% (1, 8) 3% (1, 7) 1% (0, 4) 3% (1, 6) 52% (45, 60) 
n = 1277. 
The multivariate model adjusted for TAS2R38 was used for comparison because it provided a better fit (AIC = 2873.103) than 
the model without adjustment (AIC = 4127.487) using the same sample (n = 1756). 
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Supplementary Table 2-10. Phenotypic correlations between PROP rating from 
one twin and ratings of SOA, quinine, caffeine, and gSweet from co-twin for MZ 
and DZ twins. 
 
MZ DZ 
SOA 0.06 (-0.07, 0.18) 0.08 (-0.01, 0.17) 
Quinine 0 (-0.12, 0.13) 0.03 (-0.07, 0.12) 
Caffeine 0.09 (-0.04, 0.21) 0.11 (0.02, 0.20) 
gSweet 0.10 (-0.03, 0.22) 0.10 (0, 0.19) 
n = 1244~1256. 
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Supplementary Figure 2-1. Distribution of intensity ratings before and after 
square root transformation. 
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Chapter 3   
Supplementary Table 3-1. Top 100 SNPs on chromosome 12 associated with 
the perceived intensity of quinine. 
Chr:Position SNP A1/A2 MAF Beta SE P 
12:11173455 rs10743937 C/T 0.469 -0.337 0.034 7.84e-23 
12:11173490 rs10772419 C/A 0.469 -0.337 0.034 7.84e-23 
12:11174276 rs10772420 G/A 0.469 -0.337 0.034 7.84e-23 
12:11134701 rs2900554 T/G 0.468 -0.337 0.034 1.15e-22 
12:11177223 rs11054173 A/T 0.469 -0.336 0.034 1.16e-22 
12:11178100 rs9651854 C/T 0.469 -0.336 0.034 1.16e-22 
12:11180204 rs2900578 T/C 0.469 -0.336 0.034 1.16e-22 
12:11180340 rs2010481 A/G 0.469 -0.336 0.034 1.16e-22 
12:11189176 rs2060705 G/A 0.475 -0.338 0.034 1.39e-22 
12:11192290 rs2597981 G/A 0.475 -0.338 0.034 1.39e-22 
12:11258446 rs2443739 C/G 0.467 -0.337 0.034 1.46e-22 
12:11131570 rs2218820 T/C 0.468 -0.336 0.034 1.58e-22 
12:11133472 rs7136588 T/C 0.468 -0.336 0.034 1.59e-22 
12:11137325 rs10772396 T/C 0.468 -0.336 0.034 1.61e-22 
12:11314285 rs34241192 C/A 0.467 -0.336 0.034 1.68e-22 
12:11315043 rs35021653 T/C 0.467 -0.336 0.034 1.68e-22 
12:11182874 rs34763234 G/A 0.47 -0.335 0.034 1.75e-22 
12:11183255 rs10845293 G/A 0.47 -0.335 0.034 1.80e-22 
12:11285300 rs2708371 C/G 0.467 -0.335 0.034 2.37e-22 
12:11285075 rs977473 T/A 0.467 -0.335 0.034 2.38e-22 
12:11285130 rs1960613 G/T 0.467 -0.335 0.034 2.38e-22 
12:11308428 rs61928597 C/T 0.467 -0.335 0.034 2.42e-22 
12:11308774 rs35340812 G/A 0.467 -0.335 0.034 2.42e-22 
12:11309593 rs35699328 C/T 0.467 -0.335 0.034 2.42e-22 
12:11310004 rs61928602 C/T 0.467 -0.335 0.034 2.44e-22 
12:11310295 rs3906996 C/T 0.467 -0.335 0.034 2.44e-22 
12:11311520 rs7310047 G/A 0.467 -0.335 0.034 2.44e-22 
12:11312860 rs6488355 C/T 0.467 -0.335 0.034 2.44e-22 
12:11312877 rs6488356 A/G 0.467 -0.335 0.034 2.44e-22 
12:11312948 rs7486717 A/C 0.467 -0.335 0.034 2.44e-22 
12:11313673 rs7955495 C/T 0.467 -0.335 0.034 2.47e-22 
12:11266222 rs2264229 C/G 0.466 -0.335 0.034 2.47e-22 
12:11253373 rs2597972 A/G 0.467 -0.335 0.034 2.49e-22 
12:11307312 rs34082341 T/C 0.467 -0.334 0.034 2.54e-22 
12:11307693 rs7302010 A/G 0.467 -0.334 0.034 2.54e-22 
12:11306777 rs7976211 G/T 0.467 -0.334 0.034 2.54e-22 
12:11307147 rs35124606 G/C 0.467 -0.334 0.034 2.58e-22 
12:11306346 rs34536990 T/C 0.467 -0.334 0.034 2.60e-22 
12:11263015 rs2708354 A/C 0.467 -0.335 0.034 2.74e-22 
12:11293821 rs35017789 A/G 0.468 -0.333 0.034 2.83e-22 
12:11294026 rs7312327 G/A 0.468 -0.333 0.034 2.83e-22 
12:11294191 rs7298544 A/C 0.468 -0.333 0.034 2.83e-22 
12:11296917 rs61931270 G/A 0.468 -0.333 0.034 2.83e-22 
12:11296975 rs36115011 C/G 0.468 -0.333 0.034 2.83e-22 
12:11297165 rs34685506 C/A 0.468 -0.333 0.034 2.83e-22 
12:11297752 rs6488350 G/A 0.468 -0.333 0.034 2.83e-22 
12:11297854 rs6488351 A/G 0.468 -0.333 0.034 2.83e-22 
12:11299449 rs35856529 A/G 0.468 -0.333 0.034 2.83e-22 
12:11299605 rs35893804 C/T 0.468 -0.333 0.034 2.83e-22 
12:11299685 rs34288418 T/C 0.468 -0.333 0.034 2.83e-22 
12:11299687 rs34843817 A/G 0.468 -0.333 0.034 2.83e-22 
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12:11299851 rs34927715 A/G 0.468 -0.333 0.034 2.83e-22 
12:11299977 rs61931278 G/C 0.468 -0.333 0.034 2.83e-22 
12:11300006 rs61931279 C/T 0.468 -0.333 0.034 2.83e-22 
12:11300369 rs7973730 C/T 0.468 -0.333 0.034 2.83e-22 
12:11304086 rs61928564 T/A 0.468 -0.333 0.034 2.83e-22 
12:11304159 rs61928565 G/T 0.468 -0.333 0.034 2.83e-22 
12:11304327 rs61928566 T/C 0.468 -0.333 0.034 2.83e-22 
12:11305373 rs34548551 G/C 0.468 -0.333 0.034 2.83e-22 
12:11305514 rs34769150 G/T 0.468 -0.333 0.034 2.83e-22 
12:11296329 rs35280352 C/T 0.468 -0.333 0.034 2.84e-22 
12:11305724 rs7959320 A/G 0.468 -0.333 0.034 2.88e-22 
12:11306064 rs7965506 T/C 0.468 -0.333 0.034 2.88e-22 
12:11198678 rs2708322 T/C 0.468 -0.334 0.034 2.91e-22 
12:11204944 rs2597992 T/A 0.468 -0.333 0.034 2.96e-22 
12:11206217 rs2597994 A/G 0.468 -0.333 0.034 2.96e-22 
12:11207864 rs2708386 A/C 0.468 -0.333 0.034 2.96e-22 
12:11208989 rs2597998 C/T 0.468 -0.333 0.034 2.96e-22 
12:11209938 rs2598000 T/C 0.468 -0.333 0.034 2.96e-22 
12:11211904 rs2708383 C/T 0.468 -0.333 0.034 2.96e-22 
12:11250938 rs2443094 A/G 0.468 -0.333 0.034 2.96e-22 
12:11256413 rs2597966 C/T 0.467 -0.334 0.034 3.01e-22 
12:11256437 rs2600332 T/C 0.467 -0.334 0.034 3.01e-22 
12:11256660 rs2708361 C/T 0.467 -0.334 0.034 3.01e-22 
12:11257001 rs2597965 A/G 0.467 -0.334 0.034 3.01e-22 
12:11257149 rs2600341 T/C 0.467 -0.334 0.034 3.01e-22 
12:11257235 rs2597964 A/G 0.467 -0.334 0.034 3.01e-22 
12:11257876 rs2708359 T/A 0.467 -0.334 0.034 3.01e-22 
12:11258011 rs2597963 C/T 0.467 -0.334 0.034 3.01e-22 
12:11258149 rs2600349 C/T 0.467 -0.334 0.034 3.01e-22 
12:11258253 rs2708358 C/T 0.467 -0.334 0.034 3.01e-22 
12:11259871 rs2599405 C/G 0.467 -0.334 0.034 3.01e-22 
12:11259894 rs2597960 A/G 0.467 -0.334 0.034 3.01e-22 
12:11260410 rs2597959 A/C 0.467 -0.334 0.034 3.01e-22 
12:11260644 rs2600338 G/A 0.467 -0.334 0.034 3.01e-22 
12:11260761 rs2600339 G/C 0.467 -0.334 0.034 3.01e-22 
12:11261123 rs2708356 G/A 0.467 -0.334 0.034 3.01e-22 
12:11261967 rs2600342 T/G 0.467 -0.334 0.034 3.01e-22 
12:11262086 rs2597952 T/C 0.467 -0.334 0.034 3.01e-22 
12:11262265 rs2599411 A/G 0.467 -0.334 0.034 3.01e-22 
12:11262724 rs2597951 G/C 0.467 -0.334 0.034 3.01e-22 
12:11262955 rs2597950 T/C 0.467 -0.334 0.034 3.01e-22 
12:11263089 rs2597949 G/A 0.467 -0.334 0.034 3.01e-22 
12:11263112 rs2708353 A/G 0.467 -0.334 0.034 3.01e-22 
12:11263318 rs2597947 T/C 0.467 -0.334 0.034 3.01e-22 
12:11263744 rs75814885 T/G 0.467 -0.334 0.034 3.01e-22 
12:11264798 rs2708352 T/C 0.467 -0.334 0.034 3.01e-22 
12:11264980 rs2264190 G/A 0.467 -0.334 0.034 3.01e-22 
12:11265851 rs2600344 C/T 0.467 -0.334 0.034 3.01e-22 
12:11266342 rs2264192 C/T 0.467 -0.334 0.034 3.01e-22 
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Supplementary Table 3-2. Top 100 SNPs on chromosome 12 associated with 
the perceived intensity of caffeine. 
Chr:Position SNP A1/A2 MAF Beta SE P 
12:11189966 rs2597979 G/C 0.163 0.26 0.05 4.17e-8 
12:11351229 rs1669436 C/G 0.139 0.28 0.05 8.98e-8 
12:11174753 rs1868769 G/A 0.194 0.23 0.04 9.18e-8 
12:11180299 rs2084648 A/T 0.193 0.23 0.04 1.04e-7 
12:11183451 rs10743938 A/T 0.193 0.23 0.04 1.09e-7 
12:11184140 rs10845296 G/A 0.193 0.23 0.04 1.09e-7 
12:11203065 rs2597988 T/C 0.145 0.26 0.05 1.12e-7 
12:11329548 rs73053413 T/C 0.14 0.27 0.05 1.21e-7 
12:11139589 rs10772398 C/T 0.147 0.26 0.05 1.24e-7 
12:11128666 rs10772395 C/T 0.147 0.26 0.05 1.28e-7 
12:11131462 rs6488333 C/T 0.147 0.26 0.05 1.28e-7 
12:11202522 rs2257110 G/C 0.145 0.26 0.05 1.30e-7 
12:11293130 rs2600337 G/C 0.14 0.27 0.05 1.37e-7 
12:11198433 rs2708323 A/G 0.145 0.26 0.05 1.64e-7 
12:11199734 rs2597984 T/C 0.145 0.26 0.05 1.64e-7 
12:11345936 rs1650024 A/G 0.141 0.27 0.05 1.91e-7 
12:11345005 rs1669421 T/C 0.141 0.26 0.05 2.21e-7 
12:11345136 rs1650022 T/G 0.141 0.26 0.05 2.21e-7 
12:11346562 rs1669424 T/C 0.141 0.26 0.05 2.21e-7 
12:11083677 rs10772391 T/C 0.144 0.26 0.05 2.29e-7 
12:11347219 rs1669425 A/G 0.141 0.26 0.05 2.33e-7 
12:11347223 rs1650025 G/C 0.141 0.26 0.05 2.33e-7 
12:11309537 rs34692077 T/C 0.143 0.26 0.05 2.51e-7 
12:11347649 rs1669426 T/C 0.141 0.26 0.05 2.53e-7 
12:11347716 rs1650026 T/C 0.141 0.26 0.05 2.53e-7 
12:11347751 rs1650027 A/G 0.141 0.26 0.05 2.53e-7 
12:11347798 rs1650028 A/G 0.141 0.26 0.05 2.53e-7 
12:11348296 rs1427754 C/T 0.141 0.26 0.05 2.53e-7 
12:11348862 rs1669430 T/C 0.141 0.26 0.05 2.53e-7 
12:11348886 rs1669431 G/T 0.141 0.26 0.05 2.53e-7 
12:11349622 rs1650032 A/G 0.141 0.26 0.05 2.53e-7 
12:11349671 rs2600373 A/G 0.141 0.26 0.05 2.53e-7 
12:11349938 rs1669434 T/G 0.141 0.26 0.05 2.53e-7 
12:11350263 rs1669435 T/C 0.141 0.26 0.05 2.53e-7 
12:11350661 rs1650033 T/C 0.141 0.26 0.05 2.53e-7 
12:11350951 rs1650034 T/G 0.141 0.26 0.05 2.53e-7 
12:11350963 rs1650035 T/G 0.141 0.26 0.05 2.53e-7 
12:11345572 rs1650023 A/G 0.141 0.26 0.05 2.54e-7 
12:11342401 rs1669415 C/T 0.141 0.26 0.05 2.63e-7 
12:11342415 rs1669416 G/C 0.141 0.26 0.05 2.63e-7 
12:11342525 rs1669417 G/A 0.141 0.26 0.05 2.63e-7 
12:11343422 rs1669419 G/A 0.141 0.26 0.05 2.63e-7 
12:11349605 rs1669432 G/T 0.14 0.26 0.05 2.64e-7 
12:11349732 rs1669433 A/G 0.14 0.26 0.05 2.64e-7 
12:11311787 rs61928603 C/T 0.148 0.26 0.05 2.70e-7 
12:11343964 rs1650021 T/A 0.141 0.26 0.05 2.79e-7 
12:11203459 rs2597990 G/A 0.144 0.26 0.05 2.86e-7 
12:11098139 rs2418223 T/A 0.147 0.25 0.05 3.05e-7 
12:11341878 rs61928650 T/C 0.141 0.26 0.05 3.16e-7 
12:11215852 rs1817043 G/A 0.144 0.26 0.05 3.31e-7 
12:11216315 rs2708377 C/T 0.144 0.26 0.05 3.31e-7 
12:11216972 rs2255418 C/T 0.144 0.26 0.05 3.31e-7 
12:11217237 rs2599415 G/A 0.144 0.26 0.05 3.31e-7 
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12:11338781 rs1669413 C/A 0.142 0.26 0.05 3.59e-7 
12:11079998 rs10743936 C/T 0.147 0.25 0.05 3.68e-7 
12:11307615 rs4763634 T/C 0.142 0.26 0.05 3.88e-7 
12:11164751 rs7315843 G/A 0.148 0.25 0.05 3.93e-7 
12:11165233 rs1376249 A/T 0.148 0.25 0.05 3.93e-7 
12:11324559 rs8181 C/G 0.141 0.26 0.05 4.07e-7 
12:11326071 rs2900127 G/A 0.141 0.26 0.05 4.07e-7 
12:11326315 rs4763637 T/C 0.141 0.26 0.05 4.07e-7 
12:11328768 rs1650051 G/A 0.141 0.26 0.05 4.07e-7 
12:11329053 rs1669406 G/A 0.141 0.26 0.05 4.07e-7 
12:11329249 rs1669407 C/T 0.141 0.26 0.05 4.07e-7 
12:11331479 rs187328 T/C 0.141 0.26 0.05 4.07e-7 
12:11331726 rs319266 G/A 0.141 0.26 0.05 4.07e-7 
12:11332584 rs319269 C/A 0.142 0.26 0.05 4.09e-7 
12:11333542 rs319270 C/A 0.142 0.26 0.05 4.09e-7 
12:11337442 rs319277 G/A 0.142 0.26 0.05 4.09e-7 
12:11338983 rs1650019 T/C 0.141 0.26 0.05 4.15e-7 
12:11316437 rs61928609 A/C 0.142 0.26 0.05 4.18e-7 
12:11165540 rs7306087 A/C 0.149 0.25 0.05 4.19e-7 
12:11167674 rs2900577 G/C 0.149 0.25 0.05 4.19e-7 
12:11307278 rs4763632 A/G 0.142 0.26 0.05 4.24e-7 
12:11315112 rs61928606 G/A 0.141 0.26 0.05 4.29e-7 
12:11150579 rs1463237 C/T 0.148 0.25 0.05 4.34e-7 
12:11305844 rs7962445 T/C 0.142 0.26 0.05 4.38e-7 
12:11119119 rs6488331 T/C 0.159 0.24 0.05 4.39e-7 
12:11320130 rs4763636 A/G 0.142 0.26 0.05 4.40e-7 
12:11320643 rs61928615 A/G 0.142 0.26 0.05 4.40e-7 
12:11324401 rs1047713 C/G 0.142 0.26 0.05 4.53e-7 
12:11320297 rs61928614 A/G 0.142 0.26 0.05 4.58e-7 
12:11311159 rs7298947 T/C 0.142 0.26 0.05 4.59e-7 
12:11311590 rs7296270 A/T 0.142 0.26 0.05 4.59e-7 
12:11311947 rs61928604 C/T 0.142 0.26 0.05 4.59e-7 
12:11313886 rs7973298 T/C 0.142 0.26 0.05 4.59e-7 
12:11150551 rs4388985 G/A 0.149 0.25 0.05 4.61e-7 
12:11158728 rs10772414 C/G 0.149 0.25 0.05 4.61e-7 
12:11171846 rs10734843 A/G 0.149 0.25 0.05 4.61e-7 
12:11309750 rs35318883 T/C 0.141 0.26 0.05 4.62e-7 
12:11091432 rs3741843 C/T 0.147 0.25 0.05 4.72e-7 
12:11252797 rs2597975 C/T 0.143 0.25 0.05 5.06e-7 
12:11252845 rs2597974 T/C 0.143 0.25 0.05 5.06e-7 
12:11338555 rs1669409 A/T 0.142 0.26 0.05 5.06e-7 
12:11267880 rs2600347 G/A 0.142 0.25 0.05 5.41e-7 
12:11299218 rs7487324 C/T 0.142 0.25 0.05 5.42e-7 
12:11300255 rs61931280 C/T 0.142 0.25 0.05 5.42e-7 
12:11304413 rs61928567 T/C 0.142 0.25 0.05 5.42e-7 
12:11170837 rs10732561 T/G 0.148 0.24 0.05 5.68e-7 
12:11261589 rs2600340 T/C 0.143 0.25 0.05 5.71e-7 
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Supplementary Table 3-3. Top 100 SNPs on chromosome 12 associated with 
the perceived intensity of sucrose octaacetate (SOA). 
Chr:Position SNP A1/A2 MAF Beta SE P 
12:11194384 rs67487380 A/G 0.275 -0.202 0.040 3.78e-7 
12:11195162 rs1901188 T/C 0.275 -0.202 0.040 3.78e-7 
12:11170152 rs10845291 T/C 0.274 -0.197 0.040 7.52e-7 
12:11196583 rs7310224 G/A 0.264 -0.198 0.040 1.09e-6 
12:11195322 rs35969800 A/G 0.265 -0.197 0.040 1.14e-6 
12:11211734 rs35846189 C/A 0.321 -0.183 0.038 1.66e-6 
12:11211781 rs35413384 C/G 0.321 -0.183 0.038 1.66e-6 
12:11220455 rs11526041 A/C 0.321 -0.183 0.038 1.75e-6 
12:11205292 rs2900581 G/A 0.321 -0.182 0.038 1.89e-6 
12:11205343 rs2900582 A/G 0.321 -0.182 0.038 1.89e-6 
12:11166968 rs7310849 G/A 0.32 -0.181 0.038 1.99e-6 
12:11272192 rs7313683 G/T 0.348 -0.185 0.039 2.06e-6 
12:11252729 rs35097305 C/A 0.32 -0.182 0.038 2.16e-6 
12:11315644 rs1349553 G/A 0.315 -0.185 0.039 2.23e-6 
12:11167763 rs10845290 A/G 0.284 -0.187 0.039 2.32e-6 
12:11175414 rs4763235 G/C 0.321 -0.179 0.038 2.52e-6 
12:11256031 rs28419178 T/C 0.319 -0.181 0.038 2.65e-6 
12:11138852 rs1376251 T/C 0.321 -0.179 0.038 2.80e-6 
12:11141752 rs2418302 T/C 0.321 -0.179 0.038 2.80e-6 
12:11314022 rs35746980 T/C 0.315 -0.183 0.039 2.82e-6 
12:11318574 rs1551193 A/C 0.314 -0.183 0.039 3.00e-6 
12:11147660 rs11054140 T/C 0.321 -0.178 0.038 3.05e-6 
12:11259611 rs66840927 T/G 0.319 -0.180 0.039 3.26e-6 
12:11166536 rs11054164 T/C 0.32 -0.177 0.038 3.47e-6 
12:11166578 rs1901190 C/T 0.32 -0.177 0.038 3.47e-6 
12:11143223 rs12296784 A/C 0.266 -0.186 0.040 3.83e-6 
12:11272738 rs3851590 C/G 0.261 -0.194 0.042 3.95e-6 
12:11131212 rs2900553 T/G 0.32 -0.176 0.038 4.11e-6 
12:11131791 rs7138953 A/G 0.32 -0.176 0.038 4.11e-6 
12:11177580 rs10772421 A/C 0.266 -0.185 0.040 4.25e-6 
12:11262180 rs4763627 A/G 0.318 -0.178 0.039 4.38e-6 
12:11311958 rs2290318 C/G 0.315 -0.179 0.039 4.42e-6 
12:11312026 rs2290319 A/C 0.315 -0.179 0.039 4.43e-6 
12:11263238 rs4763628 C/A 0.319 -0.178 0.039 4.59e-6 
12:11304132 rs34373518 G/A 0.317 -0.178 0.039 4.60e-6 
12:11263799 rs112665659 C/A 0.319 -0.178 0.039 4.61e-6 
12:11263373 rs4763629 G/A 0.319 -0.178 0.039 4.68e-6 
12:11309606 rs34274000 A/G 0.315 -0.179 0.039 4.78e-6 
12:11291030 rs7316032 G/A 0.317 -0.177 0.039 5.32e-6 
12:11293408 rs34708147 G/A 0.317 -0.177 0.039 5.32e-6 
12:11299571 rs34666803 C/T 0.317 -0.177 0.039 5.32e-6 
12:11281517 rs67961444 C/A 0.317 -0.177 0.039 5.46e-6 
12:11285233 rs7980677 C/T 0.317 -0.177 0.039 5.48e-6 
12:11289324 rs6488346 C/T 0.317 -0.177 0.039 5.48e-6 
12:11264628 rs35376087 T/A 0.318 -0.175 0.039 6.12e-6 
12:11266214 rs145696441 C/G 0.318 -0.175 0.039 6.12e-6 
12:11266828 rs77096743 C/A 0.318 -0.175 0.039 6.12e-6 
12:11271711 rs68186227 C/T 0.318 -0.175 0.039 6.12e-6 
12:11216751 rs67861347 G/A 0.329 -0.172 0.038 6.18e-6 
12:11165446 rs4763613 T/C 0.331 -0.170 0.038 6.53e-6 
12:11154236 rs10772412 C/T 0.327 -0.171 0.038 6.69e-6 
12:11149532 rs1450839 G/A 0.331 -0.169 0.038 6.82e-6 
12:11149711 rs10845279 A/C 0.331 -0.169 0.038 6.82e-6 
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12:11149720 rs10845280 G/A 0.331 -0.169 0.038 6.82e-6 
12:11149769 rs10845281 C/T 0.331 -0.169 0.038 6.82e-6 
12:11150033 rs12226919 T/G 0.331 -0.169 0.038 6.82e-6 
12:11150046 rs12226920 T/G 0.331 -0.169 0.038 6.82e-6 
12:11150214 rs11054142 A/G 0.331 -0.169 0.038 6.82e-6 
12:11150319 rs11054143 C/T 0.331 -0.169 0.038 6.82e-6 
12:11150884 rs7301234 A/G 0.331 -0.169 0.038 6.82e-6 
12:11150969 rs7135941 C/T 0.331 -0.169 0.038 6.82e-6 
12:11151003 rs7301364 A/G 0.331 -0.169 0.038 6.82e-6 
12:11151213 rs7301713 A/T 0.331 -0.169 0.038 6.82e-6 
12:11151826 rs10845282 A/G 0.331 -0.169 0.038 6.82e-6 
12:11152029 rs11054144 T/C 0.331 -0.169 0.038 6.82e-6 
12:11152200 rs11054145 T/C 0.331 -0.169 0.038 6.82e-6 
12:11152350 rs11054146 A/G 0.331 -0.169 0.038 6.82e-6 
12:11152775 rs2060702 T/C 0.331 -0.169 0.038 6.82e-6 
12:11153206 rs1450840 C/A 0.331 -0.169 0.038 6.82e-6 
12:11153547 rs11054147 T/C 0.331 -0.169 0.038 6.82e-6 
12:11154906 rs12321023 A/G 0.331 -0.169 0.038 6.82e-6 
12:11156123 rs10772413 T/C 0.331 -0.169 0.038 6.82e-6 
12:11157120 rs7138834 G/A 0.331 -0.169 0.038 6.82e-6 
12:11158299 rs10845284 T/C 0.331 -0.169 0.038 6.82e-6 
12:11158390 rs10845285 A/G 0.331 -0.169 0.038 6.82e-6 
12:11159050 rs10845286 T/C 0.331 -0.169 0.038 6.82e-6 
12:11159135 rs10845287 G/C 0.331 -0.169 0.038 6.82e-6 
12:11159512 rs11054152 G/C 0.331 -0.169 0.038 6.82e-6 
12:11159693 rs11054154 T/C 0.331 -0.169 0.038 6.82e-6 
12:11160459 rs10772415 T/A 0.331 -0.169 0.038 6.82e-6 
12:11160740 rs4298989 T/C 0.331 -0.169 0.038 6.82e-6 
12:11160840 rs1450841 A/G 0.331 -0.169 0.038 6.82e-6 
12:11161343 rs7133669 G/A 0.331 -0.169 0.038 6.82e-6 
12:11161448 rs36104587 A/G 0.331 -0.169 0.038 6.82e-6 
12:11161496 rs35653945 G/T 0.331 -0.169 0.038 6.82e-6 
12:11161838 rs28569398 A/G 0.331 -0.169 0.038 6.82e-6 
12:11161936 rs28654530 C/T 0.331 -0.169 0.038 6.82e-6 
12:11161976 rs28498385 C/T 0.331 -0.169 0.038 6.82e-6 
12:11162014 rs28630880 C/T 0.331 -0.169 0.038 6.82e-6 
12:11162131 rs11054156 G/A 0.331 -0.169 0.038 6.82e-6 
12:11162140 rs11054157 A/G 0.331 -0.169 0.038 6.82e-6 
12:11162287 rs11054158 T/C 0.331 -0.169 0.038 6.82e-6 
12:11162442 rs11054159 A/C 0.331 -0.169 0.038 6.82e-6 
12:11162533 rs11054160 C/T 0.331 -0.169 0.038 6.82e-6 
12:11162679 rs11054161 A/C 0.331 -0.169 0.038 6.82e-6 
12:11162785 rs11054162 A/G 0.331 -0.169 0.038 6.82e-6 
12:11162790 rs11054163 A/G 0.331 -0.169 0.038 6.82e-6 
12:11162991 rs4763606 G/A 0.331 -0.169 0.038 6.82e-6 
12:11163012 rs4763607 C/T 0.331 -0.169 0.038 6.82e-6 
12:11163058 rs4763608 C/T 0.331 -0.169 0.038 6.82e-6 
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Supplementary Table 3-4. Top 100 SNPs on chromosome 7 associated with the 
perceived intensity of denatonium benzoate (DB) from the bivariate analysis of 
DB and quinine. P_univaraite_DB is the P-value from the univariate analysis of 
DB. P_univariate DB_adjQ is the P-value from the univariate analysis of DB 
adjusted for the quinine score. P_bivariate DB_Q is the P-value from the 
bivariate analysis of DB and quinine. 
Chr:Position SNP A1/A2 MAF 
Beta 
Univariate 
DB 
SE 
Univariate 
DB 
P 
univariate 
DB 
P 
univariate 
DB_adjQ 
P 
bivariate 
DB_Q 
7:141398707 rs10261515 G/A 0.491 -0.136 0.037 2.54e-4 1.94e-8 3.15e-8 
7:141428042 rs2366501 T/C 0.498 0.118 0.037 1.49e-3 2.00e-7 1.90e-7 
7:141416846 rs6964456 T/C 0.499 -0.120 0.037 1.18e-3 1.74e-7 1.92e-7 
7:141419499 rs12672225 G/T 0.496 0.127 0.037 5.63e-4 1.17e-7 1.96e-7 
7:141421245 rs12113603 G/A 0.5 0.118 0.037 1.38e-3 2.10e-7 2.28e-7 
7:141421842 rs4726471 G/A 0.5 -0.118 0.037 1.38e-3 2.10e-7 2.28e-7 
7:141421101 rs6948307 T/C 0.5 -0.118 0.037 1.38e-3 2.10e-7 2.28e-7 
7:141425690 rs34184650 T/C 0.499 0.117 0.037 1.58e-3 2.48e-7 2.50e-7 
7:141421031 rs6947065 T/G 0.5 -0.119 0.037 1.26e-3 2.13e-7 2.52e-7 
7:141420264 rs10257653 T/C 0.499 0.119 0.037 1.25e-3 2.26e-7 2.74e-7 
7:141418573 rs10262864 G/T 0.499 0.119 0.037 1.24e-3 2.35e-7 2.85e-7 
7:141415102 rs9942597 T/C 0.5 -0.119 0.037 1.25e-3 2.45e-7 2.89e-7 
7:141415514 rs9942694 G/A 0.5 0.119 0.037 1.25e-3 2.45e-7 2.89e-7 
7:141421623 rs17162425 A/C 0.499 0.116 0.037 1.62e-3 2.82e-7 2.94e-7 
7:141420390 rs6966981 T/C 0.496 0.124 0.037 7.32e-4 1.83e-7 3.06e-7 
7:141420707 rs6971275 T/C 0.496 0.124 0.037 7.43e-4 1.92e-7 3.25e-7 
7:141420768 rs6967301 A/G 0.496 0.124 0.037 7.45e-4 1.93e-7 3.26e-7 
7:141389640 rs7791469 A/G 0.487 -0.115 0.036 1.60e-3 2.71e-7 3.26e-7 
7:141414317 rs2072180 A/G 0.496 0.123 0.037 8.11e-4 2.11e-7 3.30e-7 
7:141422153 rs4726472 C/T 0.496 0.120 0.037 1.10e-3 2.53e-7 3.62e-7 
7:141417484 rs4726470 T/A 0.496 0.121 0.037 9.96e-4 2.74e-7 4.27e-7 
7:141433634 rs1008318 T/G 0.495 0.119 0.037 1.26e-3 3.30e-7 4.52e-7 
7:141601523 rs1285900 C/A 0.471 0.092 0.037 1.32e-2 1.92e-6 5.17e-7 
7:141429767 rs6464452 A/G 0.433 0.115 0.037 2.05e-3 4.52e-7 5.29e-7 
7:141543711 rs12670179 C/T 0.469 0.099 0.038 8.57e-3 1.67e-6 6.21e-7 
7:141601043 rs1285899 T/A 0.471 0.085 0.037 2.09e-2 3.51e-6 6.95e-7 
7:141435436 rs12533304 C/T 0.496 0.100 0.037 7.95e-3 1.63e-6 7.00e-7 
7:141501943 rs17524275 C/G 0.486 0.096 0.037 9.41e-3 1.94e-6 7.17e-7 
7:141530918 rs6969093 A/G 0.478 0.104 0.037 5.29e-3 1.27e-6 7.33e-7 
7:141529611 rs4530955 T/A 0.478 0.107 0.037 4.21e-3 1.11e-6 7.38e-7 
7:141530176 rs7780596 T/A 0.478 0.104 0.037 5.34e-3 1.29e-6 7.41e-7 
7:141532934 rs12703410 A/G 0.477 0.102 0.037 5.83e-3 1.45e-6 7.92e-7 
7:141483590 rs12530637 A/G 0.397 0.086 0.039 2.64e-2 4.97e-6 8.25e-7 
7:141505318 rs62477743 G/T 0.486 0.094 0.037 1.10e-2 2.42e-6 8.41e-7 
7:141504196 rs11766522 G/A 0.486 0.094 0.037 1.11e-2 2.45e-6 8.53e-7 
7:141532989 rs12703411 A/C 0.477 0.104 0.037 5.29e-3 1.47e-6 8.65e-7 
7:141519959 rs1074968 G/C 0.478 0.100 0.037 7.44e-3 1.81e-6 8.97e-7 
7:141592840 rs1285954 A/G 0.471 0.085 0.037 2.19e-2 4.28e-6 9.24e-7 
7:141381467 rs12703403 G/C 0.45 -0.124 0.037 8.37e-4 3.92e-7 9.29e-7 
7:141517831 rs11770781 C/T 0.478 0.101 0.037 6.69e-3 1.78e-6 9.57e-7 
7:141517511 rs2214839 C/T 0.478 0.101 0.037 6.69e-3 1.78e-6 9.57e-7 
7:141465363 rs6962760 C/T 0.491 0.103 0.037 5.10e-3 1.47e-6 1.01e-6 
7:141589691 rs1285956 G/A 0.471 0.086 0.037 1.98e-2 4.20e-6 1.05e-6 
7:141495604 rs1859646 A/G 0.486 0.101 0.037 6.07e-3 1.76e-6 1.05e-6 
7:141398942 rs13231650 T/C 0.433 0.114 0.037 1.81e-3 6.46e-7 1.08e-6 
7:141497070 rs34378880 A/G 0.485 0.098 0.037 8.12e-3 2.20e-6 1.10e-6 
7:141412310 rs1476640 T/C 0.434 0.104 0.037 4.88e-3 1.37e-6 1.12e-6 
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7:141501747 rs12703408 G/C 0.483 0.100 0.037 6.96e-3 2.06e-6 1.17e-6 
7:141501672 rs17464668 A/G 0.483 0.100 0.037 6.96e-3 2.06e-6 1.17e-6 
7:141525153 rs7791243 T/A 0.478 0.099 0.037 7.78e-3 2.26e-6 1.19e-6 
7:141626494 rs1285931 C/G 0.451 0.079 0.037 3.42e-2 8.14e-6 1.24e-6 
7:141591345 rs1285955 A/G 0.47 0.084 0.037 2.42e-2 5.66e-6 1.26e-6 
7:141544787 rs892355 C/T 0.476 0.095 0.037 1.02e-2 3.03e-6 1.28e-6 
7:141524776 rs6464454 A/G 0.478 0.100 0.037 7.06e-3 2.28e-6 1.30e-6 
7:141498467 rs11762219 C/T 0.483 0.102 0.037 5.89e-3 1.97e-6 1.31e-6 
7:141530057 rs4636113 A/T 0.474 0.106 0.037 4.44e-3 1.61e-6 1.33e-6 
7:141475161 rs35046848 A/G 0.399 0.089 0.038 2.03e-2 4.87e-6 1.37e-6 
7:141504604 rs11763806 T/C 0.483 0.098 0.037 8.21e-3 2.58e-6 1.38e-6 
7:141503999 rs58726075 A/G 0.483 0.098 0.037 8.21e-3 2.58e-6 1.38e-6 
7:141502792 rs11766169 C/T 0.483 0.098 0.037 8.11e-3 2.57e-6 1.39e-6 
7:141578863 rs1830211 C/T 0.47 0.093 0.037 1.20e-2 3.44e-6 1.44e-6 
7:141607214 rs1799658 G/A 0.471 0.082 0.037 2.69e-2 6.86e-6 1.46e-6 
7:141504298 rs11769672 A/G 0.483 0.097 0.037 8.55e-3 2.79e-6 1.49e-6 
7:141496256 rs9648785 C/T 0.483 0.103 0.037 5.25e-3 1.99e-6 1.56e-6 
7:141540548 rs12533399 C/T 0.476 0.096 0.037 9.38e-3 3.28e-6 1.63e-6 
7:141464765 rs2270009 T/C 0.486 0.104 0.037 4.45e-3 1.80e-6 1.69e-6 
7:141439907 rs6464453 C/G 0.494 0.098 0.037 8.47e-3 2.79e-6 1.72e-6 
7:141468253 rs12667295 T/C 0.49 0.100 0.037 6.32e-3 2.43e-6 1.74e-6 
7:141467838 rs974008 G/A 0.49 0.100 0.037 6.32e-3 2.43e-6 1.74e-6 
7:141486321 rs11773137 G/A 0.49 0.093 0.037 1.13e-2 3.83e-6 1.78e-6 
7:141540492 rs12532841 G/A 0.476 0.097 0.037 8.54e-3 3.31e-6 1.79e-6 
7:141537735 rs12669721 G/T 0.476 0.097 0.037 8.54e-3 3.31e-6 1.79e-6 
7:141538865 rs12703412 G/A 0.476 0.097 0.037 8.54e-3 3.31e-6 1.79e-6 
7:141442213 rs2301924 A/G 0.495 0.094 0.037 1.21e-2 3.77e-6 1.81e-6 
7:141407716 rs6963959 A/C 0.431 0.106 0.037 4.19e-3 1.64e-6 1.82e-6 
7:141518505 rs34706333 C/A 0.474 0.101 0.037 6.60e-3 2.55e-6 1.83e-6 
7:141512088 rs13223389 A/C 0.474 0.101 0.037 6.76e-3 2.59e-6 1.83e-6 
7:141518836 rs12534862 G/A 0.474 0.101 0.037 6.67e-3 2.58e-6 1.84e-6 
7:141514009 rs34285424 C/T 0.474 0.101 0.037 6.74e-3 2.60e-6 1.84e-6 
7:141514595 rs7779209 A/G 0.474 0.101 0.037 6.71e-3 2.60e-6 1.85e-6 
7:141565938 rs1918301 C/T 0.47 0.091 0.037 1.42e-2 4.79e-6 1.85e-6 
7:141407424 rs4726468 T/C 0.43 0.107 0.037 3.84e-3 1.59e-6 1.94e-6 
7:141442652 rs2013816 G/A 0.495 0.095 0.037 1.11e-2 3.82e-6 2.01e-6 
7:141614005 rs1285912 G/A 0.471 0.078 0.037 3.56e-2 1.11e-5 2.14e-6 
7:141561184 rs1655265 C/T 0.469 0.090 0.037 1.52e-2 5.63e-6 2.16e-6 
7:141558725 rs2436718 G/A 0.469 0.090 0.037 1.52e-2 5.63e-6 2.16e-6 
7:141561751 rs2695133 G/A 0.469 0.090 0.037 1.52e-2 5.63e-6 2.16e-6 
7:141466179 rs62476658 A/G 0.487 0.105 0.037 4.26e-3 2.14e-6 2.20e-6 
7:141564780 rs1285896 T/C 0.469 0.088 0.037 1.75e-2 6.43e-6 2.28e-6 
7:141524822 rs7806962 A/G 0.475 0.102 0.037 5.91e-3 2.82e-6 2.32e-6 
7:141480936 rs17464086 A/G 0.489 0.097 0.036 7.66e-3 3.53e-6 2.35e-6 
7:141478800 rs2234002 A/G 0.489 0.097 0.036 7.66e-3 3.53e-6 2.35e-6 
7:141444414 rs17462840 C/G 0.494 0.092 0.037 1.36e-2 4.96e-6 2.35e-6 
7:141526913 rs7804754 C/T 0.479 0.098 0.037 8.24e-3 3.71e-6 2.35e-6 
7:141469679 rs2023998 A/G 0.487 0.103 0.037 5.01e-3 2.52e-6 2.40e-6 
7:141572858 rs1285895 A/G 0.47 0.088 0.037 1.77e-2 6.90e-6 2.43e-6 
7:141489911 rs2234007 A/G 0.489 0.089 0.037 1.50e-2 5.86e-6 2.44e-6 
7:141488985 rs10952507 A/G 0.489 0.089 0.037 1.50e-2 5.86e-6 2.44e-6 
7:141489866 rs2234006 T/C 0.489 0.089 0.037 1.50e-2 5.86e-6 2.44e-6 
7:141475054 rs4535645 C/T 0.49 0.098 0.037 7.60e-3 3.58e-6 2.46e-6 
 
 
 
 
 
 
159 
Supplementary Table 3-5. Top 100 SNPs on chromosome 7 associated with the 
perceived intensity of PROP solution. 
Chr:Position SNP A1/A2 MAF Beta SE P 
7:141672604 rs10246939 C/T 0.443 0.968 0.028 2.80e-199 
7:141672705 rs1726866 G/A 0.443 0.965 0.028 5.62e-198 
7:141662394 rs2695135 T/C 0.282 0.756 0.040 1.80e-73 
7:141658390 rs2436717 T/C 0.278 0.741 0.039 2.24e-73 
7:141661450 rs6962383 C/A 0.28 0.749 0.040 1.82e-72 
7:141660700 rs1726867 A/G 0.281 0.740 0.039 7.28e-72 
7:141653637 rs7794708 T/C 0.275 0.696 0.039 1.81e-66 
7:141639975 rs1285944 C/T 0.282 0.687 0.039 8.13e-65 
7:141636563 rs1285950 C/A 0.282 0.687 0.039 1.38e-64 
7:141647022 rs1285968 A/G 0.279 0.683 0.039 1.17e-63 
7:141613205 rs13240104 G/A 0.282 0.677 0.039 4.09e-63 
7:141613248 rs34588922 C/T 0.282 0.677 0.039 4.09e-63 
7:141612717 rs6976028 T/C 0.282 0.676 0.039 5.09e-63 
7:141546847 rs12703413 A/G 0.278 0.676 0.039 5.28e-62 
7:141544200 rs9640205 G/C 0.273 0.684 0.040 5.41e-62 
7:141551958 rs34894166 C/T 0.279 0.674 0.039 1.12e-61 
7:141564646 rs62475469 A/G 0.279 0.674 0.039 1.70e-61 
7:141560990 rs60165685 A/G 0.278 0.674 0.039 2.22e-61 
7:141586441 rs6955562 G/C 0.276 0.676 0.039 2.43e-61 
7:141556519 rs58093678 G/C 0.278 0.673 0.039 3.38e-61 
7:141560655 rs17133534 T/G 0.279 0.673 0.039 3.60e-61 
7:141562424 rs13232651 T/C 0.279 0.673 0.039 3.60e-61 
7:141533757 rs35647444 T/G 0.279 0.672 0.039 4.94e-61 
7:141633062 rs1527309 T/C 0.28 0.671 0.039 5.11e-61 
7:141531140 rs6969430 A/G 0.28 0.667 0.039 6.91e-60 
7:141590705 rs10808016 G/T 0.281 0.663 0.039 9.97e-60 
7:141532187 rs10464444 A/G 0.28 0.666 0.039 1.01e-59 
7:141588426 rs35634557 C/T 0.283 0.661 0.039 1.31e-59 
7:141565357 rs6957037 G/A 0.282 0.660 0.039 3.35e-59 
7:141588055 rs873818 T/G 0.281 0.662 0.039 3.77e-59 
7:141543098 rs9640357 T/C 0.282 0.659 0.039 3.94e-59 
7:141543810 rs35836873 G/A 0.282 0.659 0.039 3.94e-59 
7:141543882 rs9640358 A/G 0.282 0.659 0.039 3.94e-59 
7:141544100 rs9640204 G/A 0.28 0.660 0.039 8.05e-59 
7:141537968 rs11765575 G/A 0.282 0.657 0.039 8.48e-59 
7:141544199 rs9640359 A/C 0.275 0.666 0.040 1.04e-58 
7:141584184 rs13235900 G/A 0.279 0.659 0.039 2.58e-58 
7:141585166 rs1980369 G/T 0.279 0.659 0.039 2.58e-58 
7:141574911 rs12668089 T/C 0.281 0.655 0.039 2.78e-58 
7:141575800 rs12668693 T/C 0.281 0.655 0.039 2.78e-58 
7:141577186 rs2082551 G/A 0.281 0.655 0.039 2.78e-58 
7:141569606 rs6959360 A/C 0.281 0.654 0.039 3.40e-58 
7:141573055 rs12534927 C/T 0.281 0.654 0.039 3.77e-58 
7:141567569 rs2163953 C/T 0.281 0.653 0.039 4.89e-58 
7:141661585 rs10435196 T/A 0.248 0.686 0.042 6.28e-57 
7:141658886 rs67596995 G/A 0.25 0.678 0.041 7.06e-57 
7:141662547 rs12531134 C/T 0.249 0.687 0.042 1.06e-56 
7:141656487 rs11762634 A/G 0.25 0.661 0.041 1.16e-55 
7:141657465 rs13235385 T/C 0.246 0.666 0.041 3.47e-55 
7:141654892 rs2570407 C/A 0.251 0.658 0.041 3.97e-55 
7:141637810 rs1594777 G/A 0.253 0.642 0.041 1.04e-52 
7:141638297 rs12531781 T/C 0.253 0.642 0.041 1.04e-52 
7:141638429 rs13227402 T/C 0.253 0.642 0.041 1.04e-52 
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7:141642285 rs1594776 T/C 0.248 0.636 0.041 3.02e-51 
7:141639215 rs13237944 A/C 0.249 0.635 0.041 4.63e-51 
7:141646430 rs2293460 T/C 0.246 0.632 0.041 4.96e-50 
7:141646434 rs2293461 G/A 0.246 0.632 0.041 4.96e-50 
7:141630267 rs12539499 C/T 0.251 0.626 0.041 2.83e-49 
7:141593434 rs12538701 T/C 0.252 0.622 0.041 8.30e-49 
7:141544734 rs892354 T/C 0.251 0.622 0.041 8.72e-49 
7:141544095 rs9640203 G/A 0.25 0.624 0.041 1.07e-48 
7:141628704 rs11770855 C/T 0.25 0.622 0.041 1.32e-48 
7:141550780 rs13236432 C/G 0.251 0.621 0.041 1.47e-48 
7:141590684 rs10952509 C/A 0.25 0.622 0.041 1.51e-48 
7:141627899 rs13222726 G/A 0.25 0.619 0.041 2.20e-48 
7:141602476 rs11765106 G/A 0.252 0.616 0.041 4.46e-48 
7:141609424 rs7802271 A/T 0.254 0.610 0.041 7.34e-48 
7:141609758 rs7782886 A/G 0.254 0.610 0.041 7.34e-48 
7:141610572 rs35412929 C/T 0.254 0.610 0.041 7.34e-48 
7:141610891 rs994808 C/A 0.254 0.610 0.041 7.34e-48 
7:141611285 rs994809 C/T 0.254 0.610 0.041 7.34e-48 
7:141611392 rs7808421 G/A 0.254 0.610 0.041 7.34e-48 
7:141611499 rs7789123 C/G 0.254 0.610 0.041 7.34e-48 
7:141612116 rs11767119 A/G 0.254 0.610 0.041 7.34e-48 
7:141612621 rs11767947 A/G 0.254 0.610 0.041 7.34e-48 
7:141614110 rs11769089 A/G 0.253 0.611 0.041 8.40e-48 
7:141614190 rs11765974 G/A 0.253 0.611 0.041 8.40e-48 
7:141605899 rs7786202 C/T 0.253 0.613 0.041 1.11e-47 
7:141531917 rs34726057 C/T 0.252 0.611 0.041 1.39e-46 
7:141579215 rs10952508 G/T 0.25 0.607 0.041 1.99e-46 
7:141611955 rs7785954 G/A 0.258 0.592 0.041 2.32e-45 
7:141526020 rs6967189 C/T 0.255 0.591 0.042 1.42e-43 
7:141511858 rs12703409 C/T 0.253 0.593 0.042 3.63e-42 
7:141510353 rs35010424 T/C 0.25 0.587 0.043 1.62e-40 
7:141627149 rs1285933 G/A 0.469 0.479 0.036 1.80e-38 
7:141614005 rs1285912 G/A 0.471 0.479 0.036 3.24e-38 
7:141607214 rs1799658 G/A 0.47 0.480 0.036 3.46e-38 
7:141616506 rs745162 G/A 0.471 0.478 0.036 3.92e-38 
7:141615875 rs1285914 G/A 0.471 0.478 0.036 5.03e-38 
7:141475161 rs35046848 A/G 0.399 0.497 0.038 5.08e-38 
7:141615867 rs1285913 C/G 0.471 0.478 0.036 5.33e-38 
7:141591345 rs1285955 A/G 0.47 0.477 0.036 1.20e-37 
7:141589691 rs1285956 G/A 0.471 0.477 0.036 1.26e-37 
7:141429767 rs6464452 A/G 0.432 0.482 0.037 1.64e-37 
7:141592840 rs1285954 A/G 0.47 0.476 0.036 1.65e-37 
7:141601043 rs1285899 T/A 0.471 0.476 0.036 1.74e-37 
7:141601523 rs1285900 C/A 0.471 0.475 0.036 1.99e-37 
7:141563970 rs1433594 A/G 0.466 0.476 0.036 2.04e-37 
7:141368300 rs12154227 T/C 0.424 -0.483 0.037 2.50e-37 
7:141549635 rs34708913 A/T 0.465 0.475 0.036 3.14e-37 
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Supplementary Table 3-6. Top 100 SNPs on chromosome 7 associated with the 
perceived intensity of PROP paper. 
Chr:Position SNP A1/A2 MAF Beta SE P 
7:141672705 rs1726866 G/A 0.441 0.535 0.032 3.38e-59 
7:141672604 rs10246939 C/T 0.441 0.534 0.032 5.40e-59 
7:141658390 rs2436717 T/C 0.278 0.461 0.038 4.37e-33 
7:141660700 rs1726867 A/G 0.281 0.457 0.038 8.77e-32 
7:141661450 rs6962383 C/A 0.28 0.458 0.039 1.73e-31 
7:141662394 rs2695135 T/C 0.282 0.459 0.039 2.41e-31 
7:141653637 rs7794708 T/C 0.276 0.433 0.037 4.68e-30 
7:141639975 rs1285944 C/T 0.283 0.427 0.037 2.87e-29 
7:141636563 rs1285950 C/A 0.283 0.427 0.037 3.32e-29 
7:141647022 rs1285968 A/G 0.279 0.424 0.037 9.69e-29 
7:141613205 rs13240104 G/A 0.282 0.415 0.037 5.34e-28 
7:141613248 rs34588922 C/T 0.282 0.415 0.037 5.34e-28 
7:141612717 rs6976028 T/C 0.283 0.413 0.037 9.20e-28 
7:141633062 rs1527309 T/C 0.282 0.413 0.038 2.61e-27 
7:141586441 rs6955562 G/C 0.276 0.409 0.038 1.68e-26 
7:141546847 rs12703413 A/G 0.279 0.407 0.038 1.96e-26 
7:141551958 rs34894166 C/T 0.279 0.406 0.038 2.32e-26 
7:141533757 rs35647444 T/G 0.279 0.405 0.038 2.89e-26 
7:141590705 rs10808016 G/T 0.282 0.404 0.038 3.00e-26 
7:141531140 rs6969430 A/G 0.28 0.406 0.038 3.11e-26 
7:141532187 rs10464444 A/G 0.28 0.406 0.038 3.40e-26 
7:141588426 rs35634557 C/T 0.283 0.403 0.038 3.44e-26 
7:141564646 rs62475469 A/G 0.28 0.405 0.038 3.46e-26 
7:141556519 rs58093678 G/C 0.279 0.405 0.038 3.53e-26 
7:141560655 rs17133534 T/G 0.279 0.405 0.038 3.63e-26 
7:141562424 rs13232651 T/C 0.279 0.405 0.038 3.63e-26 
7:141560990 rs60165685 A/G 0.279 0.405 0.038 4.13e-26 
7:141544200 rs9640205 G/C 0.273 0.408 0.038 6.69e-26 
7:141544100 rs9640204 G/A 0.279 0.401 0.038 1.22e-25 
7:141588055 rs873818 T/G 0.281 0.400 0.038 1.31e-25 
7:141537968 rs11765575 G/A 0.282 0.397 0.038 2.00e-25 
7:141584184 rs13235900 G/A 0.279 0.400 0.038 2.06e-25 
7:141585166 rs1980369 G/T 0.279 0.400 0.038 2.06e-25 
7:141543098 rs9640357 T/C 0.282 0.396 0.038 2.78e-25 
7:141543810 rs35836873 G/A 0.282 0.396 0.038 2.78e-25 
7:141543882 rs9640358 A/G 0.282 0.395 0.038 3.62e-25 
7:141565357 rs6957037 G/A 0.282 0.395 0.038 4.15e-25 
7:141567569 rs2163953 C/T 0.281 0.394 0.038 6.24e-25 
7:141574911 rs12668089 T/C 0.281 0.393 0.038 6.97e-25 
7:141575800 rs12668693 T/C 0.281 0.393 0.038 6.97e-25 
7:141577186 rs2082551 G/A 0.281 0.393 0.038 6.97e-25 
7:141569606 rs6959360 A/C 0.281 0.393 0.038 7.20e-25 
7:141658886 rs67596995 G/A 0.25 0.410 0.039 7.70e-25 
7:141573055 rs12534927 C/T 0.28 0.392 0.038 8.83e-25 
7:141544199 rs9640359 A/C 0.274 0.397 0.038 1.10e-24 
7:141661585 rs10435196 T/A 0.247 0.410 0.040 2.72e-24 
7:141662547 rs12531134 C/T 0.248 0.410 0.040 4.32e-24 
7:141654892 rs2570407 C/A 0.251 0.398 0.039 4.74e-24 
7:141657465 rs13235385 T/C 0.245 0.402 0.039 5.92e-24 
7:141656487 rs11762634 A/G 0.25 0.397 0.039 6.23e-24 
7:141637810 rs1594777 G/A 0.253 0.387 0.039 7.01e-23 
7:141638297 rs12531781 T/C 0.253 0.387 0.039 7.01e-23 
7:141638429 rs13227402 T/C 0.253 0.387 0.039 7.01e-23 
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7:141642285 rs1594776 T/C 0.248 0.384 0.039 2.13e-22 
7:141639215 rs13237944 A/C 0.249 0.384 0.039 2.71e-22 
7:141614110 rs11769089 A/G 0.253 0.378 0.039 5.97e-22 
7:141614190 rs11765974 G/A 0.253 0.378 0.039 5.97e-22 
7:141630267 rs12539499 C/T 0.251 0.375 0.039 2.86e-21 
7:141646430 rs2293460 T/C 0.245 0.377 0.039 3.02e-21 
7:141646434 rs2293461 G/A 0.245 0.377 0.039 3.02e-21 
7:141628704 rs11770855 C/T 0.25 0.373 0.039 4.30e-21 
7:141609424 rs7802271 A/T 0.254 0.367 0.039 8.13e-21 
7:141609758 rs7782886 A/G 0.254 0.367 0.039 8.13e-21 
7:141610572 rs35412929 C/T 0.254 0.367 0.039 8.13e-21 
7:141610891 rs994808 C/A 0.254 0.367 0.039 8.13e-21 
7:141611285 rs994809 C/T 0.254 0.367 0.039 8.13e-21 
7:141611392 rs7808421 G/A 0.254 0.367 0.039 8.13e-21 
7:141611499 rs7789123 C/G 0.254 0.367 0.039 8.13e-21 
7:141612116 rs11767119 A/G 0.254 0.367 0.039 8.13e-21 
7:141612621 rs11767947 A/G 0.254 0.367 0.039 8.13e-21 
7:141627899 rs13222726 G/A 0.25 0.370 0.039 8.62e-21 
7:141590684 rs10952509 C/A 0.25 0.370 0.039 1.13e-20 
7:141593434 rs12538701 T/C 0.252 0.369 0.039 1.18e-20 
7:141602476 rs11765106 G/A 0.252 0.365 0.039 2.54e-20 
7:141605899 rs7786202 C/T 0.252 0.362 0.039 4.85e-20 
7:141611955 rs7785954 G/A 0.257 0.356 0.039 8.37e-20 
7:141544095 rs9640203 G/A 0.249 0.362 0.040 1.32e-19 
7:141544734 rs892354 T/C 0.251 0.355 0.039 3.56e-19 
7:141550780 rs13236432 C/G 0.251 0.355 0.039 3.84e-19 
7:141531917 rs34726057 C/T 0.253 0.354 0.039 5.57e-19 
7:141579215 rs10952508 G/T 0.25 0.353 0.039 6.28e-19 
7:141526020 rs6967189 C/T 0.256 0.349 0.039 2.23e-18 
7:141511858 rs12703409 C/T 0.254 0.343 0.040 3.23e-17 
7:141510353 rs35010424 T/C 0.252 0.337 0.041 1.93e-16 
7:141616506 rs745162 G/A 0.471 0.265 0.034 1.91e-14 
7:141614005 rs1285912 G/A 0.471 0.265 0.034 2.45e-14 
7:141615875 rs1285914 G/A 0.47 0.263 0.035 3.83e-14 
7:141615867 rs1285913 C/G 0.47 0.263 0.035 3.92e-14 
7:141627149 rs1285933 G/A 0.469 0.260 0.034 5.98e-14 
7:141592840 rs1285954 A/G 0.472 0.260 0.035 8.25e-14 
7:141591345 rs1285955 A/G 0.471 0.259 0.035 1.05e-13 
7:141607214 rs1799658 G/A 0.47 0.258 0.035 1.21e-13 
7:141589691 rs1285956 G/A 0.472 0.258 0.035 1.31e-13 
7:141563970 rs1433594 A/G 0.467 0.257 0.035 1.91e-13 
7:141601043 rs1285899 T/A 0.471 0.255 0.035 2.15e-13 
7:141549635 rs34708913 A/T 0.467 0.256 0.035 2.21e-13 
7:141530057 rs4636113 A/T 0.474 0.257 0.035 2.32e-13 
7:141518505 rs34706333 C/A 0.474 0.258 0.035 2.39e-13 
7:141518836 rs12534862 G/A 0.474 0.257 0.035 2.43e-13 
7:141522086 rs79390963 G/A 0.475 0.256 0.035 2.58e-13 
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Supplementary Table 3-7. Top 100 SNPs on chromosome 2 associated with the 
perceived intensity of PROP paper and their associations with PROP solution. 
Chr:Position SNP A1/A2 MAF Beta_paper SE_paper P_paper P_solution 
2:218218646 rs6761655 G/A 0.186 -0.246 0.044 2.69e-8 7.38e-4 
2:218218695 rs6736242 A/G 0.186 -0.246 0.044 2.69e-8 7.38e-4 
2:218219311 rs7586502 A/G 0.142 -0.259 0.049 1.31e-7 1.03e-3 
2:218220180 rs80312552 G/A 0.14 -0.258 0.049 1.70e-7 9.43e-4 
2:218219166 rs6435978 T/C 0.142 -0.256 0.049 1.85e-7 2.48e-3 
2:218219074 rs6435976 T/C 0.142 -0.253 0.049 2.15e-7 2.34e-3 
2:218219139 rs6435977 A/G 0.143 -0.254 0.049 2.18e-7 2.12e-3 
2:218221469 rs4674157 A/G 0.14 -0.255 0.049 2.59e-7 1.07e-3 
2:218220849 rs4674155 A/G 0.139 -0.252 0.049 3.60e-7 1.67e-3 
2:218220860 rs4674156 T/C 0.139 -0.252 0.049 3.60e-7 1.67e-3 
2:218218855 rs6707253 G/A 0.142 -0.248 0.049 3.77e-7 3.04e-3 
2:218218774 rs6707229 C/A 0.143 -0.248 0.049 4.00e-7 3.09e-3 
2:218188539 rs13023129 C/T 0.232 -0.211 0.042 4.99e-7 6.02e-3 
2:218216220 rs1863193 C/T 0.211 -0.215 0.043 5.25e-7 7.78e-4 
2:218214057 rs13008830 C/T 0.211 -0.214 0.043 6.69e-7 5.76e-4 
2:218175472 rs4141835 A/G 0.231 -0.205 0.041 8.12e-7 5.93e-3 
2:218200026 rs13432162 A/G 0.229 -0.206 0.042 1.14e-6 1.75e-3 
2:218177694 rs1863183 T/C 0.235 -0.201 0.041 1.18e-6 1.09e-2 
2:218197359 rs16857324 C/T 0.231 -0.204 0.042 1.47e-6 2.73e-3 
2:218226173 rs13417769 G/A 0.137 -0.240 0.051 2.24e-6 5.42e-3 
2:218228349 rs7561131 C/T 0.205 -0.203 0.043 3.31e-6 1.38e-3 
2:218220232 rs112802287 G/A 0.208 -0.195 0.042 4.26e-6 3.89e-4 
2:218222700 rs4674158 T/A 0.209 -0.193 0.042 5.50e-6 6.82e-4 
2:218207688 rs5028238 G/A 0.233 -0.193 0.043 6.09e-6 1.20e-3 
2:160387482 rs34251858 C/A 0.094 0.258 0.059 1.31e-5 1.41e-2 
2:112444296 rs10186692 G/T 0.451 0.150 0.035 1.58e-5 2.82e-2 
2:112443852 rs10175681 T/C 0.449 0.148 0.034 1.83e-5 2.03e-2 
2:218219697 rs78832202 G/A 0.102 -0.240 0.056 2.01e-5 8.90e-2 
2:218219641 rs79707432 A/G 0.102 -0.239 0.056 2.02e-5 1.02e-1 
2:218219226 rs55848226 A/G 0.105 -0.235 0.055 2.28e-5 1.37e-1 
2:160340777 rs35745662 C/T 0.102 0.245 0.058 2.49e-5 4.27e-2 
2:160362019 rs34081025 A/T 0.102 0.243 0.057 2.54e-5 3.12e-2 
2:96777168 rs2312955 T/G 0.34 0.151 0.036 2.70e-5 2.96e-1 
2:160340014 rs13017222 A/G 0.102 0.245 0.058 2.71e-5 4.22e-2 
2:96780716 rs2229169 T/G 0.34 0.151 0.036 2.74e-5 2.67e-1 
2:96751395 rs2140938 C/T 0.353 0.153 0.036 2.78e-5 5.76e-1 
2:96774981 rs7561198 C/G 0.34 0.151 0.036 2.81e-5 3.06e-1 
2:96781986 rs3111873 G/C 0.34 0.151 0.036 2.82e-5 2.79e-1 
2:96784934 rs2692894 T/G 0.34 0.151 0.036 2.82e-5 2.79e-1 
2:105548062 rs10496387 T/C 0.273 -0.166 0.040 2.89e-5 2.94e-1 
2:218163031 rs74910011 T/G 0.119 -0.223 0.053 3.04e-5 4.38e-1 
2:96780122 rs4907299 T/G 0.314 0.160 0.038 3.22e-5 1.68e-1 
2:96931846 rs2301707 C/T 0.322 0.155 0.037 3.29e-5 4.40e-1 
2:105605488 rs7574780 C/A 0.267 -0.166 0.040 3.49e-5 4.04e-1 
2:96831355 rs1724125 A/G 0.34 0.150 0.036 3.53e-5 3.40e-1 
2:160352948 rs71423016 T/C 0.097 0.244 0.059 3.70e-5 5.67e-2 
2:112445659 rs6708131 C/T 0.448 0.143 0.035 3.78e-5 3.54e-2 
2:105602952 rs6543279 G/A 0.267 -0.165 0.040 3.79e-5 4.11e-1 
2:96794957 rs2917662 A/G 0.34 0.148 0.036 3.81e-5 2.91e-1 
2:96794982 rs2969491 T/C 0.34 0.148 0.036 3.81e-5 2.91e-1 
2:96787899 rs1168965 C/G 0.34 0.148 0.036 4.18e-5 2.98e-1 
2:105555869 rs7595767 G/T 0.272 -0.162 0.040 4.44e-5 4.06e-1 
2:112447888 rs10174353 C/T 0.448 0.142 0.035 4.49e-5 4.81e-2 
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2:105536116 rs2889336 G/C 0.286 -0.163 0.040 4.54e-5 2.75e-1 
2:96855241 rs4907230 A/G 0.323 0.152 0.037 4.55e-5 4.40e-1 
2:105557895 rs2033303 T/C 0.273 -0.161 0.039 4.57e-5 3.78e-1 
2:218227288 rs78096412 G/T 0.098 -0.237 0.058 4.61e-5 1.17e-1 
2:218157502 rs74899380 C/G 0.109 -0.229 0.056 4.65e-5 4.77e-1 
2:105550991 rs72832219 C/A 0.271 -0.162 0.040 4.78e-5 3.03e-1 
2:112441433 rs6728061 A/G 0.449 0.140 0.034 4.80e-5 1.60e-2 
2:218227410 rs73991072 T/C 0.097 -0.237 0.058 4.95e-5 1.17e-1 
2:96777340 rs7604842 C/T 0.342 0.147 0.036 5.06e-5 3.90e-1 
2:218222372 rs28542381 A/G 0.101 -0.230 0.057 5.06e-5 1.17e-1 
2:112447296 rs55937046 G/A 0.449 0.141 0.035 5.07e-5 4.75e-2 
2:218157508 rs74631012 G/A 0.109 -0.228 0.056 5.07e-5 4.66e-1 
2:218188700 rs10804257 C/T 0.113 -0.222 0.055 5.11e-5 4.43e-1 
2:96774786 rs10183151 T/G 0.342 0.146 0.036 5.35e-5 4.13e-1 
2:105544888 rs6734108 A/G 0.27 -0.161 0.040 5.52e-5 3.72e-1 
2:96822373 rs1030864 G/A 0.341 0.146 0.036 5.76e-5 3.73e-1 
2:105559947 rs6705953 C/T 0.273 -0.159 0.039 5.87e-5 4.12e-1 
2:160352115 rs13003356 C/T 0.093 0.243 0.060 5.94e-5 2.89e-2 
2:218226516:1 rs77820558 C/T 0.099 -0.231 0.058 5.98e-5 1.20e-1 
2:218194886 rs56163890 A/G 0.112 -0.222 0.055 6.02e-5 3.28e-1 
2:96825363 rs1168968 A/G 0.34 0.145 0.036 6.31e-5 3.50e-1 
2:112451387 rs3860380 G/A 0.449 0.140 0.035 6.40e-5 4.55e-2 
2:96745729 rs2692936 A/G 0.348 0.144 0.036 6.50e-5 6.59e-1 
2:96880147 rs58448550 T/G 0.324 0.148 0.037 6.50e-5 4.70e-1 
2:96751871 rs2692937 A/G 0.347 0.144 0.036 6.64e-5 6.52e-1 
2:96737083 rs2579552 G/A 0.347 0.143 0.036 7.03e-5 6.37e-1 
2:96756547 rs2692893 T/C 0.346 0.144 0.036 7.09e-5 5.54e-1 
2:112437140 rs1464095 G/A 0.449 0.135 0.034 7.47e-5 1.20e-2 
2:96741944 rs2579550 A/G 0.347 0.143 0.036 7.49e-5 6.82e-1 
2:96742833 rs2579549 G/T 0.347 0.143 0.036 7.49e-5 6.82e-1 
2:105531516 rs34489771 T/G 0.265 -0.160 0.040 7.61e-5 3.58e-1 
2:218177312 rs55884900 G/A 0.121 -0.208 0.052 7.78e-5 5.73e-1 
2:218162330 rs78665806 G/A 0.12 -0.210 0.053 7.85e-5 5.56e-1 
2:112440772 rs4459742 G/A 0.446 0.137 0.035 7.94e-5 1.12e-2 
2:96737860 rs2692934 T/C 0.347 0.142 0.036 8.07e-5 6.59e-1 
2:218159244 rs6752033 T/C 0.16 -0.191 0.048 8.12e-5 6.99e-1 
2:96813480 rs1168976 A/G 0.341 0.143 0.036 8.12e-5 3.66e-1 
2:96814075 rs1168975 A/G 0.341 0.143 0.036 8.12e-5 3.66e-1 
2:96814928 rs1168974 A/G 0.341 0.143 0.036 8.12e-5 3.66e-1 
2:96815492 rs1168972 A/G 0.341 0.143 0.036 8.12e-5 3.66e-1 
2:96816606 rs1168970 T/C 0.341 0.143 0.036 8.12e-5 3.66e-1 
2:179039491 rs334128 T/G 0.422 0.141 0.036 8.25e-5 2.66e-2 
2:218181721 rs79286679 C/T 0.116 -0.213 0.054 8.35e-5 4.05e-1 
2:228136823 rs12619141 T/A 0.148 -0.190 0.048 8.58e-5 5.21e-2 
2:228137049 rs12619189 G/A 0.148 -0.190 0.048 8.58e-5 5.21e-2 
2:228137357 rs78908239 A/T 0.147 -0.189 0.048 8.82e-5 4.39e-2 
2:105563377 rs113534447 A/G 0.271 -0.155 0.040 8.91e-5 4.38e-1 
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Supplementary Table 3-8. Mean, standard deviation, and heritability estimates 
for the perceived intensity of bitter tastes. 
Trait Mean SD Heritability SE 
PROP 36.54 29.73 0.71 0.03 
PROP paper 38.82 28.95 0.40 0.04 
Quinine 46.03 22.77 0.38 0.05 
Caffeine 52.32 23.28 0.31 0.05 
SOA 52.03 22.62 0.40 0.05 
DB 79.50 24.77 0.45 0.05 
PROP, propylthiouracil. SOA, sucrose octaacetate. DB, denatonium benzoate. SD/SE, standard 
deviation/error. Perceived intensity were ratings on general Labelled Magnitude Scale (gLMS). 
Heritabilities were estimated using GEMMA based on genetic relatedness matrix. 
 
 
 
Supplementary Table 3-9. Phenotypic and genetic variance in the perceived 
intensity of quinine, caffeine, sucrose octaacetate (SOA) and denatonium 
benzoate (DB) explained by rs10772420, rs2597979, rs67487380 and 
rs10261515. 
 Phenotypic variance explained (%)  Genetic variance explained (%) 
SNP Quinine Caffeine SOA DB  Quinine Caffeine SOA DB 
rs10772420 5.67 0.57 0.94 0.56  14.92 1.49 2.46 1.48 
rs2597979 0.52 1.91 0.05 0.02  1.69 6.15 0.16 0.05 
rs67487380 3.36 0.10 1.63 0.72  8.40 0.25 4.07 1.79 
rs10261515 0.14 0.00 0.15 0.93  0.31 0.01 0.32 2.06 
 
 
 
Supplementary Table 3-10. Top PROP paper-associated SNPs (P < 1e-6) on 
chromosome 2 in the current study (n = 1999) and their associations in GWAS 
of (1) 225 subjects from the general population of the São Paulo metropolitan 
area of Brazil, (2) 466 subjects from Silk Road and (3) 2588 subjects from three 
Italian cohorts. 
SNP Chr:Position A1/A2 MAF β SE r2 
P 
Current 
Sample 
P 
Brazilian 
Sample 
P Silk 
Road 
Sample 
P 
Italian 
Sample 
rs6761655 2:218218646 G/A 0.186 -0.246 4.41e-2 1.83% 2.69e-8 NA 0.95 0.99 
rs6736242 2:218218695 A/G 0.186 -0.246 4.41e-2 1.83% 2.69e-8 NA - - 
rs7586502 2:218219311 A/G 0.142 -0.259 4.88e-2 1.63% 1.31e-7 NA - - 
rs80312552 2:218220180 G/A 0.140 -0.258 4.91e-2 1.60% 1.70e-7 NA - - 
rs6435978 2:218219166 T/C 0.142 -0.256 4.89e-2 1.59% 1.85e-7 0.87 - - 
rs6435976 2:218219074 T/C 0.142 -0.253 4.87e-2 1.56% 2.15e-7 NA - - 
rs6435977 2:218219139 A/G 0.143 -0.254 4.88e-2 1.58% 2.18e-7 NA - - 
rs4674157 2:218221469 A/G 0.140 -0.255 4.93e-2 1.56% 2.59e-7 NA - - 
rs4674155 2:218220849 A/G 0.139 -0.252 4.94e-2 1.52% 3.60e-7 NA - - 
rs4674156 2:218220860 T/C 0.139 -0.252 4.94e-2 1.52% 3.60e-7 NA - - 
rs6707253 2:218218855 G/A 0.142 -0.248 4.87e-2 1.50% 3.77e-7 NA - - 
rs6707229 2:218218774 C/A 0.143 -0.248 4.87e-2 1.50% 4.00e-7 NA - - 
rs13023129 2:218188539 C/T 0.232 -0.211 4.19e-2 1.59% 4.99e-7 NA - - 
rs1863193 2:218216220 C/T 0.211 -0.215 4.27e-2 1.54% 5.25e-7 NA - - 
rs13008830 2:218214057 C/T 0.211 -0.214 4.30e-2 1.53% 6.69e-7 NA - - 
rs4141835 2:218175472 A/G 0.231 -0.205 4.14e-2 1.49% 8.12e-7 0.95 - - 
We give allele frequency and effect sizes with reference to allele A1. Base-pair position is based on GRCh37; A1/A2, 
minor/major allele; MAF, minor allele frequency; β, the effect size; SE, standard error of the β; r2, percent variance of the trait 
accounted for by the SNP; NA, SNP information was not available. The PMID is 22132133 for the GWAS of the Brazilian 
sample. For the Silk Road and Italian studies, only the P-values for rs6761655 is shown here because they are obtained 
through personal communication with Dr. Robino Antonietta from the Italian Ministry of Health. 
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pos_hg38, base-pair position in the Genome Reference Consortium human genome build 38; CR, conserved region; eQTL, 
expression quantitative trait loci; LD, linkage disequilibrium; mQTL, methylation quantitative trait loci; SNP, single-nucleotide 
polymorphism. SOA, sucrose octa-acetate; DB, dentonium benzoate. aLead SNP and the associated bitter taste. bNon-
synonymous SNPs in LD (CEU: r2⩾0.80) with lead SNP. cCheck marks (✓) denote the presence of a conserved region 
(spanning lead SNP and its correlated proxies, CEU: r2⩾ 0.8). dTissues with the presence of DNase-I hypersensitivity sites at 
region spanning lead SNP and its correlated proxies, CEU: r2⩾ 0.8. DNAse hypersensitivity sites are related to transcriptional 
activity because these are chromatin regions that are less condensed and more accessible to transcription factors. fEnhancer 
(H3K4me1) or promoter (H3K4me3) histone marks spanning lead SNP and its correlated proxies, CEU: r2⩾ 0.8. Enhancer: a 
short region of DNA (50-1500 bp) that can be bound by proteins (activators) to increase the transcription of a gene. An 
enhancer can be 1MB upstream/downstream of its targeted gene. Promoter: a region of DNA (100-1000 bp) that initiates 
transcription of a gene. A promoter is located near transcription start site (5’) of a gene. fRegulatory motifs altered by lead SNP 
and its correlated proxies. Regulatory motifs are short nucleotide sequences typically upstream of genes where transcription 
factors bind to control the expression of genes. gExpression QTL (cis-eQTL, variants are within 1 Mb up- and downstream of 
the transcription start site) for lead SNP and its correlated proxies, CEU: r2⩾ 0.8, derived from eQTL studies including results 
with P < 1e-5 from the GTEx (Genotype-Tissue Expression) and GRASP (Genome-Wide Repository of Associations Between 
SNPs and Phenotypes). Tissues include esophagus, muscle, salivary gland, lung, heart, ovary, uterus, artery, fallopian tube, 
vagina, skin, cervix, bladder, thyroid, adipose, colon, breast, testis, nerve, small intestine, pituitary, pancreas, colon, stomach, 
prostate, adrenal gland, liver, spleen, and kidney. hMethylation QTLs for lead SNP derived from temporal cortex, frontal cortex 
and caudal pons. The results are obtained using GRASP. All associations have P < 1e-8. 
 
Brief summary of Supplementary Table 3-11 
1. PROP, quinine, caffeine, and SOA-associated SNPs include missense 
variants. 
2. PROP, quinine, and DB-associated SNPs are located within conserved region. 
3. Except for caffeine-associated SNPs, all SNPs are in high DNAse 
hypersensitivity sites. 
4. PROP, SOA, and DB-associated SNPs are inside promoter and/or enhancer 
regions. 
5. All SNPs may cause regulatory motif change of a protein.  
6. All SNPs are eQTLs. 
7. Quinine, caffeine, and SOA-associated SNPs are mQTLs. 
8. None of these analyses was performed using taste tissues. 
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Supplementary Figure 3-1. Direction and size of the effects of SNP 
associations on the perceived intensities of quinine, caffeine, sucrose 
octaacetate (SOA) and denatonium benzoate (DB). rs10772420 has the 
strongest effect on quinine is in the same direction (negative) as its effect on 
SOA and DB (Qs and Qd) but the opposite (positive) on caffeine (Qc). The 
effect size (; see Supplementary Table 9 for variance explained) is the largest 
for quinine, and it is smaller but at a similar level for the others. The minor 
allele of rs2597979 has opposite effects on caffeine and quinine (Cq). The 
direction of effect on SOA and DB (Cs and Cd) is the same as that on caffeine 
but the size of their effects is subtle. The minor allele of rs67487380 has 
negative effects on all bitter tastes. The effect size for SOA is similar to those 
for quinine and DB (Sq and Sd), which positions them close to the diagonal 
line. The effect on caffeine is the minimum. The minor allele of rs10261515 has 
the largest and negative effect on DB. Its effects on the others are subtle, but 
they tend to be negative, null and positive on SOA, caffeine and quinine (Ds, 
Dc and Dq), respectively. add effect sizes for each SNPs. 
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Supplementary Figure 3-2. Univariate GWAS for the perception of (a) PROP 
solution (n = 1757) and (b) PROP paper (n = 1999). Left part are Manhattan 
plots displaying the association P-value for each SNP in the genome 
(displayed as –log10 of the P-value). The red line indicates the genome-wide 
significance threshold of P = 5.0e-8. Right part are regional plots ± 400kb from 
the top SNPs on chromosome 7 for PROP solution and chromosome 2 for 
PROP paper with the gene model below. 
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Supplementary Figure 3-3. Univariate GWAS for the perception of PROP paper 
from our previous GWAS of 1756 Australian adolescents. A Manhattan plot 
displays the association P-value for each SNP in the genome (displayed as –
log10 of the P-value). This figure is the Figure 1B from our previous published 
paper (PMID: 20675712). 
 
Supplementary Figure 3-4. The Q-Q plots for each of the univariate analyses. 
PROP: propylthiouracil. 
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Supplementary Figure 3-5. The Q-Q plots for each of the bivariate analyses. 
SOA: sucrose octaacetate. DB: denatonium benzoate 
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Chapter 4   
Supplementary Table 4-1. Genetic instruments of perceived intensity for PROP, 
quinine, and caffeine. 
Trait SNP Chr EA Beta SE r2 P-value 
PROP rs1726866 7 G 9.65E-01 2.81E-02 45.94% 5.62E-198 
Quinine rs10772420 12 A 3.37E-01 3.38E-02 5.67% 7.84E-23 
Caffeine rs2597979 12 G 2.64E-01 4.80E-02 1.91% 4.17E-08 
EA is the effect allele corresponding to increasing level of perceived intensity. SE is the standard error. r2 refers 
to the proportion of phenotypic variance explained by the SNP. Association estimates were extracted from 
Chapter 3. 
 
Supplementary Table 4-2. Frequencies of bitter perception SNP genotypes in 
UK Biobank samples (N=438,870) 
SNP 
Ref. Allele 
(A1) 
Alt. Allele 
(A2) 
Ref. Allele 
Frequency 
Genotype 
Frequency 
(A1A1, A1A2, A2A2) 
rs1726866 G A 0.45 0.21,0.49,0.30 
rs10772420 G A 0.48 0.23,0.50,0.27 
rs2597979* G C 0.21 0.05,0.32,0.63 
*The genotypes for rs2597979 were imputed using the HRC reference panel. Genotype values were given in 
dosages, and rounded to the nearest integer in calculating percentage of allele carriers. 
 
Supplementary Table 4-3. SNP associations with the intake of  coffee, tea, and 
alcohol (linear). 
  
Coffee 
 
Tea 
 
Alcohol 
SNP EA Beta SE P-value 
 
Beta SE P-value 
 
Beta SE P-value 
rs1726866 G -2.00e-2 4.70e-3 2.20e-5 
 
3.45e-2 6.26e-3 3.60e-8 
 
-1.92e-2 3.10e-3 5.90e-10 
rs10772420 A -2.74e-2 4.69e-3 5.00e-9 
 
2.76e-2 6.24e-3 9.80e-6 
 
5.61e-3 3.09e-3 7.00e-2 
rs2597979 G 3.86e-2 5.93e-3 7.70e-11 
 
-4.55e-2 7.90e-3 8.70e-9 
 
-4.05e-3 3.91e-3 3.00e-1 
EA is the effect allele corresponding to increasing level of perceived intensity. SE is the standard error. 
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Supplementary Table 4-4. SNP associations with the drinker status of  coffee, 
tea, and alcohol (logistic). 
  Coffee  Tea  Alcohol 
SNP EA Beta SE P-value 
 
Beta SE P-value 
 
Beta SE P-value 
rs1726866 G -2.96e-2 7.45e-3 7.01e-5  3.77e-2 6.88e-3 4.36e-8  0.977 8.95e-3 1.05e-2 
rs10772420 A -4.37e-2 7.44e-3 4.19e-9  2.80e-2 6.87e-3 4.69e-5  1.000 8.94e-3 9.66e-1 
rs2597979 G 4.97e-2 9.36e-3 1.13e-7  -4.69e-2 8.68e-3 6.47e-8  1.005 1.13e-2 6.38e-1 
EA is the effect allele corresponding to increasing level of perceived intensity. SE is the standard error. 
 
 
Supplementary Table 4-5. Cross-conditional MR analyses to evaluate 
association between increased bitter perception on coffee/tea intake. 
Taste  2-SD increase in Bitter against 
coffee adjusted for tea intake 
2-SD increase in Bitter against tea 
adjusted for coffee intake 
Beta SE P-value Beta SE P-value 
PROP -0.025 0.01 1.22e-2 0.055 0.013 3.47e-5 
Quinine -0.135 0.028 1.27e-6 0.094 0.038 1.34e-2 
Caffeine 0.22 0.045 1.07e-6 -0.248 0.062 5.88e-5 
SE is the standard error. 
 
 
Supplementary Table 4-6. MR association for increased bitter perception with 
coffee intake among tea non-drinkers. 
Taste Unstratified* 
(N = 408,191) 
 Among tea non-drinkers 
(tea per day <2) 
(N = 90,706) 
 Among strict tea non-
drinkers (tea per day <1) 
(N = 58,951) 
Beta SE P-value 
 
Beta SE P-value 
 
Beta SE P-value 
PROP -0.040 0.009 2.20e-5 
 
-0.031 0.025 0.211 
 
-0.018 0.034 0.590 
Quinine -0.055 0.009 5.00e-9 
 
-0.231 0.071 0.001 
 
-0.248 0.096 0.010 
Caffeine 0.077 0.012 7.70e-11 
 
0.248 0.114 0.030 
 
0.260 0.154 0.090 
*Unstratified model were performed using BOLT-LMM to account for genetic relatedness among 
individuals to maximise power. Stratified analyses were performed after removing related individuals. 
SE is the standard error. 
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Supplementary Table 4-7. MR association for increased bitter perception with 
tea intake among non-coffee drinkers 
Taste Unstratified 
(n=425,378) 
 Among coffee non-drinkers 
(coffee per day <2) 
(n=165,751) 
 Among strict coffee non-
drinkers (coffee per day <1) 
(n=85,077) 
Beta SE P-value 
 
Beta SE P-value 
 
Beta SE P-value 
PROP 0.069 0.013 3.60e-8 
 
0.042 0.021 0.052 
 
0.042 0.033 0.208 
Quinine 0.055 0.012 9.80e-6 
 
0.085 0.062 0.167 
 
0.065 0.096 0.498 
Caffeine -0.091 0.016 8.70e-9 
 
-0.314 0.100 0.002 
 
-0.317 0.156 0.042 
*Unstratified model were performed using BOLT-LMM to account for genetic relatedness among individuals to 
maximise power. Stratified analyses were performed after removing related individuals. SE is the standard error. 
 
 
 
Supplementary Table 4-8. MR association of bitter taste and bitter beverage 
consumption quantity stratified by sex. 
Bitter 
taste 
Beverage Sex-specific causal estimate of decreased perception on 
consumption behaviour 
  Chisq-
diff.* 
P-value 
of diff.* 
Males Females  
Beta SE P-value Beta SE P-value   
PROP 
Coffee 
-0.042 0.016 8.33e-3 -0.040 0.013 2.15e-3 
 
0.007 0.932 
Quinine -0.214 0.045 2.17e-6 -0.147 0.037 8.48e-5 
 
1.318 0.251 
Caffeine 0.297 0.073 4.76e-5 0.308 0.060 3.22e-7 
 
0.012 0.912 
  
          
PROP 
Tea 
0.093 0.021 7.97e-6 0.047 0.018 7.48e-3 
 
2.843 0.092 
Quinine 0.145 0.060 1.47e-2 0.189 0.050 1.78e-4 
 
0.315 0.574 
Caffeine -0.181 0.096 6.03e-2 -0.523 0.081 1.37e-10 
 
7.334 0.007 
  
          
PROP 
Alcohol 
-0.045 0.009 1.82e-6 -0.040 0.010 3.00e-5 
 
0.169 0.681 
Quinine 0.005 0.027 0.858 0.058 0.027 3.27e-2 
 
1.931 0.165 
Caffeine 0.033 0.044 0.454 -0.098 0.044 2.62e-2 
 
4.429 0.035 
SE is the standard error. *Difference between males and females. 
 
Supplementary Table 4-9. Stratified analyses on association of PROP 
perception on different types of wine 
Consumption Beta SE P-value 
All alcohol (frequency score) -0.038 0.006 5.9e-10 
White wine (glass/day) 0.076 0.024 1.3e-3 
Red wine (glass/day) -0.171 0.028 1.3e-9 
Note: Association estimates are scaled to 2-SD increase in PROP perception. 
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Supplementary Table 4-10. Association of bitter perception SNP with potential 
confounders on beverage consumption 
SNP Perception Ref. 
Allele 
Potential Confounder Beta P-
value 
Diet 
rs1726866 PROP A Cheese intake -5.83e-3 9.35e-3 
rs10772420 Quinine A Cheese intake 4.72e-3 3.53e-2 
rs10845296 Caffeine A Cheese intake 8.49e-3 2.37e-3 
rs1726866 PROP A Variation in diet 7.99e-4 0.535 
rs10772420 Quinine A Variation in diet -1.50e-3 0.243 
rs10845296 Caffeine A Variation in diet -4.56e-4 0.776 
 
Tobacco use 
rs1726866 PROP A Smoking status 6.24e-4 0.658 
rs10772420 Quinine A Smoking status 1.89e-4 0.893 
rs10845296 Caffeine A Smoking status 7.83e-4 0.655 
rs1726866 PROP A Current tobacco smoking 2.69e-4 0.678 
rs10772420 Quinine A Current tobacco smoking 4.44e-4 0.493 
rs10845296 Caffeine A Current tobacco smoking 3.89e-4 0.630 
  
Beverage temperature  
rs1726866 PROP A Hot drink temperature 5.47e-4 0.652 
rs10772420 Quinine A Hot drink temperature 1.48e-3 0.221 
rs10845296 Caffeine A Hot drink temperature -1.95e-3 0.196 
  
Sleep related traits  
rs1726866 PROP A Sleep duration -3.77e-3 0.107 
rs10772420 Quinine A Sleep duration -2.50e-3 0.283 
rs10845296 Caffeine A Sleep duration -3.21e-3 0.269 
rs1726866 PROP A G47 Sleep disorders -5.17e-5 0.835 
rs10772420 Quinine A G47 Sleep disorders -3.88e-6 0.988 
rs10845296 Caffeine A G47 Sleep disorders -2.07e-5 0.947 
rs1726866 PROP A sleep apnoea -8.58e-5 0.495 
rs10772420 Quinine A sleep apnoea 1.36e-5 0.914 
rs10845296 Caffeine A sleep apnoea -2.31e-5 0.883 
  
Socio-economic 
rs1726866 PROP A 
Townsend deprivation index at 
recruitment 
3.59e-3 0.549 
rs10772420 Quinine A 
Townsend deprivation index at 
recruitment 
6.49e-3 0.279 
rs10845296 Caffeine A 
Townsend deprivation index at 
recruitment 
-1.51e-4 0.984 
rs1726866 PROP A Body mass index (BMI) -5.78e-3 0.535 
rs10772420 Quinine A Body mass index (BMI) -4.11e-4 0.965 
rs10845296 Caffeine A Body mass index (BMI) -6.50e-3 0.580 
rs1726866 PROP A Number of vehicles in household -3.28e-3 0.070 
rs10772420 Quinine A Number of vehicles in household -1.92e-3 0.287 
rs10845296 Caffeine A Number of vehicles in household 1.16e-3 0.607 
Estimates were extracted from the GENEATLAS PheWAS database for UK Biobank traits (available 
at http://geneatlas.roslin.ed.ac.uk/). SNP rs10845296 is used as the best proxy in high-LD (Linkage 
Disequilibrium) with rs2597979 at an r^2 of 0.83. Ref. allele refers to the allele associated with the 
magnitude of association on the potential confounder for a given SNP. 
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Coffee, tea and alcohol consumption are associated with various health conditions. Individual differences 
in taste shape food preferences and dietary behaviour. However, findings from observational studies on bitter 
taste perception and bitter-tasting beverage consumption are limited and inconclusive. We used Mendelian 
randomization to examine causal associations between the perception of three bitter substances, caffeine, 
quinine and propylthiouracil, and the intake of coffee, tea and alcohol among 409,000 UK Biobank participants. 
The results showed that genetically predicted perception of caffeine (rs2597979) was positively associated with 
coffee consumption, whereas predicted perception of quinine (rs10772420) and propylthiouracil (rs1726866) 
was negatively associated with coffee consumption. For tea, the associations are at the opposite direction. 
Alcohol intake was negatively associated with predicted perception of propylthiouracil. We demonstrated the 
causal relationships between bitter taste and bitter-tasting beverage consumption, further providing insight into 
the development and prevention of addiction on these beverages and its health consequences. 
 
Figure. Effect of genetically predicted perception of bitter tastes on coffee, tea and alcohol consumption. For 
coffee, every 2-SD increase in predicted ratings (e.g., ratings of Strong vs Moderate on a general Labelled 
Magnitude Scale) of propylthiouracil and quinine leads to 0.03 and 0.12 fewer cups per day. Every 2-SD 
increase in predicted ratings of caffeine leads to 0.17 more cups per day. The three bitter tastes have opposite 
effects on tea. For alcohol, a higher predicted intensity of propylthiouracil leads to lower intake. Icons of coffee, 
tea and wine are designed by Roundicons, Smashicons and Freepik from www.flaticon.com. 
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Chapter 5  
  
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 5-1. Correlation Between PGRS of BMI and BMI at the 
age of taste (BMI-1) and BMI 8 year later (BMI-2). 
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Chapter 6   
Supplementary Table 6-1. Means and standard deviations of the volume of 82 
brain regions (mm3) and intensity ratings of 4 taste solutions. L and R indicate 
the volume is extracted for left and right hemisphere respectively.  
Trait 
 
Mean SD 
Superiorfrontal L 25231.51 2814.10 
Superiorfrontal R 23728.82 2585.80 
Rostralmiddlefrontal L 17168.97 2526.18 
Rostralmiddlefrontal R 16402.25 2205.08 
Caudalmiddlefrontal L 7295.87 1287.88 
Caudalmiddlefrontal R 6477.83 1301.25 
Parsopercularis L 5636.38 918.53 
Parsopercularis R 4468.55 697.65 
Parstriangularis L 4129.98 670.25 
Parstriangularis R 4611.97 798.76 
Parsorbitalis L 2352.27 360.75 
Parsorbitalis R 2701.37 423.32 
Lateralorbitofrontal L 7333.59 995.59 
Lateralorbitofrontal R 7023.36 887.62 
Medialorbitofrontal L 5065.64 709.43 
Medialorbitofrontal R 5050.21 689.92 
Precentral L 14574.89 1826.91 
Precentral R 14315.77 1812.49 
Paracentral L 3785.63 590.51 
Paracentral R 4207.45 734.25 
Frontalpole L 881.12 179.28 
Frontalpole R 1104.12 211.73 
    Superiorparietal L 14293.69 1942.22 
Superiorparietal R 14533.67 1998.66 
Inferiorparietal L 13473.34 2124.75 
Inferiorparietal R 16469.48 2383.42 
Supramarginal L 12212.46 1900.68 
Supramarginal R 11467.19 1820.56 
Postcentral L 10386.17 1442.58 
Postcentral R 9901.54 1549.91 
Precuneus L 10738.76 1405.76 
Precuneus R 11124.21 1503.47 
    Lateraloccipital L 12100.25 1567.39 
Lateraloccipital R 12466.07 1723.31 
Lingual L 6877.38 1025.56 
Lingual R 7208.11 980.20 
Cuneus L 3135.17 494.18 
Cuneus R 3388.44 543.67 
Pericalcarine L 2248.07 395.20 
Pericalcarine R 2464.63 421.94 
    Superiortemporal L 12569.51 1710.49 
Superiortemporal R 11896.11 1562.96 
Middletemporal L 10008.35 1812.46 
Middletemporal R 10993.63 1818.32 
Inferiortemporal L 8864.62 1585.91 
Inferiortemporal R 8913.35 1656.07 
Bankssts L 2667.12 507.50 
Bankssts R 2568.12 458.83 
Fusiform L 9275.03 1305.85 
Fusiform R 9453.18 1320.68 
Transversetemporal L 1264.65 237.22 
Transversetemporal R 969.51 185.21 
Entorhinal L 1534.59 351.14 
Entorhinal R 1430.68 426.84 
Temporalpole L 2240.49 483.36 
Temporalpole R 2029.40 484.02 
Parahippocampal L 2361.58 336.71 
Parahippocampal R 2199.39 308.60 
    Rostralanteriorcingulate L 2938.91 562.33 
Rostralanteriorcingulate R 2338.79 503.31 
Caudalanteriorcingulate L 2052.40 491.53 
Caudalanteriorcingulate R 2340.55 554.80 
Posteriorcingulate L 3514.94 582.15 
Posteriorcingulate R 3520.22 565.09 
Isthmuscingulate L 2851.76 520.06 
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Isthmuscingulate R 2624.08 476.65 
    Insula L 6884.53 873.66 
Insula R 6926.51 914.00 
    Accumbens L 684.67 123.67 
Accumbens R 732.03 112.92 
Amygdala L 1676.85 212.16 
Amygdala R 1695.26 232.55 
Caudate L 3982.09 488.10 
Caudate R 4159.23 533.75 
Hippocampus L 4216.38 449.22 
Hippocampus R 4304.58 439.57 
Pallidum L 1672.22 231.86 
Pallidum R 1550.92 190.54 
Putamen L 6370.69 733.53 
Putamen R 5928.72 705.53 
Thalamus L 8090.54 879.91 
Thalamus R 7492.56 802.62 
Sweetness   31.81 16.10 
PROP 
 
36.28 30.33 
Quinine 
 
45.31 22.79 
Caffeine  53.52 23.70 
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Supplementary Table 6-2. Association between sweet intensity ratings and 
brain volumes. Significant associations are bold. Interval is the time interval 
between taste test and brain scan. Taste is the perceived intensity ratings of 
sweet solutions. r is the correlation coefficient between taste and brain 
phenotypes. L and R indicate the volume is extracted for left and right 
hemisphere respectively. 
Region of interest 
 
n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 546 -58.78 54.12 2.78e-1 1.10 5.43 8.40e-1 0.01 
Superiorfrontal R 546 -62.96 51.04 2.18e-1 -3.26 5.22 5.32e-1 -0.03 
Rostralmiddlefrontal L 545 -114.98 47.33 1.56e-2 5.03 4.98 3.14e-1 0.04 
Rostralmiddlefrontal R 543 -71.47 47.09 1.30e-1 0.00 4.85 1.00 0.00 
Caudalmiddlefrontal L 546 -6.48 30.98 8.34e-1 2.73 3.19 3.92e-1 0.04 
Caudalmiddlefrontal R 546 -1.64 30.34 9.57e-1 1.61 3.36 6.31e-1 0.02 
Parsopercularis L 548 -28.27 23.07 2.21e-1 2.80 2.42 2.47e-1 0.05 
Parsopercularis R 545 -4.88 16.83 7.72e-1 0.19 1.83 9.18e-1 0.00 
Parstriangularis L 546 -4.98 16.66 7.65e-1 3.73 1.80 3.86e-2 0.09 
Parstriangularis R 547 3.98 20.54 8.47e-1 1.72 2.25 4.43e-1 0.03 
Parsorbitalis L 547 5.24 9.02 5.61e-1 -0.01 0.98 9.90e-1 0.00 
Parsorbitalis R 548 -2.36 11.01 8.30e-1 1.65 1.18 1.60e-1 0.06 
Lateralorbitofrontal L 547 25.59 21.95 2.45e-1 0.67 2.26 7.66e-1 0.01 
Lateralorbitofrontal R 547 -12.58 20.12 5.32e-1 -0.17 2.15 9.36e-1 0.00 
Medialorbitofrontal L 548 -32.72 18.43 7.66e-2 -1.81 1.96 3.57e-1 -0.04 
Medialorbitofrontal R 547 19.94 16.76 2.35e-1 1.17 1.83 5.23e-1 0.03 
Precentral L 543 -27.36 36.96 4.60e-1 0.39 3.68 9.15e-1 0.00 
Precentral R 541 -42.36 36.88 2.52e-1 4.70 3.81 2.19e-1 0.05 
Paracentral L 544 -20.37 14.83 1.70e-1 -0.35 1.60 8.25e-1 -0.01 
Paracentral R 543 -34.92 17.88 5.16e-2 1.86 1.89 3.25e-1 0.04 
Frontalpole L 547 -0.20 5.07 9.69e-1 0.23 0.55 6.81e-1 0.02 
Frontalpole R 547 3.54 5.93 5.51e-1 -0.17 0.65 7.97e-1 -0.01 
          Superiorparietal L 545 -20.65 38.15 5.89e-1 6.94 3.83 7.11e-2 0.07 
Superiorparietal R 544 -8.21 39.55 8.36e-1 4.50 4.11 2.75e-1 0.04 
Inferiorparietal L 545 -48.37 42.20 2.53e-1 -0.88 4.30 8.38e-1 -0.01 
Inferiorparietal R 548 -60.03 48.42 2.16e-1 -2.31 5.11 6.52e-1 -0.02 
Supramarginal L 539 1.86 38.09 9.61e-1 -1.19 3.92 7.61e-1 -0.01 
Supramarginal R 537 -3.26 37.71 9.31e-1 1.43 3.97 7.18e-1 0.02 
Postcentral L 543 -27.91 30.15 3.55e-1 1.20 3.15 7.04e-1 0.02 
Postcentral R 541 20.18 32.04 5.29e-1 -0.13 3.40 9.70e-1 0.00 
Precuneus L 544 1.50 25.70 9.53e-1 -2.49 2.62 3.43e-1 -0.04 
Precuneus R 545 -10.04 27.70 7.17e-1 -1.83 2.81 5.17e-1 -0.03 
          Lateraloccipital L 546 2.37 34.55 9.45e-1 1.44 3.56 6.87e-1 0.02 
Lateraloccipital R 547 16.26 38.85 6.76e-1 -0.75 4.00 8.52e-1 -0.01 
Lingual L 545 -29.87 25.69 2.46e-1 -3.74 2.62 1.55e-1 -0.06 
Lingual R 546 -14.14 23.97 5.56e-1 -2.52 2.42 3.00e-1 -0.04 
Cuneus L 546 6.75 12.90 6.01e-1 1.94 1.29 1.34e-1 0.06 
Cuneus R 545 2.48 13.31 8.52e-1 3.40 1.37 1.32e-2 0.10 
Pericalcarine L 546 1.86 11.15 8.68e-1 -0.63 1.05 5.49e-1 -0.02 
Pericalcarine R 549 13.09 11.89 2.72e-1 -0.47 1.11 6.75e-1 -0.02 
          Superiortemporal L 548 81.29 37.33 3.03e-2 3.54 3.73 3.42e-1 0.04 
Superiortemporal R 546 18.59 33.91 5.84e-1 0.77 3.42 8.23e-1 0.01 
Middletemporal L 548 79.36 43.18 6.74e-2 2.30 4.25 5.89e-1 0.02 
Middletemporal R 547 47.39 40.56 2.44e-1 2.89 4.17 4.90e-1 0.03 
Inferiortemporal L 547 2.24 37.57 9.52e-1 -1.55 3.84 6.86e-1 -0.02 
Inferiortemporal R 547 117.76 38.26 2.28e-3 5.32 3.96 1.80e-1 0.05 
Bankssts L 547 -13.22 11.55 2.53e-1 -2.85 1.26 2.44e-2 -0.09 
Bankssts R 546 -11.80 10.67 2.69e-1 -0.52 1.16 6.53e-1 -0.02 
Fusiform L 541 -11.36 26.39 6.67e-1 -3.57 2.88 2.15e-1 -0.05 
Fusiform R 546 1.96 27.78 9.44e-1 -2.32 2.96 4.33e-1 -0.03 
Transversetemporal L 546 7.11 5.93 2.31e-1 1.51 0.66 2.15e-2 0.09 
Transversetemporal R 546 4.08 4.68 3.84e-1 0.50 0.51 3.22e-1 0.04 
Entorhinal L 545 7.67 8.68 3.77e-1 0.05 0.95 9.54e-1 0.00 
Entorhinal R 543 28.54 10.68 7.92e-3 1.14 1.11 3.05e-1 0.04 
Temporalpole L 548 63.23 13.52 4.26e-6 1.00 1.42 4.79e-1 0.03 
Temporalpole R 545 36.72 13.52 6.92e-3 2.58 1.43 7.19e-2 0.07 
Parahippocampal L 543 -13.41 8.83 1.30e-1 -1.75 0.92 5.73e-2 -0.08 
Parahippocampal R 545 10.32 7.90 1.93e-1 -0.01 0.81 9.93e-1 0.00 
          Rostralanteriorcingulate L 548 -17.67 13.49 1.91e-1 -0.20 1.44 8.89e-1 -0.01 
Rostralanteriorcingulate R 546 -14.72 13.01 2.59e-1 -1.72 1.43 2.30e-1 -0.05 
Caudalanteriorcingulate L 544 -1.22 12.85 9.24e-1 3.14 1.41 2.59e-2 0.09 
Caudalanteriorcingulate R 547 -2.42 15.07 8.72e-1 0.93 1.63 5.66e-1 0.02 
Posteriorcingulate L 546 1.22 13.73 9.29e-1 3.51 1.46 1.69e-2 0.10 
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Posteriorcingulate R 545 -8.46 13.31 5.25e-1 2.29 1.42 1.07e-1 0.07 
Isthmuscingulate L 545 -5.79 11.09 6.02e-1 -0.25 1.16 8.30e-1 -0.01 
Isthmuscingulate R 546 -6.51 11.73 5.79e-1 0.58 1.20 6.30e-1 0.02 
          Insula L 545 34.59 18.09 5.69e-2 0.34 1.84 8.52e-1 0.01 
Insula R 543 43.45 17.87 1.57e-2 3.14 1.81 8.38e-2 0.07 
          Accumbens L 546 -7.51 3.31 2.39e-2 -0.16 0.34 6.44e-1 -0.02 
Accumbens R 545 -3.11 2.73 2.56e-1 -0.11 0.28 6.93e-1 -0.02 
Amygdala L 547 -0.36 5.32 9.47e-1 1.00 0.55 7.14e-2 0.08 
Amygdala R 544 -8.66 5.72 1.31e-1 -0.07 0.59 9.02e-1 -0.01 
Caudate L 543 15.96 12.16 1.92e-1 -1.58 0.96 1.04e-1 -0.05 
Caudate R 540 4.92 12.82 7.02e-1 -1.96 1.05 6.57e-2 -0.06 
Hippocampus L 545 18.15 10.37 8.17e-2 0.48 0.99 6.27e-1 0.02 
Hippocampus R 545 9.51 10.15 3.50e-1 0.93 0.91 3.10e-1 0.04 
Pallidum L 545 8.24 5.45 1.32e-1 0.46 0.55 4.07e-1 0.03 
Pallidum R 544 -1.64 3.81 6.68e-1 -0.31 0.39 4.30e-1 -0.03 
Putamen L 546 3.40 16.90 8.41e-1 0.01 1.51 9.93e-1 0.00 
Putamen R 543 -0.86 15.09 9.54e-1 1.11 1.35 4.11e-1 0.03 
Thalamus L 541 -1.88 14.63 8.98e-1 -0.10 1.50 9.46e-1 0.00 
Thalamus R 548 17.94 13.27 1.78e-1 0.73 1.24 5.56e-1 0.02 
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Supplementary Table 6-3. Association between intensity ratings of quinine and 
brain volumes. Significant associations are bold. Interval is the time interval 
between taste test and brain scan. Taste is the perceived intensity ratings of 
quinine solutions. r is the correlation coefficient between taste and brain 
phenotypes. L and R indicate the volume is extracted for left and right 
hemisphere respectively. 
Region of interest 
 
n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 555 -59.63 53.53 2.66e-1 -2.74 3.26 4.01e-1 -0.03 
Superiorfrontal R 555 -71.52 50.91 1.61e-1 -3.69 3.16 2.44e-1 -0.05 
Rostralmiddlefrontal L 554 -111.47 46.79 1.77e-2 1.11 2.97 7.09e-1 0.02 
Rostralmiddlefrontal R 552 -73.66 46.89 1.17e-1 -2.95 2.91 3.12e-1 -0.04 
Caudalmiddlefrontal L 555 -8.11 30.60 7.91e-1 -1.57 1.91 4.12e-1 -0.03 
Caudalmiddlefrontal R 555 -3.30 30.41 9.14e-1 -0.46 2.01 8.20e-1 -0.01 
Parsopercularis L 557 -32.16 22.86 1.60e-1 -0.35 1.45 8.09e-1 -0.01 
Parsopercularis R 554 -4.51 16.68 7.87e-1 1.43 1.09 1.90e-1 0.06 
Parstriangularis L 555 -5.24 16.43 7.50e-1 -1.49 1.06 1.62e-1 -0.06 
Parstriangularis R 556 6.05 20.31 7.66e-1 0.01 1.33 9.92e-1 0.00 
Parsorbitalis L 556 6.41 8.91 4.72e-1 0.02 0.58 9.66e-1 0.00 
Parsorbitalis R 557 -3.02 10.99 7.84e-1 0.78 0.71 2.71e-1 0.05 
Lateralorbitofrontal L 555 20.39 21.54 3.45e-1 -2.28 1.34 9.04e-2 -0.07 
Lateralorbitofrontal R 556 -12.13 19.91 5.43e-1 -1.03 1.28 4.21e-1 -0.03 
Medialorbitofrontal L 557 -32.58 18.31 7.59e-2 0.08 1.17 9.48e-1 0.00 
Medialorbitofrontal R 556 19.33 16.61 2.45e-1 0.81 1.09 4.58e-1 0.03 
Precentral L 552 -28.97 36.32 4.26e-1 -1.41 2.21 5.22e-1 -0.03 
Precentral R 550 -44.18 36.19 2.23e-1 -0.54 2.30 8.15e-1 -0.01 
Paracentral L 553 -21.25 14.60 1.46e-1 -0.62 0.95 5.14e-1 -0.03 
Paracentral R 552 -38.03 17.64 3.17e-2 -1.74 1.13 1.23e-1 -0.06 
Frontalpole L 556 0.14 5.05 9.77e-1 -0.21 0.33 5.20e-1 -0.03 
Frontalpole R 556 3.27 5.97 5.84e-1 0.22 0.39 5.65e-1 0.02 
          Superiorparietal L 554 -16.95 37.67 6.53e-1 0.83 2.31 7.20e-1 0.01 
Superiorparietal R 553 -6.01 39.03 8.78e-1 -1.22 2.45 6.19e-1 -0.02 
Inferiorparietal L 554 -41.00 42.06 3.30e-1 0.89 2.61 7.34e-1 0.01 
Inferiorparietal R 557 -55.58 48.10 2.49e-1 2.23 3.05 4.65e-1 0.03 
Supramarginal L 548 7.38 37.49 8.44e-1 3.72 2.32 1.10e-1 0.06 
Supramarginal R 547 -0.01 37.44 1.00 -0.39 2.35 8.69e-1 -0.01 
Postcentral L 552 -24.42 29.93 4.15e-1 0.69 1.86 7.10e-1 0.02 
Postcentral R 550 23.89 31.65 4.51e-1 2.01 2.01 3.18e-1 0.04 
Precuneus L 553 10.33 25.85 6.90e-1 -0.16 1.59 9.20e-1 0.00 
Precuneus R 554 -6.55 27.60 8.13e-1 0.01 1.69 9.95e-1 0.00 
          Lateraloccipital L 555 -0.54 34.32 9.88e-1 -3.38 2.14 1.15e-1 -0.07 
Lateraloccipital R 556 20.56 38.27 5.92e-1 -1.61 2.37 4.99e-1 -0.03 
Lingual L 554 -28.69 25.42 2.60e-1 1.13 1.56 4.70e-1 0.03 
Lingual R 555 -12.45 23.74 6.00e-1 -0.94 1.44 5.14e-1 -0.03 
Cuneus L 555 6.21 12.87 6.30e-1 0.86 0.78 2.68e-1 0.04 
Cuneus R 554 2.88 13.11 8.26e-1 2.02 0.81 1.38e-2 0.10 
Pericalcarine L 555 2.08 11.00 8.50e-1 0.06 0.63 9.19e-1 0.00 
Pericalcarine R 558 14.34 11.72 2.23e-1 0.75 0.66 2.62e-1 0.04 
          Superiortemporal L 557 85.67 37.25 2.23e-2 1.04 2.24 6.44e-1 0.02 
Superiortemporal R 554 19.54 33.82 5.64e-1 -0.73 2.09 7.29e-1 -0.01 
Middletemporal L 557 82.62 42.85 5.51e-2 1.38 2.53 5.87e-1 0.02 
Middletemporal R 556 47.62 40.54 2.41e-1 1.92 2.50 4.42e-1 0.03 
Inferiortemporal L 556 -1.78 37.17 9.62e-1 1.05 2.30 6.48e-1 0.02 
Inferiortemporal R 556 113.04 38.06 3.21e-3 6.76 2.37 4.58e-3 0.12 
Bankssts L 556 -10.43 11.48 3.64e-1 -0.68 0.76 3.70e-1 -0.04 
Bankssts R 555 -12.80 10.60 2.28e-1 0.42 0.70 5.50e-1 0.03 
Fusiform L 550 -12.32 26.52 6.42e-1 1.39 1.74 4.23e-1 0.03 
Fusiform R 555 2.52 27.59 9.27e-1 -0.09 1.77 9.60e-1 0.00 
Transversetemporal L 555 6.64 6.00 2.69e-1 1.07 0.39 6.87e-3 0.11 
Transversetemporal R 555 3.49 4.68 4.56e-1 0.11 0.30 7.26e-1 0.01 
Entorhinal L 554 8.04 8.56 3.48e-1 -1.64 0.56 3.71e-3 -0.12 
Entorhinal R 551 29.24 10.47 5.57e-3 -0.82 0.66 2.11e-1 -0.05 
Temporalpole L 557 60.82 13.51 9.29e-6 0.11 0.85 8.95e-1 0.01 
Temporalpole R 554 34.86 13.41 9.70e-3 1.05 0.85 2.20e-1 0.05 
Parahippocampal L 552 -12.49 8.73 1.53e-1 -0.95 0.55 8.70e-2 -0.07 
Parahippocampal R 554 9.35 7.84 2.34e-1 -0.46 0.49 3.45e-1 -0.04 
          Rostralanteriorcingulate L 556 -18.63 13.27 1.61e-1 0.94 0.85 2.68e-1 0.05 
Rostralanteriorcingulate R 555 -13.15 12.97 3.11e-1 -1.09 0.85 1.98e-1 -0.05 
Caudalanteriorcingulate L 553 -1.05 12.84 9.35e-1 -0.10 0.84 9.05e-1 -0.01 
Caudalanteriorcingulate R 556 -3.27 15.04 8.28e-1 0.12 0.98 8.98e-1 0.01 
Posteriorcingulate L 555 0.90 13.67 9.47e-1 0.87 0.88 3.21e-1 0.04 
 
 
183 
Posteriorcingulate R 554 -9.18 13.19 4.87e-1 -0.66 0.85 4.33e-1 -0.03 
Isthmuscingulate L 554 -4.88 10.99 6.57e-1 -1.25 0.69 7.22e-2 -0.07 
Isthmuscingulate R 554 -4.67 11.50 6.85e-1 0.04 0.71 9.58e-1 0.00 
          Insula L 554 34.01 17.74 5.63e-2 -1.50 1.09 1.69e-1 -0.06 
Insula R 552 42.42 17.75 1.75e-2 -0.12 1.09 9.15e-1 0.00 
          Accumbens L 554 -7.30 3.28 2.69e-2 0.07 0.21 7.52e-1 0.01 
Accumbens R 554 -2.85 2.73 2.98e-1 0.03 0.17 8.50e-1 0.01 
Amygdala L 556 0.76 5.29 8.86e-1 0.68 0.33 4.04e-2 0.09 
Amygdala R 553 -9.17 5.66 1.07e-1 0.25 0.35 4.82e-1 0.03 
Caudate L 552 15.41 12.06 2.04e-1 -1.55 0.56 7.00e-3 -0.09 
Caudate R 547 3.40 12.71 7.90e-1 -1.93 0.64 3.03e-3 -0.11 
Hippocampus L 554 19.36 10.31 6.19e-2 0.20 0.59 7.28e-1 0.01 
Hippocampus R 554 10.13 10.09 3.17e-1 0.56 0.56 3.19e-1 0.04 
Pallidum L 554 9.21 5.50 9.53e-2 0.30 0.33 3.69e-1 0.04 
Pallidum R 552 -1.17 3.81 7.59e-1 -0.29 0.23 2.03e-1 -0.05 
Putamen L 555 3.64 16.88 8.29e-1 -0.17 0.91 8.55e-1 -0.01 
Putamen R 552 -2.00 14.97 8.94e-1 -0.47 0.82 5.66e-1 -0.02 
Thalamus L 550 -2.47 14.67 8.67e-1 0.39 0.90 6.68e-1 0.02 
Thalamus R 556 17.32 13.24 1.92e-1 0.40 0.75 5.92e-1 0.02 
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Supplementary Table 6-4. Association between intensity ratings of caffeine 
and brain volumes. Significant associations are bold. Interval is the time 
interval between taste test and brain scan. Taste is the perceived intensity 
ratings of caffeine solutions. r is the correlation coefficient between taste and 
brain phenotypes. L and R indicate the volume is extracted for left and right 
hemisphere respectively. 
Region of interest   n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 555 -59.41 53.59 2.69e-1 -2.04 3.15 5.17e-1 -0.03 
Superiorfrontal R 555 -73.83 50.82 1.47e-1 -6.34 3.04 3.78e-2 -0.09 
Rostralmiddlefrontal L 554 -113.33 46.70 1.57e-2 -1.71 2.87 5.53e-1 -0.02 
Rostralmiddlefrontal R 552 -73.97 46.76 1.15e-1 -3.90 2.81 1.66e-1 -0.06 
Caudalmiddlefrontal L 555 -8.60 30.62 7.79e-1 -0.97 1.85 5.99e-1 -0.02 
Caudalmiddlefrontal R 555 -3.87 30.42 8.99e-1 -1.05 1.94 5.90e-1 -0.02 
Parsopercularis L 557 -32.68 22.87 1.54e-1 -0.93 1.40 5.08e-1 -0.03 
Parsopercularis R 554 -6.10 16.65 7.14e-1 -0.61 1.06 5.63e-1 -0.02 
Parstriangularis L 555 -5.14 16.43 7.55e-1 0.07 1.03 9.47e-1 0.00 
Parstriangularis R 556 5.83 20.33 7.75e-1 0.24 1.29 8.53e-1 0.01 
Parsorbitalis L 556 5.78 8.93 5.18e-1 -0.77 0.56 1.71e-1 -0.06 
Parsorbitalis R 557 -3.28 11.05 7.66e-1 0.56 0.69 4.18e-1 0.03 
Lateralorbitofrontal L 556 22.78 21.73 2.95e-1 -2.00 1.30 1.27e-1 -0.06 
Lateralorbitofrontal R 556 -12.54 19.94 5.30e-1 -1.76 1.23 1.55e-1 -0.06 
Medialorbitofrontal L 557 -33.31 18.22 6.82e-2 -0.33 1.12 7.67e-1 -0.01 
Medialorbitofrontal R 556 18.89 16.57 2.55e-1 0.65 1.05 5.37e-1 0.03 
Precentral L 552 -31.14 36.32 3.92e-1 -2.57 2.14 2.31e-1 -0.05 
Precentral R 550 -45.08 36.21 2.14e-1 -1.31 2.23 5.57e-1 -0.02 
Paracentral L 553 -21.76 14.62 1.38e-1 -0.75 0.92 4.13e-1 -0.03 
Paracentral R 552 -38.09 17.64 3.15e-2 -1.84 1.08 9.07e-2 -0.07 
Frontalpole L 556 0.31 5.06 9.52e-1 0.01 0.32 9.86e-1 0.00 
Frontalpole R 556 3.58 5.94 5.47e-1 0.29 0.37 4.45e-1 0.03 
          Superiorparietal L 554 -18.65 37.52 6.20e-1 -2.98 2.23 1.82e-1 -0.05 
Superiorparietal R 553 -6.95 39.02 8.59e-1 -1.48 2.37 5.34e-1 -0.03 
Inferiorparietal L 554 -39.75 41.97 3.44e-1 1.89 2.51 4.54e-1 0.03 
Inferiorparietal R 557 -55.64 48.02 2.47e-1 0.21 2.94 9.42e-1 0.00 
Supramarginal L 548 6.40 37.62 8.65e-1 0.61 2.25 7.87e-1 0.01 
Supramarginal R 546 -0.23 37.42 9.95e-1 -1.81 2.26 4.24e-1 -0.03 
Postcentral L 552 -27.01 29.79 3.65e-1 -3.31 1.80 6.77e-2 -0.08 
Postcentral R 550 22.86 31.58 4.70e-1 -0.21 1.94 9.15e-1 0.00 
Precuneus L 553 9.26 25.81 7.20e-1 -1.37 1.54 3.75e-1 -0.04 
Precuneus R 554 -7.49 27.47 7.85e-1 0.03 1.63 9.84e-1 0.00 
          Lateraloccipital L 555 0.36 34.54 9.92e-1 -0.57 2.07 7.84e-1 -0.01 
Lateraloccipital R 556 19.15 38.32 6.18e-1 -2.35 2.30 3.09e-1 -0.04 
Lingual L 554 -30.29 25.38 2.34e-1 -2.71 1.51 7.38e-2 -0.07 
Lingual R 555 -12.75 23.66 5.90e-1 -1.94 1.40 1.68e-1 -0.06 
Cuneus L 555 6.36 12.87 6.21e-1 0.39 0.76 6.09e-1 0.02 
Cuneus R 554 2.75 13.18 8.35e-1 1.84 0.79 2.05e-2 0.10 
Pericalcarine L 555 1.85 10.97 8.66e-1 -0.62 0.61 3.16e-1 -0.04 
Pericalcarine R 558 13.95 11.76 2.37e-1 0.00 0.65 9.98e-1 0.00 
          Superiortemporal L 557 84.08 37.31 2.51e-2 -0.72 2.17 7.41e-1 -0.01 
Superiortemporal R 554 18.07 33.86 5.94e-1 -1.10 2.01 5.83e-1 -0.02 
Middletemporal L 557 81.03 42.89 6.01e-2 0.81 2.47 7.43e-1 0.01 
Middletemporal R 556 45.85 40.53 2.59e-1 1.96 2.42 4.18e-1 0.03 
Inferiortemporal L 556 -2.19 37.18 9.53e-1 1.73 2.23 4.37e-1 0.03 
Inferiortemporal R 556 113.51 37.99 3.04e-3 5.06 2.29 2.79e-2 0.09 
Bankssts L 556 -10.53 11.46 3.59e-1 -0.55 0.73 4.46e-1 -0.03 
Bankssts R 555 -12.39 10.49 2.38e-1 1.14 0.67 8.69e-2 0.07 
Fusiform L 550 -11.69 26.47 6.59e-1 2.61 1.69 1.23e-1 0.06 
Fusiform R 555 2.56 27.56 9.26e-1 -0.61 1.71 7.23e-1 -0.01 
Transversetemporal L 555 6.51 6.02 2.80e-1 0.70 0.38 6.81e-2 0.08 
Transversetemporal R 555 3.42 4.67 4.65e-1 0.02 0.29 9.53e-1 0.00 
Entorhinal L 554 8.02 8.66 3.55e-1 -0.80 0.55 1.44e-1 -0.06 
Entorhinal R 551 28.70 10.44 6.32e-3 -0.78 0.64 2.21e-1 -0.05 
Temporalpole L 557 60.76 13.48 9.02e-6 -0.50 0.82 5.46e-1 -0.02 
Temporalpole R 554 34.45 13.45 1.08e-2 0.78 0.83 3.49e-1 0.04 
Parahippocampal L 552 -12.49 8.75 1.54e-1 -0.76 0.54 1.57e-1 -0.06 
Parahippocampal R 554 9.40 7.81 2.30e-1 -0.17 0.47 7.25e-1 -0.01 
          Rostralanteriorcingulate L 556 -18.52 13.23 1.63e-1 0.35 0.82 6.69e-1 0.02 
Rostralanteriorcingulate R 555 -13.27 12.99 3.07e-1 -1.23 0.81 1.31e-1 -0.06 
Caudalanteriorcingulate L 553 -1.09 12.83 9.32e-1 0.26 0.81 7.52e-1 0.01 
Caudalanteriorcingulate R 556 -2.97 15.01 8.43e-1 1.07 0.94 2.55e-1 0.05 
Posteriorcingulate L 555 1.18 13.64 9.31e-1 1.37 0.85 1.08e-1 0.07 
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Posteriorcingulate R 554 -8.95 13.18 4.97e-1 -0.74 0.82 3.69e-1 -0.04 
Isthmuscingulate L 554 -4.56 11.04 6.80e-1 -0.58 0.67 3.92e-1 -0.04 
Isthmuscingulate R 554 -5.07 11.48 6.59e-1 -0.48 0.69 4.87e-1 -0.03 
          Insula L 554 33.64 17.83 6.02e-2 -0.44 1.06 6.77e-1 -0.02 
Insula R 552 41.69 17.82 2.00e-2 0.01 1.06 9.89e-1 0.00 
          Accumbens L 554 -7.13 3.28 3.04e-2 0.20 0.20 3.11e-1 0.04 
Accumbens R 554 -2.77 2.73 3.10e-1 0.18 0.16 2.54e-1 0.05 
Amygdala L 556 0.61 5.27 9.08e-1 0.37 0.32 2.52e-1 0.05 
Amygdala R 553 -9.28 5.67 1.03e-1 0.23 0.34 5.06e-1 0.03 
Caudate L 552 15.25 12.00 2.07e-1 -1.44 0.57 1.23e-2 -0.09 
Caudate R 547 4.23 12.71 7.40e-1 -1.37 0.63 3.33e-2 -0.08 
Hippocampus L 554 19.36 10.25 6.04e-2 1.09 0.57 5.72e-2 0.08 
Hippocampus R 554 10.11 10.05 3.16e-1 1.52 0.54 5.19e-3 0.11 
Pallidum L 554 9.15 5.50 9.71e-2 0.28 0.32 3.84e-1 0.04 
Pallidum R 552 -1.05 3.80 7.82e-1 -0.08 0.22 7.12e-1 -0.01 
Putamen L 555 4.32 16.87 7.98e-1 1.26 0.88 1.56e-1 0.05 
Putamen R 552 -1.83 14.94 9.02e-1 -0.21 0.80 7.95e-1 -0.01 
Thalamus L 550 -2.29 14.68 8.76e-1 0.62 0.87 4.78e-1 0.03 
Thalamus R 556 17.47 13.23 1.88e-1 1.04 0.72 1.53e-1 0.06 
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Supplementary Table 6-5. Association between intensity ratings of PROP and 
brain volumes. Significant associations are bold. Interval is the time interval 
between taste test and brain scan. Taste is the perceived intensity ratings of 
PROP solutions. r is the correlation coefficient between taste and brain 
phenotypes. L and R indicate the volume is extracted for left and right 
hemisphere respectively. 
Region of interest   n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 553 -52.31 53.95 3.33e-1 3.40 2.54 1.82e-1 0.06 
Superiorfrontal R 553 -65.63 51.41 2.03e-1 1.27 2.44 6.04e-1 0.02 
Rostralmiddlefrontal L 552 -115.19 47.10 1.49e-2 -0.88 2.28 6.99e-1 -0.02 
Rostralmiddlefrontal R 550 -74.13 47.29 1.18e-1 -2.64 2.25 2.41e-1 -0.05 
Caudalmiddlefrontal L 553 -11.93 30.68 6.98e-1 -0.75 1.48 6.12e-1 -0.02 
Caudalmiddlefrontal R 553 -3.48 30.62 9.10e-1 0.19 1.52 9.01e-1 0.01 
Parsopercularis L 555 -33.89 22.97 1.41e-1 0.06 1.11 9.60e-1 0.00 
Parsopercularis R 552 -7.48 16.71 6.55e-1 0.32 0.83 7.04e-1 0.02 
Parstriangularis L 553 -4.79 16.55 7.72e-1 0.22 0.81 7.88e-1 0.01 
Parstriangularis R 554 6.05 20.44 7.67e-1 0.27 1.02 7.93e-1 0.01 
Parsorbitalis L 554 5.73 8.97 5.23e-1 -0.46 0.44 2.98e-1 -0.04 
Parsorbitalis R 555 -2.18 11.09 8.44e-1 0.89 0.54 1.02e-1 0.07 
Lateralorbitofrontal L 553 17.79 21.61 4.11e-1 -1.20 1.04 2.47e-1 -0.05 
Lateralorbitofrontal R 554 -13.80 19.94 4.89e-1 -0.65 0.98 5.08e-1 -0.03 
Medialorbitofrontal L 555 -32.89 18.40 7.46e-2 0.10 0.89 9.09e-1 0.01 
Medialorbitofrontal R 554 18.62 16.71 2.66e-1 0.07 0.83 9.37e-1 0.00 
Precentral L 550 -31.46 36.44 3.89e-1 -2.32 1.72 1.77e-1 -0.06 
Precentral R 548 -49.39 36.35 1.75e-1 -2.54 1.77 1.52e-1 -0.06 
Paracentral L 551 -21.97 14.71 1.36e-1 -0.52 0.73 4.73e-1 -0.03 
Paracentral R 550 -37.83 17.85 3.48e-2 -0.06 0.87 9.49e-1 0.00 
Frontalpole L 554 -0.31 5.09 9.51e-1 -0.23 0.25 3.63e-1 -0.04 
Frontalpole R 554 3.03 6.01 6.14e-1 -0.14 0.30 6.43e-1 -0.02 
          Superiorparietal L 552 -11.60 37.92 7.60e-1 2.88 1.79 1.08e-1 0.07 
Superiorparietal R 551 0.41 39.24 9.92e-1 2.60 1.89 1.69e-1 0.06 
Inferiorparietal L 552 -44.41 42.25 2.94e-1 -1.17 2.01 5.62e-1 -0.02 
Inferiorparietal R 555 -55.58 48.31 2.51e-1 -0.42 2.34 8.59e-1 -0.01 
Supramarginal L 546 10.71 37.83 7.77e-1 1.86 1.80 3.01e-1 0.04 
Supramarginal R 545 -2.46 37.74 9.48e-1 -1.34 1.81 4.58e-1 -0.03 
Postcentral L 550 -29.01 30.09 3.36e-1 -1.55 1.44 2.82e-1 -0.05 
Postcentral R 548 19.28 31.88 5.46e-1 -1.33 1.55 3.89e-1 -0.03 
Precuneus L 551 12.00 25.99 6.45e-1 0.69 1.24 5.80e-1 0.02 
Precuneus R 552 -5.32 27.78 8.48e-1 1.14 1.32 3.89e-1 0.04 
          Lateraloccipital L 553 5.00 34.74 8.86e-1 0.57 1.66 7.34e-1 0.01 
Lateraloccipital R 554 27.50 38.50 4.76e-1 1.23 1.85 5.06e-1 0.03 
Lingual L 552 -29.53 25.46 2.47e-1 0.50 1.21 6.81e-1 0.02 
Lingual R 553 -14.25 23.81 5.50e-1 -1.47 1.13 1.92e-1 -0.06 
Cuneus L 553 7.28 12.95 5.75e-1 0.23 0.61 7.07e-1 0.02 
Cuneus R 552 3.57 13.25 7.88e-1 0.40 0.64 5.33e-1 0.03 
Pericalcarine L 553 2.43 11.08 8.26e-1 0.12 0.51 8.15e-1 0.01 
Pericalcarine R 556 14.55 11.81 2.20e-1 0.17 0.54 7.50e-1 0.01 
          Superiortemporal L 555 88.33 37.53 1.94e-2 1.11 1.76 5.28e-1 0.03 
Superiortemporal R 552 18.32 33.90 5.89e-1 -2.11 1.63 1.95e-1 -0.06 
Middletemporal L 555 76.68 43.03 7.61e-2 -0.44 2.00 8.26e-1 -0.01 
Middletemporal R 554 41.54 40.78 3.09e-1 -0.53 1.95 7.87e-1 -0.01 
Inferiortemporal L 554 -0.46 37.40 9.90e-1 1.26 1.79 4.82e-1 0.03 
Inferiortemporal R 554 112.69 38.37 3.57e-3 1.18 1.84 5.23e-1 0.03 
Bankssts L 554 -9.71 11.55 4.01e-1 -0.04 0.57 9.39e-1 0.00 
Bankssts R 553 -13.92 10.69 1.93e-1 -0.17 0.53 7.45e-1 -0.01 
Fusiform L 548 -9.71 26.67 7.16e-1 1.35 1.33 3.08e-1 0.04 
Fusiform R 553 5.79 27.69 8.35e-1 0.37 1.35 7.84e-1 0.01 
Transversetemporal L 553 7.53 6.06 2.15e-1 0.52 0.30 8.60e-2 0.07 
Transversetemporal R 553 4.30 4.71 3.62e-1 0.34 0.23 1.48e-1 0.06 
Entorhinal L 552 7.93 8.75 3.66e-1 -0.50 0.43 2.47e-1 -0.05 
Entorhinal R 549 28.28 10.54 7.65e-3 -0.76 0.51 1.33e-1 -0.06 
Temporalpole L 555 60.35 13.56 1.16e-5 -0.56 0.66 3.98e-1 -0.04 
Temporalpole R 552 34.27 13.50 1.15e-2 -0.41 0.66 5.36e-1 -0.03 
Parahippocampal L 550 -12.59 8.82 1.55e-1 -0.12 0.43 7.76e-1 -0.01 
Parahippocampal R 552 8.70 7.83 2.67e-1 0.15 0.37 6.98e-1 0.02 
          Rostralanteriorcingulate L 554 -17.53 13.35 1.90e-1 0.30 0.65 6.45e-1 0.02 
Rostralanteriorcingulate R 553 -12.12 13.08 3.55e-1 -0.08 0.65 9.03e-1 -0.01 
Caudalanteriorcingulate L 551 -0.51 12.92 9.68e-1 0.24 0.64 7.07e-1 0.02 
Caudalanteriorcingulate R 554 -3.35 15.15 8.25e-1 0.12 0.74 8.70e-1 0.01 
Posteriorcingulate L 553 -0.68 13.77 9.61e-1 -0.51 0.67 4.46e-1 -0.03 
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Posteriorcingulate R 552 -10.08 13.29 4.49e-1 -0.63 0.65 3.37e-1 -0.04 
Isthmuscingulate L 552 -4.96 11.12 6.56e-1 0.01 0.54 9.79e-1 0.00 
Isthmuscingulate R 552 -7.79 11.49 4.98e-1 -1.09 0.55 4.94e-2 -0.08 
          Insula L 552 34.15 17.82 5.63e-2 -1.11 0.85 1.92e-1 -0.06 
Insula R 550 41.63 17.85 2.04e-2 -0.34 0.85 6.89e-1 -0.02 
          Accumbens L 552 -7.45 3.31 2.50e-2 -0.02 0.16 9.17e-1 0.00 
Accumbens R 552 -3.08 2.75 2.64e-1 -0.02 0.13 8.65e-1 -0.01 
Amygdala L 554 0.48 5.31 9.28e-1 0.11 0.26 6.72e-1 0.02 
Amygdala R 551 -9.14 5.68 1.09e-1 0.32 0.27 2.41e-1 0.05 
Caudate L 550 16.36 12.14 1.81e-1 -0.16 0.50 7.43e-1 -0.01 
Caudate R 545 5.17 12.84 6.88e-1 -0.12 0.53 8.19e-1 -0.01 
Hippocampus L 552 20.10 10.35 5.37e-2 0.09 0.47 8.53e-1 0.01 
Hippocampus R 552 10.20 10.12 3.15e-1 0.18 0.45 6.93e-1 0.02 
Pallidum L 552 8.87 5.54 1.11e-1 -0.21 0.26 4.23e-1 -0.03 
Pallidum R 550 -0.47 3.82 9.02e-1 0.10 0.18 5.65e-1 0.02 
Putamen L 553 4.94 16.99 7.72e-1 0.29 0.74 7.02e-1 0.02 
Putamen R 550 -0.29 15.05 9.85e-1 0.01 0.67 9.86e-1 0.00 
Thalamus L 548 0.50 14.71 9.73e-1 0.71 0.70 3.12e-1 0.04 
Thalamus R 554 20.37 13.24 1.26e-1 1.47 0.60 1.42e-2 0.10 
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Supplementary Table 6-6. Association between intensity ratings of PROP and 
brain volumes adjusted for TAS2R38 genotype. Significant associations are 
bold. Interval is the time interval between taste test and brain scan. Taste is 
the perceived intensity ratings of PROP solutions. r is the correlation 
coefficient between taste and brain phenotypes. L and R indicate the volume is 
extracted for left and right hemisphere respectively. 
Region of interest 
 
n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 527 -44.48 54.30 4.14e-1 5.11 3.45 1.39e-1 0.06 
Superiorfrontal R 527 -63.82 51.60 2.17e-1 3.87 3.36 2.50e-1 0.05 
Rostralmiddlefrontal L 526 -112.89 47.67 1.84e-2 0.23 3.13 9.42e-1 0.00 
Rostralmiddlefrontal R 524 -72.23 47.84 1.32e-1 -2.93 3.11 3.46e-1 -0.04 
Caudalmiddlefrontal L 527 -8.47 30.90 7.84e-1 -1.52 2.02 4.53e-1 -0.03 
Caudalmiddlefrontal R 527 -1.75 31.12 9.55e-1 0.28 2.11 8.94e-1 0.01 
Parsopercularis L 529 -35.27 22.84 1.24e-1 1.10 1.51 4.66e-1 0.03 
Parsopercularis R 526 -3.71 16.66 8.24e-1 0.89 1.13 4.30e-1 0.03 
Parstriangularis L 527 -6.47 16.57 6.96e-1 1.03 1.11 3.55e-1 0.04 
Parstriangularis R 528 4.54 20.46 8.24e-1 0.99 1.40 4.77e-1 0.03 
Parsorbitalis L 528 5.80 9.10 5.25e-1 -0.79 0.61 2.01e-1 -0.06 
Parsorbitalis R 529 -0.26 11.13 9.81e-1 1.59 0.74 3.24e-2 0.09 
Lateralorbitofrontal L 527 18.90 21.76 3.86e-1 -0.45 1.42 7.53e-1 -0.01 
Lateralorbitofrontal R 528 -10.89 20.19 5.90e-1 0.50 1.34 7.09e-1 0.02 
Medialorbitofrontal L 529 -30.94 18.49 9.52e-2 0.67 1.23 5.84e-1 0.02 
Medialorbitofrontal R 528 20.72 16.90 2.21e-1 1.40 1.14 2.20e-1 0.05 
Precentral L 524 -25.64 36.84 4.87e-1 0.82 2.34 7.28e-1 0.01 
Precentral R 522 -42.07 36.59 2.51e-1 -0.04 2.43 9.87e-1 0.00 
Paracentral L 525 -19.99 14.80 1.78e-1 -0.17 0.99 8.60e-1 -0.01 
Paracentral R 524 -38.26 18.17 3.60e-2 -0.18 1.18 8.80e-1 -0.01 
Frontalpole L 528 -0.72 5.18 8.90e-1 -0.03 0.35 9.33e-1 0.00 
Frontalpole R 528 3.35 6.07 5.81e-1 0.20 0.41 6.18e-1 0.02 
          Superiorparietal L 526 -17.21 38.01 6.51e-1 3.02 2.45 2.18e-1 0.05 
Superiorparietal R 525 -0.57 39.64 9.89e-1 3.76 2.58 1.47e-1 0.06 
Inferiorparietal L 526 -49.18 42.37 2.47e-1 -2.07 2.75 4.52e-1 -0.03 
Inferiorparietal R 529 -52.02 49.27 2.92e-1 1.00 3.23 7.57e-1 0.01 
Supramarginal L 520 13.60 38.42 7.24e-1 2.63 2.47 2.87e-1 0.04 
Supramarginal R 519 -6.83 38.06 8.58e-1 -1.72 2.48 4.89e-1 -0.03 
Postcentral L 525 -26.18 30.44 3.90e-1 0.06 1.98 9.75e-1 0.00 
Postcentral R 523 22.55 32.42 4.87e-1 -0.73 2.13 7.32e-1 -0.01 
Precuneus L 525 7.22 26.10 7.82e-1 0.46 1.69 7.86e-1 0.01 
Precuneus R 525 -7.74 27.16 7.76e-1 1.27 1.75 4.69e-1 0.03 
          Lateraloccipital L 527 15.07 35.07 6.68e-1 -0.72 2.25 7.49e-1 -0.01 
Lateraloccipital R 528 32.17 38.89 4.09e-1 1.02 2.53 6.88e-1 0.02 
Lingual L 526 -28.09 25.77 2.77e-1 -1.05 1.66 5.25e-1 -0.03 
Lingual R 527 -12.43 23.59 5.99e-1 -2.82 1.51 6.34e-2 -0.08 
Cuneus L 527 9.52 13.05 4.67e-1 0.49 0.83 5.53e-1 0.03 
Cuneus R 526 4.50 13.37 7.37e-1 1.35 0.87 1.22e-1 0.07 
Pericalcarine L 527 2.59 11.19 8.18e-1 0.16 0.69 8.18e-1 0.01 
Pericalcarine R 530 14.96 12.03 2.15e-1 0.86 0.72 2.33e-1 0.05 
          Superiortemporal L 529 89.45 37.78 1.87e-2 2.96 2.39 2.17e-1 0.05 
Superiortemporal R 526 21.70 34.12 5.25e-1 -1.89 2.20 3.91e-1 -0.04 
Middletemporal L 529 72.63 43.34 9.51e-2 -2.61 2.71 3.37e-1 -0.04 
Middletemporal R 529 32.00 41.59 4.42e-1 0.36 2.68 8.93e-1 0.01 
Inferiortemporal L 528 6.49 37.75 8.64e-1 0.98 2.45 6.90e-1 0.02 
Inferiortemporal R 528 113.34 39.21 4.20e-3 1.93 2.47 4.36e-1 0.03 
Bankssts L 528 -10.03 11.68 3.91e-1 -0.30 0.80 7.02e-1 -0.02 
Bankssts R 527 -11.61 10.63 2.76e-1 -0.80 0.72 2.72e-1 -0.05 
Fusiform L 523 -10.36 26.62 6.97e-1 2.64 1.81 1.46e-1 0.06 
Fusiform R 527 5.60 27.93 8.41e-1 -0.61 1.87 7.43e-1 -0.01 
Transversetemporal L 527 7.54 6.08 2.16e-1 0.82 0.41 4.70e-2 0.08 
Transversetemporal R 527 4.29 4.75 3.67e-1 0.59 0.32 6.61e-2 0.08 
Entorhinal L 526 8.78 8.69 3.13e-1 -1.03 0.59 8.27e-2 -0.07 
Entorhinal R 524 30.04 10.72 5.41e-3 -1.09 0.70 1.19e-1 -0.06 
Temporalpole L 529 60.33 13.48 1.04e-5 -0.39 0.89 6.62e-1 -0.02 
Temporalpole R 526 36.82 13.62 7.22e-3 0.10 0.90 9.13e-1 0.00 
Parahippocampal L 525 -11.44 8.80 1.94e-1 -0.52 0.58 3.75e-1 -0.04 
Parahippocampal R 526 10.00 7.89 2.06e-1 0.16 0.51 7.49e-1 0.01 
          Rostralanteriorcingulate L 528 -16.11 13.49 2.33e-1 0.09 0.90 9.25e-1 0.00 
Rostralanteriorcingulate R 527 -8.78 13.24 5.08e-1 0.01 0.89 9.95e-1 0.00 
Caudalanteriorcingulate L 526 -3.26 13.19 8.05e-1 -0.54 0.89 5.48e-1 -0.03 
Caudalanteriorcingulate R 528 0.21 15.37 9.89e-1 0.34 1.03 7.40e-1 0.01 
Posteriorcingulate L 528 -1.14 14.01 9.35e-1 -0.42 0.92 6.47e-1 -0.02 
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Posteriorcingulate R 526 -7.12 13.68 6.03e-1 -0.56 0.89 5.32e-1 -0.03 
Isthmuscingulate L 527 -3.29 11.29 7.71e-1 -0.22 0.74 7.65e-1 -0.01 
Isthmuscingulate R 526 -6.21 11.60 5.93e-1 -1.04 0.75 1.66e-1 -0.06 
          Insula L 526 35.67 18.02 4.88e-2 -0.59 1.15 6.08e-1 -0.02 
Insula R 524 42.01 18.04 2.06e-2 -0.41 1.16 7.24e-1 -0.02 
          Accumbens L 526 -7.63 3.33 2.25e-2 -0.20 0.22 3.63e-1 -0.04 
Accumbens R 526 -2.68 2.79 3.37e-1 -0.05 0.18 7.67e-1 -0.01 
Amygdala L 528 -0.17 5.38 9.74e-1 0.00 0.35 9.95e-1 0.00 
Amygdala R 525 -9.27 5.73 1.07e-1 0.03 0.37 9.42e-1 0.00 
Caudate L 524 15.86 12.32 2.01e-1 0.06 0.65 9.24e-1 0.00 
Caudate R 521 4.83 13.14 7.14e-1 -0.96 0.72 1.87e-1 -0.05 
Hippocampus L 527 20.98 10.51 4.74e-2 -0.16 0.64 7.98e-1 -0.01 
Hippocampus R 526 10.37 10.21 3.11e-1 0.14 0.61 8.20e-1 0.01 
Pallidum L 526 9.17 5.54 9.92e-2 -0.47 0.35 1.81e-1 -0.06 
Pallidum R 524 -0.51 3.83 8.93e-1 -0.02 0.24 9.36e-1 0.00 
Putamen L 528 4.16 17.23 8.10e-1 -0.10 0.99 9.22e-1 0.00 
Putamen R 526 5.09 15.28 7.40e-1 -0.15 0.90 8.66e-1 -0.01 
Thalamus L 523 0.77 14.52 9.58e-1 0.96 0.94 3.09e-1 0.05 
Thalamus R 528 18.86 13.21 1.55e-1 1.89 0.79 1.86e-2 0.10 
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Supplementary Table 6-7. Association between intensity ratings of quinine and 
brain volumes in Human Connectome Project (HCP). Significant associations 
are bold. Interval is the time interval between taste test and brain scan. Taste 
is the perceived intensity ratings of quinine solutions (‘Taste_Unadj’ in HCP). r 
is the correlation coefficient between taste and brain phenotypes. L and R 
indicate the volume is extracted for left and right hemisphere respectively. 
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Supplementary Table 6-8. Association between intensity ratings of sucrose 
octaacetate and brain volumes. Significant associations are bold. Interval is 
the time interval between taste test and brain scan. Taste is the perceived 
intensity ratings of sucrose octaacetate solutions. r is the correlation 
coefficient between taste and brain phenotypes. L and R indicate the volume is 
extracted for left and right hemisphere respectively. 
Region of interest 
 
n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 555 -65.07 53.76 2.27e-1 -4.37 3.27 1.83e-1 -0.06 
Superiorfrontal R 555 -76.85 51.20 1.34e-1 -4.12 3.16 1.93e-1 -0.05 
Rostralmiddlefrontal L 554 -113.89 47.01 1.59e-2 -1.00 2.96 7.35e-1 -0.01 
Rostralmiddlefrontal R 552 -74.85 47.17 1.14e-1 -2.10 2.90 4.70e-1 -0.03 
Caudalmiddlefrontal L 555 -7.54 30.89 8.07e-1 -0.05 1.92 9.81e-1 0.00 
Caudalmiddlefrontal R 555 -4.51 30.69 8.83e-1 -0.96 2.01 6.34e-1 -0.02 
Parsopercularis L 557 -33.18 22.92 1.49e-1 -0.76 1.45 6.02e-1 -0.02 
Parsopercularis R 554 -4.99 16.74 7.66e-1 0.49 1.09 6.53e-1 0.02 
Parstriangularis L 555 -6.77 16.58 6.83e-1 -0.87 1.07 4.17e-1 -0.03 
Parstriangularis R 556 7.62 20.42 7.09e-1 1.14 1.33 3.92e-1 0.04 
Parsorbitalis L 556 5.61 8.98 5.32e-1 -0.35 0.58 5.45e-1 -0.03 
Parsorbitalis R 557 -2.98 11.11 7.88e-1 0.32 0.71 6.48e-1 0.02 
Lateralorbitofrontal L 555 18.13 21.64 4.03e-1 -1.87 1.35 1.67e-1 -0.06 
Lateralorbitofrontal R 556 -13.11 19.95 5.12e-1 -0.79 1.28 5.35e-1 -0.03 
Medialorbitofrontal L 557 -31.28 18.30 8.82e-2 1.02 1.16 3.81e-1 0.04 
Medialorbitofrontal R 556 18.75 16.71 2.62e-1 0.00 1.09 9.96e-1 0.00 
Precentral L 552 -34.23 36.51 3.49e-1 -2.93 2.22 1.88e-1 -0.05 
Precentral R 550 -51.34 36.32 1.58e-1 -4.45 2.30 5.41e-2 -0.08 
Paracentral L 553 -24.05 14.65 1.01e-1 -1.61 0.94 8.84e-2 -0.07 
Paracentral R 552 -39.77 17.77 2.58e-2 -1.45 1.13 2.00e-1 -0.05 
Frontalpole L 556 0.14 5.08 9.77e-1 -0.12 0.33 7.16e-1 -0.02 
Frontalpole R 556 3.29 5.99 5.83e-1 -0.04 0.39 9.26e-1 0.00 
          Superiorparietal L 554 -20.57 37.84 5.87e-1 -1.61 2.31 4.88e-1 -0.03 
Superiorparietal R 553 -9.25 39.18 8.14e-1 -1.89 2.45 4.41e-1 -0.03 
Inferiorparietal L 554 -38.52 42.19 3.62e-1 1.26 2.61 6.30e-1 0.02 
Inferiorparietal R 557 -59.27 48.53 2.23e-1 -1.63 3.04 5.92e-1 -0.02 
Supramarginal L 548 6.49 37.78 8.64e-1 0.31 2.33 8.94e-1 0.01 
Supramarginal R 546 0.82 37.66 9.83e-1 0.82 2.34 7.27e-1 0.01 
Postcentral L 552 -32.13 29.98 2.85e-1 -4.04 1.87 3.13e-2 -0.09 
Postcentral R 550 24.20 31.79 4.47e-1 1.14 2.02 5.72e-1 0.02 
Precuneus L 553 9.06 25.96 7.27e-1 -0.53 1.61 7.40e-1 -0.01 
Precuneus R 554 -5.53 27.75 8.42e-1 1.03 1.69 5.42e-1 0.03 
          Lateraloccipital L 555 -2.57 34.60 9.41e-1 -1.95 2.14 3.63e-1 -0.04 
Lateraloccipital R 556 17.99 38.44 6.40e-1 -0.95 2.38 6.89e-1 -0.02 
Lingual L 554 -30.49 25.50 2.33e-1 -0.69 1.57 6.63e-1 -0.02 
Lingual R 555 -12.26 23.84 6.07e-1 -0.26 1.46 8.58e-1 -0.01 
Cuneus L 555 7.23 12.89 5.75e-1 0.88 0.78 2.59e-1 0.05 
Cuneus R 554 2.61 13.23 8.44e-1 0.51 0.82 5.33e-1 0.03 
Pericalcarine L 555 3.07 11.05 7.81e-1 0.85 0.64 1.84e-1 0.05 
Pericalcarine R 558 13.11 11.80 2.68e-1 -0.23 0.67 7.33e-1 -0.01 
          Superiortemporal L 557 84.26 37.44 2.53e-2 0.01 2.26 9.96e-1 0.00 
Superiortemporal R 554 17.83 34.10 6.01e-1 -0.94 2.09 6.54e-1 -0.02 
Middletemporal L 557 81.75 43.00 5.85e-2 1.15 2.56 6.54e-1 0.02 
Middletemporal R 556 48.18 40.79 2.39e-1 2.05 2.51 4.15e-1 0.03 
Inferiortemporal L 556 0.89 37.35 9.81e-1 2.41 2.31 2.98e-1 0.04 
Inferiortemporal R 556 119.07 38.45 2.14e-3 4.86 2.37 4.14e-2 0.08 
Bankssts L 556 -10.27 11.53 3.74e-1 -0.06 0.75 9.37e-1 0.00 
Bankssts R 555 -9.57 10.47 3.61e-1 1.85 0.69 7.75e-3 0.11 
Fusiform L 550 -8.45 26.56 7.50e-1 2.96 1.74 8.99e-2 0.07 
Fusiform R 555 5.89 27.65 8.31e-1 1.85 1.77 2.95e-1 0.04 
Transversetemporal L 555 8.35 5.97 1.63e-1 1.38 0.39 4.71e-4 0.14 
Transversetemporal R 555 3.64 4.70 4.40e-1 0.11 0.30 7.17e-1 0.02 
Entorhinal L 554 7.68 8.73 3.79e-1 -0.47 0.57 4.09e-1 -0.03 
Entorhinal R 551 28.26 10.51 7.53e-3 -0.48 0.66 4.67e-1 -0.03 
Temporalpole L 557 60.30 13.54 1.15e-5 -0.39 0.86 6.46e-1 -0.02 
Temporalpole R 554 35.36 13.55 9.44e-3 0.83 0.86 3.35e-1 0.04 
Parahippocampal L 552 -13.73 8.77 1.18e-1 -1.01 0.55 6.75e-2 -0.08 
Parahippocampal R 554 9.80 7.87 2.14e-1 0.11 0.49 8.25e-1 0.01 
          Rostralanteriorcingulate L 556 -17.92 13.27 1.78e-1 0.47 0.85 5.82e-1 0.02 
Rostralanteriorcingulate R 555 -13.60 13.05 2.98e-1 -0.53 0.85 5.34e-1 -0.03 
Caudalanteriorcingulate L 553 -0.62 12.93 9.61e-1 0.22 0.84 7.91e-1 0.01 
Caudalanteriorcingulate R 556 -3.01 15.11 8.42e-1 0.21 0.98 8.32e-1 0.01 
Posteriorcingulate L 555 1.76 13.74 8.98e-1 0.75 0.88 3.90e-1 0.04 
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Posteriorcingulate R 554 -9.30 13.26 4.83e-1 -0.45 0.85 5.95e-1 -0.02 
Isthmuscingulate L 554 -5.48 11.07 6.21e-1 -0.71 0.70 3.10e-1 -0.04 
Isthmuscingulate R 554 -4.81 11.56 6.78e-1 -0.19 0.71 7.89e-1 -0.01 
          Insula L 554 33.01 17.91 6.63e-2 -0.48 1.10 6.60e-1 -0.02 
Insula R 552 42.24 17.88 1.88e-2 0.30 1.10 7.85e-1 0.01 
          Accumbens L 550 -2.66 14.72 8.57e-1 -0.01 0.91 9.88e-1 0.00 
Accumbens R 552 -1.94 3.81 6.11e-1 -0.52 0.23 2.66e-2 -0.09 
Amygdala L 556 18.47 13.28 1.66e-1 1.34 0.75 7.60e-2 0.07 
Amygdala R 554 20.89 10.32 4.44e-2 1.18 0.59 4.77e-2 0.08 
Caudate L 552 14.02 12.12 2.50e-1 0.10 0.58 8.60e-1 0.01 
Caudate R 554 10.66 10.12 2.94e-1 0.86 0.56 1.29e-1 0.06 
Hippocampus L 547 3.71 12.82 7.73e-1 -0.27 0.64 6.77e-1 -0.01 
Hippocampus R 556 1.17 5.30 8.25e-1 0.42 0.33 2.05e-1 0.05 
Pallidum L 555 6.15 16.93 7.17e-1 1.92 0.91 3.65e-2 0.08 
Pallidum R 553 -8.50 5.69 1.36e-1 0.55 0.35 1.20e-1 0.06 
Putamen L 552 -1.60 15.05 9.15e-1 0.48 0.83 5.65e-1 0.02 
Putamen R 554 -6.73 3.27 4.04e-2 0.34 0.21 9.67e-2 0.07 
Thalamus L 554 9.89 5.53 7.49e-2 0.52 0.33 1.19e-1 0.06 
Thalamus R 554 -2.48 2.74 3.66e-1 0.22 0.17 1.82e-1 0.05 
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Supplementary Table 6-9. Association between intensity ratings of denatonium 
benzoate and brain volumes. Significant associations are bold. Interval is the 
time interval between taste test and brain scan. Taste is the perceived intensity 
ratings of denatonium benzoate solutions. r is the correlation coefficient 
between taste and brain phenotypes. L and R indicate the volume is extracted 
for left and right hemisphere respectively. 
Region of interest 
 
n 
Beta 
Interval 
SD 
Interval 
P 
Interval 
Beta 
Taste 
SD 
Taste 
P 
Taste 
r 
Taste 
Superiorfrontal L 552 -58.49 53.73 2.77e-1 -2.17 3.04 4.76e-1 -0.03 
Superiorfrontal R 552 -71.87 51.41 1.63e-1 -4.33 2.95 1.44e-1 -0.06 
Rostralmiddlefrontal L 551 -113.42 47.01 1.63e-2 1.32 2.77 6.33e-1 0.02 
Rostralmiddlefrontal R 549 -71.75 47.32 1.30e-1 -1.86 2.72 4.95e-1 -0.03 
Caudalmiddlefrontal L 552 -12.22 30.64 6.90e-1 -1.95 1.78 2.74e-1 -0.05 
Caudalmiddlefrontal R 552 -6.05 30.52 8.43e-1 -3.01 1.87 1.08e-1 -0.07 
Parsopercularis L 554 -34.72 22.97 1.32e-1 -0.66 1.35 6.27e-1 -0.02 
Parsopercularis R 551 -7.82 16.70 6.40e-1 0.23 1.02 8.17e-1 0.01 
Parstriangularis L 552 -4.96 16.53 7.64e-1 0.03 1.00 9.79e-1 0.00 
Parstriangularis R 553 6.58 20.39 7.47e-1 1.03 1.24 4.10e-1 0.04 
Parsorbitalis L 553 6.34 8.96 4.79e-1 -0.08 0.54 8.78e-1 -0.01 
Parsorbitalis R 554 -1.51 11.04 8.91e-1 1.26 0.65 5.45e-2 0.08 
Lateralorbitofrontal L 552 16.98 21.52 4.31e-1 -2.10 1.25 9.39e-2 -0.07 
Lateralorbitofrontal R 553 -14.37 19.90 4.71e-1 -1.70 1.19 1.54e-1 -0.06 
Medialorbitofrontal L 554 -32.66 18.40 7.68e-2 0.38 1.09 7.28e-1 0.01 
Medialorbitofrontal R 553 17.78 16.69 2.87e-1 -0.52 1.02 6.08e-1 -0.02 
Precentral L 549 -30.98 36.17 3.92e-1 -1.52 2.06 4.63e-1 -0.03 
Precentral R 548 -47.24 36.30 1.94e-1 -1.94 2.15 3.69e-1 -0.04 
Paracentral L 550 -22.10 14.69 1.33e-1 -0.94 0.89 2.90e-1 -0.04 
Paracentral R 549 -39.19 17.82 2.85e-2 -0.63 1.05 5.50e-1 -0.02 
Frontalpole L 553 0.07 5.09 9.89e-1 0.09 0.31 7.65e-1 0.01 
Frontalpole R 553 3.45 6.01 5.66e-1 -0.03 0.36 9.35e-1 0.00 
          Superiorparietal L 551 -17.71 37.87 6.40e-1 -2.16 2.16 3.18e-1 -0.04 
Superiorparietal R 550 -2.45 39.26 9.50e-1 0.73 2.30 7.52e-1 0.01 
Inferiorparietal L 551 -40.64 42.23 3.37e-1 3.29 2.42 1.74e-1 0.06 
Inferiorparietal R 554 -55.95 48.22 2.47e-1 -0.55 2.85 8.48e-1 -0.01 
Supramarginal L 545 3.69 37.80 9.22e-1 -2.15 2.17 3.21e-1 -0.04 
Supramarginal R 544 0.49 37.68 9.90e-1 1.07 2.20 6.28e-1 0.02 
Postcentral L 549 -28.41 29.87 3.42e-1 -0.47 1.75 7.90e-1 -0.01 
Postcentral R 547 17.95 31.66 5.71e-1 -1.37 1.88 4.68e-1 -0.03 
Precuneus L 550 11.42 25.88 6.59e-1 1.63 1.50 2.76e-1 0.05 
Precuneus R 551 -4.62 27.66 8.68e-1 -0.09 1.57 9.54e-1 0.00 
          Lateraloccipital L 552 1.81 34.63 9.58e-1 -1.48 2.00 4.62e-1 -0.03 
Lateraloccipital R 553 27.09 38.52 4.83e-1 1.09 2.22 6.22e-1 0.02 
Lingual L 551 -31.02 25.44 2.24e-1 -0.72 1.46 6.24e-1 -0.02 
Lingual R 552 -13.36 23.76 5.74e-1 -1.01 1.35 4.56e-1 -0.03 
Cuneus L 552 7.84 12.96 5.46e-1 0.83 0.73 2.54e-1 0.05 
Cuneus R 551 4.46 13.19 7.35e-1 1.69 0.76 2.77e-2 0.09 
Pericalcarine L 552 2.31 11.08 8.35e-1 0.08 0.59 8.88e-1 0.01 
Pericalcarine R 555 13.70 11.81 2.47e-1 -0.55 0.62 3.77e-1 -0.04 
          Superiortemporal L 554 87.05 37.51 2.11e-2 0.79 2.10 7.05e-1 0.02 
Superiortemporal R 551 20.09 33.96 5.55e-1 -0.41 1.94 8.32e-1 -0.01 
Middletemporal L 554 77.43 43.03 7.32e-2 -0.34 2.37 8.87e-1 -0.01 
Middletemporal R 553 42.73 40.66 2.94e-1 1.32 2.33 5.72e-1 0.02 
Inferiortemporal L 553 -3.08 37.37 9.34e-1 -0.63 2.15 7.70e-1 -0.01 
Inferiortemporal R 553 112.52 38.26 3.52e-3 1.89 2.22 3.95e-1 0.04 
Bankssts L 553 -10.88 11.55 3.47e-1 -0.99 0.70 1.60e-1 -0.06 
Bankssts R 552 -13.39 10.63 2.08e-1 0.56 0.65 3.90e-1 0.04 
Fusiform L 547 -12.46 26.68 6.41e-1 0.07 1.63 9.66e-1 0.00 
Fusiform R 552 3.13 27.61 9.10e-1 -0.65 1.64 6.94e-1 -0.02 
Transversetemporal L 552 7.86 6.01 1.92e-1 1.17 0.37 1.55e-3 0.13 
Transversetemporal R 552 3.70 4.71 4.33e-1 -0.03 0.28 9.10e-1 0.00 
Entorhinal L 551 7.21 8.66 4.05e-1 -1.57 0.53 2.99e-3 -0.12 
Entorhinal R 548 28.89 10.53 6.41e-3 -0.43 0.61 4.81e-1 -0.03 
Temporalpole L 554 60.01 13.53 1.24e-5 -0.89 0.79 2.61e-1 -0.05 
Temporalpole R 551 34.61 13.49 1.07e-2 -0.38 0.80 6.38e-1 -0.02 
Parahippocampal L 549 -13.51 8.78 1.25e-1 -1.38 0.51 7.43e-3 -0.11 
Parahippocampal R 551 7.94 7.82 3.11e-1 -0.43 0.45 3.45e-1 -0.04 
          Rostralanteriorcingulate L 553 -18.50 13.31 1.65e-1 -0.01 0.79 9.87e-1 0.00 
Rostralanteriorcingulate R 552 -13.04 13.07 3.19e-1 -0.90 0.79 2.57e-1 -0.05 
Caudalanteriorcingulate L 550 -1.29 12.82 9.20e-1 0.55 0.78 4.80e-1 0.03 
Caudalanteriorcingulate R 553 -3.83 15.08 8.00e-1 -0.86 0.91 3.43e-1 -0.04 
Posteriorcingulate L 552 -0.14 13.70 9.92e-1 0.11 0.82 8.91e-1 0.01 
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Posteriorcingulate R 551 -10.23 13.28 4.42e-1 -0.60 0.79 4.48e-1 -0.03 
Isthmuscingulate L 551 -5.21 11.08 6.38e-1 -0.52 0.65 4.22e-1 -0.03 
Isthmuscingulate R 551 -5.71 11.53 6.21e-1 0.06 0.66 9.32e-1 0.00 
          Insula L 551 34.48 17.81 5.39e-2 -1.30 1.02 2.04e-1 -0.05 
Insula R 549 42.04 17.86 1.93e-2 0.04 1.02 9.70e-1 0.00 
          Accumbens L 547 -0.21 14.72 9.89e-1 0.14 0.84 8.72e-1 0.01 
Accumbens R 549 -1.03 3.81 7.86e-1 -0.35 0.21 1.02e-1 -0.07 
Amygdala L 553 18.65 13.28 1.62e-1 0.96 0.69 1.66e-1 0.05 
Amygdala R 551 20.59 10.34 4.79e-2 0.57 0.55 2.99e-1 0.04 
Caudate L 549 15.71 12.10 1.97e-1 -1.15 0.54 3.53e-2 -0.07 
Caudate R 551 10.41 10.11 3.05e-1 0.51 0.52 3.25e-1 0.04 
Hippocampus L 544 4.12 12.79 7.48e-1 -1.52 0.59 1.09e-2 -0.09 
Hippocampus R 553 0.86 5.31 8.71e-1 0.35 0.31 2.53e-1 0.05 
Pallidum L 552 5.56 16.96 7.43e-1 1.29 0.85 1.28e-1 0.06 
Pallidum R 550 -9.67 5.68 8.97e-2 0.07 0.33 8.30e-1 0.01 
Putamen L 549 -0.26 15.05 9.86e-1 0.04 0.77 9.59e-1 0.00 
Putamen R 551 -7.37 3.31 2.67e-2 0.08 0.19 6.65e-1 0.02 
Thalamus L 551 9.11 5.54 1.01e-1 0.04 0.31 8.97e-1 0.01 
Thalamus R 551 -3.06 2.75 2.67e-1 -0.01 0.16 9.29e-1 0.00 
 
 
 
 
